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Abstract 
The high sensitivity and non-invasive sensing capabihties of Raman micro-spectroscopy have 
made this technique an attractive tool for biochemical analysis of cells and tissues. Biochem-
ical characterization via interrogation of molecular vibrations offers several advantages over 
conventional histological, cellular, and molecular techniques, including rapid, non-invasive 
analysis in the absence of fixatives or labels, and compatibility with aqueous biological sys-
tems. Despite these advantages, the vast majority of biological Raman studies involve inva-
sive sample processing (fixation, dehydration), which are liable to produce spectral artefacts. 
The focus of this thesis is specifically on the non-invasive analysis of live cell and tissue sys-
tems using Raman micro-spectroscopy. 
The Raman spectrum of a cell or tissue is a biochemical 'fingerprint', containing molecular-
level information about all cellular and tissue matrix biopolymers. Raman spectral signatures 
have previously been used to characterize cellular phenotype, tissue composition and archi-
tecture, and to monitor cellular processes and tissue development. This thesis demonstrates 
the novel application of Raman micro-spectroscopy to explore: 
• Biochemical differences between cells synchronized in different phases of the cell cycle. 
• Characterisation of primary alveolar epithelial type II (ATII) pneumocyte differentia-
tion in vitro. 
• Biochemical differences between primary ATII cells, cancerous A549 cells and trans-
formed type I-like cells derived from primary ATII cells. 
• Mineralised bone nodule formation in vitro by several cell sources (embryonic and mes-
enchymal stem cells, and mature osteoblasts). Trends in mineralization were identified 
over a 28-day period for a detailed comparative study. 
In each investigation, spectroscopic results were correlated with those obtained using 
gold-standard biological techniques. Qualitative and quantitative chemometric techniques 
were used to process and analyse Raman spectral data, with strong emphasis on multivariate 
analysis techniques to ensure robust and objective data analysis. The work presented herein 
demonstrates the tremendous potential of Raman micro-spectroscopy for the non-invasive 
analysis of live cell and tissue systems. 
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4.10 Spectral modelling of ATII cells with Raman micro-spectroscopy. The mean 
spectrum of the 61 early time point cells (black), the model fit (grey), and the 
residual spectrum (R=0.996) 100 
15 
LIST OF FIGURES 
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B middle (dlO-11), and C late (dl7-18) time point primary ATII cells, D 
A549 and E T T l cells. The dark osmiophilic granules indicate cytoplasmic 
Lbs. Scalebar = 20 /im 112 
5.2 Characterisation of ATII, A549, and TTl cells. A ALP and B pSPC staining 
of cell monolayers. C Western blot of caveolin-1 (a- and /3-isoforms) expression 
from ATII, A549 and TT l cells. HUVEC represents the positive control for 
caveolin-1. Scalebar = 50 ^m 112 
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instrument response, EMSC normalised, baseline-corrected, the wavenumber 
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with an ellipse to designate the region probed by each scan. The spectra are 
offset for clarity. Scalebar = 10 /im 113 
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(spectrum b) and A549 (spectrum c) cell spectra. B The absolute value of the 
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5.7 Factors generated from eigenvector rotation. Factor (a) describes cellular 
phospholipids, and is extremely similar to the spectrum collected from the 
cytoplasm of early culture ATII cells (spectrum a, Figure 5.3, R=0.98). Fac-
tor (b) is a protein spectrum, and demonstrated significant correlation with 
a model protein spectrum generated by least-squares fitting with a basis set 
of protein spectra (R=0.99). Factors have been baseline-corrected and nor-
malised to maximum intensity values, and are offset for clarity. 119 
5.8 Factor score plot. Phospholipid factor scores versus protein factor scores, 
generated by constrained eigenvector rotation. The cell clusters indicate that 
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5.10 Spectral modelling of ATII, A549 and TT l cells with Raman micro-spectroscopy: 
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are offset for clarity. 122 
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Scalebar = 50 /ira 150 
6.3 Histochemical characterisation of bone nodules in dl4 cultures of mES, MOB, 
and mBMSC cells. Top row: light microscope pictures of unstained cultures. 
Middle row: Light microscope pictures of ARS stained cultures. Bottom row: 
microscope images of fluorescence from ARS stained cultures. Scalebar = 200 
/im 152 
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a nodule in MOB culture at dl4. D Raman spectra collected from a nodule 
in mBMSC culture at dl4. In each case, light microscope pictures of the 
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indicated. Scalebar = 20 /um in A, B, C, 50 yum in D 153 
6.5 Histochemical characterisation of bone nodules in d21 cultures of mES, MOB, 
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Chapter 1 
Introduction 
Medical research is increasingly interested in understanding events at the cellular and molec-
ular levels [1]. An accurate understanding of molecular interactions, cellular processes and 
responses to stimuli are of paramount importance in biomedical research areas such as cancer 
research, pharmacology and tissue engineering. Biologists have at their disposal a number of 
powerful techniques to characterise tissues, organoids, populations of cells, single cells and 
even subcellular dynamics. A plethora of immunochemical, molecular biochemical and mi-
croscopy techniques have been developed to study tissue composition, structure, and cellular 
behaviour based on probing of surface markers or intracellular content. Electron microscopy 
(EM) techniques are often used to identify and characterize the morphology and ultrastruc-
ture of tissues, cells and organelles. Tissue composition and architecture can be determined 
with histology, and cellular expression of proteins and genes has been investigated with tech-
niques such as immunofluorescence confocal microscopy, reverse transcriptase polymerase 
chain reaction, flow cytometry, and immunoblotting. 
New developments, such as total internal reflectance microscopy and fluorescence lifetime 
imaging microscopy (FLIM), enable single-molecule imaging, allowing scientists to perform 
biochemical experiments inside living cells [2]. The main drawback of most of these biolog-
ical techniques is that they are invasive, requiring cell fixation, lysis, or extraction, which 
can alter cellular biochemistry or even destroy the biological sample, and therefore, are un-
suitable for studies on hving cells or tissue in situ. Optical and spectroscopic methods, such 
as fluorescence or confocal microscopy, can be applied to the analysis of single living cells, 
but are disadvantaged because they require the introduction of molecular probes, may inter-
fere with cellular dynamics and provide information limited to a small range of subcellular 
components [3]. Many biological research fields would benefit from the development of new 
techniques which permit rapid, non-invasive, in situ monitoring of living cells and tissues. 
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Laser-based Raman micro-spectroscopy presents a rapid, reagent-free and non-invasive 
alternative for the analysis of biological samples. Raman spectroscopy is a class of vibra-
tional spectroscopy which probes the fundamental vibrational modes of the molecules within 
a sample [4]. Thus Raman spectroscopy can provide molecular-level information on the 
composition of biological samples, including cells and tissues [5]. The Raman signal is based 
on the scattering of light, and unlike conventional biochemical assays, does not require the 
use of fixatives, labels, or stains. Raman spectroscopy is uniquely suited to the analysis of 
hydrated or aqueous samples, as the weak Raman scattering of water interferes only min-
imally with Raman signals. For biomedical applications, this gives Raman spectroscopy a 
significant advantage over infrared (IR) absorption spectroscopy, the more commonly known 
class of vibrational spectroscopy, because the strong absorption of water obscures IR spectra 
(due to differences in selection rules between IR and Raman). Furthermore, the coupling 
of a Raman spectrometer to an optical microscope, known as Raman micro-spectroscopy, 
enhances spatial resolution by facilitating the collection of spectra from microscopic volumes 
(potentially < 1/im^), thus enabling the analysis of micro-scale features of biological samples 
[6]. 
1.1 Mot iva t ion 
Considering the manifold benefits afforded by modern Raman micro-spectroscopy — rapidity, 
sensitivity, non-invasive sensing, excellent spatial resolution, high information content, and 
minimal sample preparation, it is not surprising that biomedical applications of Raman 
spectroscopy have blossomed in the past two decades. What is however surprising, is that 
since Puppels et al. first demonstrated that Raman micro-spectroscopy with near infrared 
(NIR) laser excitation could be used to non-invasively analyse single living cells in vitro in the 
absence of fixatives and labels [7], the vast majority of Raman-based biological studies have 
involved the analysis of cell and tissue samples which have undergone (potentially) invasive 
sample preparation, such as fixation [8] and/or dehydration [9]. The use of fixatives to 
preserve biological samples is usually done to prevent bacterial growth and to prevent changes 
in cellular conditions (cell cycle, metabolism, death, etc.) during spectral acquisition, which 
may be relevant if the cellular process under investigation occurs on a time scale much shorter 
than that required for data collection. Also, tissue samples must be fixed and sectioned to 
study sub-surface features if a confocal microscope is not used, or if analyzing regions below 
the maximum penetration depth afforded by a confocal microscope. However, biological 
fixatives are invasive and require additional sample preparation, thereby negating the two 
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most attractive advantages of Raman spectroscopy. Fixation, dehydration and sectioning 
of samples also rely on the assumption that the various processing steps do not alter the 
biochemical properties of the sample. 
There is some debate as to how well biological fixatives preserve the biochemical com-
position and structure of cells and tissues, and the influence these have on spectroscopic 
measurements. Some evidence has been presented which indicates that invasive sample pro-
cessing can lead to degradation of signal quality [10], and more importantly can introduce 
spectral artefacts [11, 12]. The influence of fixation and dehydration (by desiccation) on 
single-cell Raman spectra are illustrated in Figure 1.1, which includes the mean spectra of 
four measurements collected from different locations within a single cell in live cell culture, 
along with spectra from identical locations in the same cell after fixation and desiccation. 
The theory and background of Raman scattering is discussed later in the current chapter, 
while the experimental methods used to collect and process these cellular Raman spectra will 
be described in detail in Chapter 2. It is clear from Figure 1.1 that fixation and desiccation 
influence cellular biochemistry — otherwise, the mean spectra of the live, fixed, and dried cell 
would be coincident, with only minimal variation between them. The effects are more severe 
for desiccation, which distorts Raman bands describing all cellular biopolymers, especially 
proteins. While the effects of fixation are less detrimental, distinct biochemical changes in 
the secondary structure of proteins in the fixed cell can be detected. Similar results were 
obtained in several other cells when analysed under similar conditions. Such artefacts could 
confound qualitative and quantitative analysis, generating spurious results in experiments 
involving invasively processed samples. 
1.2 Scope of t h e thesis 
The objective of this research is to develop novel biological applications of Raman micro-
spectroscopy, by focusing on the analysis of live cell culture systems. Taking full advantage 
of the high sensitivity and non-invasive sensing capabilities of this versatile technology avoids 
biochemical perturbations and artefacts associated with invasive sample processing methods. 
The research presented here builds directly on the work of previous members of our 
research group. The Bio-Raman group was founded by Professor Larry Hench and Dr loan 
Notingher in 2002. The early research by Notingher et al. focused on optimization of 
a Raman micro-spectroscopy system for the non-invasive analysis of single living cells in 
vitro [13], including suitable laser wavelength (s) and power (s), and the development of a 
basic Matlab software toolbox for processing and analysis of Raman spectra. After initial 
28 
Chapter 1: Introduct ion 
600 800 1000 1200 
Raman shift (cm' ) 
1400 
- 1 \ 
1600 1800 
Figure 1.1: Effects of fixation and desiccation on the mean Raman spectrum of a single cell. A Mean 
spectra were computed from four (1-4) separate measurements collected from the same sites in the live, fixed, 
and desiccated cell. Light microscope pictures of the cell in B live cell culture, and after C fixation and D 
desiccation. Scalebar = 10 //m. 
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proof-of-concept studies, Notingher et al. successfully applied Raman micro-spectroscopy 
to investigate cell death [14], differentiation [15], phenotype discrimination [16], and as 
a biosensor to study cellular responses to toxic chemical agents. Owen et al. [17] further 
investigated Raman sampling methods, suitable cell culture substrates for Raman analysis, 
and studied the effects of prolonged exposure of high power near NIR lasers on single living 
cells in culture. In addition, Owen et al. expanded on biosensor applications of Raman micro-
spectroscopy, by characterising the effects of anti-cancer pharmaceuticals on live cancer cells 
[18]. More recently, Jell et al. explored tissue engineering applications of Raman micro-
spectroscopy, by investigating the enhanced differentiation of foetal osteoblasts with the 
dissolution products of a commercially available bioglass material [19]. 
In this thesis, Raman micro-spectroscopy was used to investigate the intricate dynamics 
of the cell cycle; the clearance of surfactant during in vitro differentiation of primary pul-
monary alveolar type II epithelial cells; for spectral phenotyping of primary lung cells and 
model lung cell lines; and to compare the in vitro osteogenic potential of several murine 
cell sources (osteoblasts, embryonic and mesenchymal stem cells). These cellular systems 
play important roles in cancer research, pharmaceutical development, respiratory cell and 
molecular biology, (stem) cell-based therapies and tissue engineering. Digital signal pro-
cessing (DSP) filters and multivariate statistical analysis techniques were applied to extract 
important biochemical information from complex, high-dimensional spectral data sets. Data 
interpretation with respect to underlying biological processes {e.g. cell cycle, cellular dif-
ferentiation, bio-mineralisation) was facilitated by correlating spectral results with those 
obtained in parallel experiments with gold-standard biological techniques. These innovative 
applications demonstrate the potential of Raman micro-spectroscopy as a powerful tool for 
the rapid, non-invasive analysis of live cell culture systems. 
1.3 Overview 
The remainder of Chapter 1 provides a background review of the origin and development of 
Raman micro-spectroscopy, along with its applications in biomedical research. The relevant 
methodologies for Raman micro-spectroscopy, signal processing and multivariate statistical 
analysis of spectral data generated by the experiments herein are discussed in Chapter 2. 
Chapters 3-6 discuss the main experimental results, and also include application-specific 
literature reviews, experimental methodologies, and suggestions for future work. Final con-
clusions and a general overview of potential future developments are presented in Chapter 7. 
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1.4 Background 
1.4.1 R a m a n scatter ing 
The Raman effect is a fundamental process based on the interaction of light and matter, and 
was discovered by C.V. Raman in 1928 [20]. When a beam of monochromatic light [e.g. 
a laser beam) illuminates a substance, some of the light is transmitted, some is absorbed, 
and some is scattered. Scattering arises when electrons in the molecules of the substance 
oscillate with the incident electromagnetic wave. The oscillating molecules absorb the energy 
of incident photons and are promoted from the ground state to higher energy level, a 'virtual' 
state. The virtual state is not a stationary energy state of the molecule in the quantum-
mechanical sense; rather it is a distortion of the electron distribution of a covalent bond. 
Because they are unstable at this virtual state, molecules immediately relax back to the 
original electronic state by emitting a photon, which is observed as scattered radiation. Hence 
scattering is an incoherent, two-photon process. The major portion of the re-radiated light is 
Rayleigh scattered light, which has the same frequency as the incident light, and is also called 
elastic scattering. In this case, the molecule returns to its original vibrational energy level, 
and no energy is transferred to the molecule. A small fraction of the scattered light, however, 
is shifted in frequency from the incident light due to the transfer of some incident light energy 
to the molecules (or vice versa) during the electron oscillation. This is what is known as 
inelastic or Raman scattering, and the energy differences between incident and scattered 
photons correspond to the specific vibrational (or rotational) energies of chemical bonds of 
the scattering molecules. Stokes Raman scattering occurs when the scattered photon has less 
energy than the incident photon, while the opposite case corresponds to anti-Stokes Raman 
scattering. Energy level diagrams describing Rayleigh and Raman scattering are included in 
Figure 1.2. The energy of the incident photon with wavelength Aq is defined as 
EQ = hvQ = — , 
where i/Q is the frequency of the laser beam, h is Plank's constant (6.62 x 10"^^ erg • s), and 
c is the speed of light (3 x 10® m/s). The frequency of the Stokes and anti-Stokes Raman 
scattered photons are denoted by z/g and z/as, respectively. 
The change in energy between the incident photon and the (Stokes) Raman scattered 
photon, AE, is given by 
A £ = h{VQ — l/g), 
and corresponds to the energy of a molecular vibration [21]. 
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Figure 1.2; Energy level diagrams showing Rayleigh, Stokes, and anti-Stokes Raman scattering with energy 
of incident and scattered photons indicated for each process. Eo and E i correspond to electronic states and 
i/Q, ui, V2 correspond to vibrational energy levels within electronic states. 
In Stokes Raman scattering, the molecule is in the lowest vibrational energy level before 
interaction with the incident photon, and returns to a higher vibrational energy level after 
the interaction. By contrast, in anti-Stokes Raman scattering, the molecule is in a higher 
vibrational energy level before the interaction and then returns to a lower level after trans-
ferring some energy from the incident photon. The intensity of Stokes Raman scattering is 
usually much higher than that of anti-Stokes Raman scattering, because at thermal equi-
librium the number of molecules in a lower vibrational energy level is always higher than 
the number of molecules in the next higher vibrational energy level. For this reason. Stokes 
Raman scattering is most often used in measurements. More comprehensive coverage of the 
theory of Raman spectroscopy can be found elsewhere [22]. 
Not all vibrations of a molecule will generate Raman scattering. A molecular vibration 
for which the Raman scattering intensity is zero is called Raman inactive or forbidden. Vi-
brations that are not Raman inactive are called Raman active, or allowed. Raman selection 
rules specify what types of vibrational transitions are allowed for a molecule of a particular 
symmetry group. In general, Raman active vibrations are those for which excitation of the 
vibration produces a change in polarizabihty of the electron cloud of a molecule [23]. In 
contrast, vibrations are active in IR spectroscopy if the vibration produces a change in the 
dipole moment of a molecule. Thus polar molecules tend to absorb strongly in the IR but 
produce weak Raman scattering, while non-polar molecules tend to be weak IR absorbers 
but strong Raman scatterers. Vibrational selection rules are the reason why water (a polar 
molecule) is a strong absorber of IR radiation but a weak Raman scatterer. Molecular sym-
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metry calculations can be used to generate character tables which can be used to determine 
whether or not a given molecular vibration is Raman active or inactive [24]. 
A Raman spectrometer is a device which collects Raman scattered light and analyses 
it with respect to its component frequencies. Many different variations in geometry and 
components are in common use, depending on spectrometer type (Fourier Transform (FT) 
Raman versus dispersive) and observation angles (usually 90° right-angle scattering or 180° 
backscattering) from which the Raman scattered light is collected, but the main components 
include: laser (monochromatic excitation source), collection optics, wavelength analyzer, 
detector and computer Figure 1.3 [4]. The collection optics include a laser rejection filter, 
also often called a notch filter, to filter out Rayleigh scattered light, which is often orders 
of magnitude more intense than Raman scattered light. The information collected by the 
spectrometer is then stored and manipulated on a computer, which is also often used to 
control spectrometer parameters and settings via custom-designed software. Data describing 
Raman scattering from a sample is usually displayed as a plot of Raman scattering intensity 
versus wavelength, and is called a Raman spectrum. Since each molecular species has its own 
unique set of molecular vibrations, the Raman spectrum of a particular species will consist 
of a series of peaks/bands, each shifted by one of the characteristic vibrational frequencies 
of the molecule. The traditional units for the x-axis of a Raman spectrum are 'wavenumbers 
of shift from the exciting wavelength', or simply 'Raman shift'. Wavenumber is simply the 
reciprocal of wavelength when the wavelength is expressed in centimeters {i.e. the number 
of waves per centimeter). The x-axis of a Raman spectrum, then, is the difference between 
the excitation wavelength and the Raman wavelength expressed in wavenumbers (w). The 
Raman shift of a given vibration is a measure of the energy of that vibration. As such, it is 
independent of the laser excitation wavelength used. Thus, the positions of peaks along the 
z-axis of the Raman spectrum of a given material do not change with different excitation 
wavelength. However, the excitation frequency does influence the Raman scattering intensity, 
which is addressed in the following section. 
1.4.2 R a m a n intensi ty 
Full classical and quantum mechanical models of Raman scattering can be found in [22]. 
These models can be used to derive complex expressions for the Raman scattering intensity 
[25], which can be condensed into a more readily interpretable form: 
7 = (1.1) 
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Figure 1.3; Generic 90° illumination Raman spectrometer showing main components: laser, collection optics, 
wavelength analyzer, detector and computer. Many variations of geometry and components are in common 
use. Laser rejection filter is often called a notch filter. 
where I is the intensity of the Raman signal, Iq is the intensity of the incident laser light, a is 
the absolute Raman cross-section, P is the sample pathlength, C is the concentration of the 
sample, and if is a constant to account for experimental parameters such as optical collection 
efficiency and optical transmission of the Raman spectrometer [6]. This expression indicates 
that the Raman scattering intensity is proportional to the excitation light intensity and to 
the molecular concentration of the sample. This is the basis for quantitative analysis using 
Raman spectroscopy: doubling the concentration of a sample will (theoretically) double the 
observed Raman scattering intensity. Although it is not obvious from this equation, the 
Raman scattering intensity is also proportional to [4], where VQ is the laser 
excitation frequency and u is the frequency of a molecular vibration, which implies that the 
Raman scattering intensity can be increased by using incident light with a higher frequency 
(shorter wavelength). The Raman scattering cross-section is proportional to the probability 
of an incident photon being scattered as a Raman-shifted photon with a particular Raman 
shift. This is analogous to molar absorptivity from Beer's law encountered in analytical 
chemistry, which is simply a cross section for absorption. Like Raman scattered intensity, 
the Raman scattering cross-section depends on the observation geometry, as well as the 
excitation frequency, so that the Raman scattering cross-section decreases as the wavelength 
of the excitation increases [i.e. as the excitation frequency decreases). 
As mentioned, the vast majority of scattered photons undergo Rayleigh scattering, while 
Raman scattering is a very weak process. In terms of the parameters affecting Raman scat-
tered intensity, the Raman scattering cross-sections of sample molecules are generally orders 
of magnitude weaker than those for the competing processes of absorption and fluorescence. 
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Thus Raman signals are inherently weak, and typically only 1 in 10®-10® photons undergo 
an inelastic light scattering event [21]. Furthermore, Raman scattering occurs in all direc-
tions from the sample, but in practice only the scattered light from sample molecules within 
a relatively small range of solid angle (normally measured in steradians) can be collected, 
which is referred to as the acceptance cone of the spectrometer. These factors meant that 
Raman spectroscopy was not practical until the development of robust laser sources to pro-
vide high illumination intensity, and holographic notch filters to filter the strong Rayleigh 
scattering. Intelligent spectrometer design has enabled researchers to take advantage of the 
fact that the intensity of Raman scattered light is not equivalent in all directions, by using 
optimal collection geometries {e.g. 90° or 180°) [6]. Further, more recent developments 
such as FT-Raman and dispersive Raman spectrometers with charge coupled device (CCD) 
detectors and near infrared (NIR) excitation were required to overcome strong fluorescence 
interference observed from biological samples. A number of special Raman techniques have 
also developed to reduce the fluorescence background and to enhance the inherent weak 
spontaneous Raman signal. 
1.4.3 Enhanced and non-linear R a m a n techniques 
Resonance Raman scattering (RRS) occurs when the excitation laser frequency is coinci-
dent (or near-coincident) with an electronic transition of a molecule. This can result in a 
10^-10® increase in the Raman scattering intensity of vibrations associated with the elec-
tronic chromophore over non-resonance intensities [6]. This dramatic increase in sensitivity 
happens for only a few vibrations of a molecule, giving resonance Raman much greater speci-
ficity than normal spontaneous Raman scattering. RRS has been used to image haemozoin 
within functional erythrocytes [26], and has been implemented with confocal imaging of 
live cells to identify subcellular components responsible for the uptake and metabolism of 
anti-cancer pharmaceuticals within cancer cells [27]. However, visible or ultraviolet light 
excitation is normally required to promote a molecule to a higher electronic energy state 
and thereby achieve resonance. This leads to issues of fluorescence interference and sample 
photo-degradation, which can hinder RRS analysis of biological samples [13]. 
The Raman scattering cross section of a material may be increased by a factor of 10^ 
or more by the presence of metal (normally Au, Ag, or Cu) colloids or a roughened metal 
surface. This effect is called surface-enhanced Raman spectroscopy (SERS) [21]. SERS 
has proven particularly useful for studying intracellular pharmacokinetics [28], for moni-
toring neurotransmitter release by rat neural cells in vitro [29], and as a nano-sensor to 
probe endosomal compartments within living cells [30]. The SERS enhancement can also 
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be combined with a chromophore to effect surface enhanced resonance Raman spectroscopy 
(SERRS), making single molecule Raman spectroscopy possible [31]. However, the chemical 
and electromagnetic effects which contribute to SERS are not fully understood, and the re-
quirements of analyte contact with a SERS substrate undermines one of the primary benefits 
of applied Raman spectroscopy, which is non-invasive, non-contact analysis. Problems with 
stability and reproducibility of SERS substrates also complicate matters, as do decomposi-
tion of sample analytes and chemical/photochemical reaction of the sample with the SERS 
substrate. With respect to SERS analysis of biological samples, the culturing of cells on a 
metal substrate or in a colloidal solution may alter cellular behaviour, and raises the issue of 
biocompatibility: it has previously been shown that uptake of metallic nano-particles by live 
cells in colloidal solution leads to aggregation and compartmentalisation of the nano-particles 
within the cellular cytoplasm — which is common behaviour for cells attempting to destroy 
foreign material [30]. 
Multiple lasers can be used to excite coherent anti-Stokes Raman scattering (CARS), 
a nonlinear optical process. This approach is based on polarisation of the sample by the 
nonlinear mixing of optical fields, where multiple lasers at different frequencies are used to 
excite scattering from higher order vibrational modes [32]. The technique produces a directed 
laser-like signal beam that is many times stronger than spontaneous Raman scattering (~ 
10® signal enhancement). The collection of a coherently-generated anti-Stokes signal (as 
opposed to Stokes signal in spontaneous Raman spectroscopy, RRS and SERS) also avoids 
fluorescence interference, which occurs exclusively on the Stokes side. CARS microscopy is 
a rapid vibrational imaging technique with three-dimensional sectioning capability, and has 
been used to image mitosis and apoptosis in live, unstained cells [33], to study lipid droplet 
organelle transport in live cells [34], differentiation of adipocytes [35] and embryonic stem 
cells [36], and for real-time visualisation of intracellular hydrodynamics [37]. The drawbacks 
of CARS include increased technical complexity, in addition to limited spectral and chemical 
resolution. 
FT-Raman spectroscopy is an alternative experimental approach to the more common 
CCD-based dispersive Raman spectroscopy [38]. Conventional Raman spectroscopy mea-
sures Raman scattered intensity versus frequency, while in FT-Raman a Michelson interfer-
ometer is used to measure the intensity of many wavelengths simultaneously. The Fourier 
transform of the time-domain interferogram is then calculated to produce the frequency-
domain Raman spectrum. While FT-Raman does not provide an increase in Raman scat-
tered intensity, it does provide Raman signal enhancement by suppression of fluorescence 
background often encountered with visible wavelength laser excitation (~300-700 nm). The 
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elimination of fluorescence achieved by excitation with a Nd:YAG laser with 1064 nm excita-
tion is an excellent option for analysis of biological samples prone to fluorescence. FT-Raman 
spectroscopy has previously been used to detect Barrett's epithelium in rat oesophageal tissue 
[39], to differentiate between malignant and normal stomach tissue [40], and to discriminate 
between suspensions of live tumorigenic and non-tumorigenic cells [41]. However, since Ra-
man scattering efficiency is proportional to ~ the use of 1064 nm laser excitation 
results in a significant reduction in Raman scattered intensity {e.g. a factor of 16 to 45 loss 
in scattered intensity compared with 532 nm excitation). The lower sensitivity of FT-Raman 
systems and noisy InGaAs detectors generally translates to long data collection times (typi-
cally 30 minutes) and unsuitable for the analysis of live cell culture systems where speed of 
measurement can be important. 
Additional biological applications of signal-enhanced Raman techniques are highlighted 
in a number of excellent review articles and book chapters (FT-Raman [42], RRS [43], 
SBRS [44], CARS [32, 45]). 
1.4.4 R a m a n spectroscopy 
The experiments discussed in this thesis involve biological applications of non-resonant, spon-
taneous Raman micro-spectroscopy, rather than the enhancement techniques discussed in 
the previous section. The advantages of 'normal' Raman micro-spectroscopy include the 
relatively inexpensive excitation lasers, its compactness, robustness, mobility, user-friendly 
instrumentation due to lower technical complexity, and broadband ability as all vibrational 
modes are excited simultaneously [3]. 
Raman micro-spectroscopy produces a spectrum describing the Raman active vibrations 
of the molecules at a single point (or more accurately, focal region) of a sample. The vi-
brations appear as peaks with characteristic Raman shifts (in cm"^) from the incident laser 
frequency which correspond to the energies of the Raman active molecular vibrations, and 
peak intensities reflect the concentration of molecular species with respect to one another. 
The (mean) Raman spectra of a biological cell included in Figure 1.1 contain several peaks 
which provide molecular-level information about all cellular biolpolymers (nucleic acids, pro-
teins, lipids and carbohydrates). Thus the Raman spectrum of a cell essentially represents a 
unique biochemical fingerprint, and as such, can be used to identify the presence of certain 
biological molecules without any labehng. For example, the sharp, narrow peak at 1003 
cm~^ in the Raman spectra of Figure 1.1 is due to a molecular vibration of the benzene ring 
in the amino acid phenylalanine. Details of the molecular vibrations which correspond to 
other Raman peaks will be discussed later. In general, Raman bands are narrow, typically 
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10-20 cm"^ in width, and in this respect Raman spectroscopy offers higher specificity than 
fluorescence and infrared spectroscopy. The complexity in the Raman spectra of Figure 1.1 
reflects the fact that the cell is a complex biochemical entity, and the presence of several 
broad peaks {e.g. the amide I band of proteins at ~1660 cm"^) indicates significant structural 
heterogeneity of some molecular moieties. 
1.4.5 R a m a n imaging 
A Raman spectrum only yields information about the local composition of a sample. In 
contrast, the aim of Raman imaging is to provide information on the spatial distribution of 
one or more chemical species within a heterogeneous sample. The advantage of Raman micro-
spectroscopy over other optical imaging techniques is the molecular specificity of Raman 
scattering, which can be probed without external markers, dyes, or labels that are usually 
required in radio-isotope and fluorescent imaging. In addition, Raman imaging is suitable 
for imaging hydrated biological samples or those in aqueous solution. 
There are three imaging methodologies which can be used to obtain a spatially resolved 
chemical image using a Raman micro-spectrometer, all of which have been used to construct 
Raman images of biological samples such as cells and tissues. In direct Raman imaging (DRI), 
also known as global or wide-field imaging, the laser beam is expanded to cover the sample 
area of interest, and the scattering of a Raman active vibration from the microscope field of 
view (FOV) is filtered and focused to produce an image directly on the detector [21, 46]. The 
intensity of the signal at a given location within the image is related to the concentration of 
the molecules undergoing the Raman active vibration at that location. The spatial resolution 
of a processed image acquired with DRI can approach the diffraction limit imposed by the 
objective lens and the excitation wavelength, e.g. a spatial resolution of 0.53 jim can be 
achieved with 782 nm excitation and an objective lens of numerical aperture 0.9 [47]. DRI 
has been used to image /3-carotene levels in live corpus luteum cells [48], and to study the 
subcellular distribution of an anti-cancer drug in living breast cancer cells [46]. In principle, 
a Raman image can be collected with DRI in the same time required to collect a Raman 
spectrum at a single point {i.e. focal region), making DRI a potentially fast technique. In 
practice however, de-focusing the laser beam to illuminate an entire FOV drastically reduces 
the intensity at the sample, thereby reducing the Raman scattered intensity. Consequently, 
image acquisition times tend to be quite long in order to excite enough Raman scattering to 
ensure adequate image quality. The other main limitation of DRI is that only a narrow band 
of scattering is detected (possibly only a single wavenumber); therefore chemical resolution 
is restricted, and only a single chemical species can be imaged at any one time. Furthermore, 
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imaging requires special system configuration (tuneable filters for wavelength selection), as 
well as a priori knowledge of the Raman band for the target molecule. 
Alternatively, a serial or scanning imaging technique can be used, whereby an image 
is constructed from several spectra collected at different spatial positions from a sample. 
In Raman micro-spectroscopic mapping, also known as hyperspectral imaging, a grid is 
defined on a microscope FOV, and a full spectrum is collected at each pixel by moving the 
sample with small step increments until the entire FOV has been scanned. Two illumination 
schemes are available for serial Raman imaging, namely point and line focus illumination. 
In point illumination, a dot laser is normally focused to a diffraction-limited spot size (~1 
fim or smaller) and a full Raman spectrum is collected at each point, pixel by pixel by 
moving the sample in a raster pattern with a motorized microscope stage (Figure 1.4A). 
Alternatively, line focus mapping involves illuminating the sample by focusing the laser to 
a line. In this configuration, several spectra are collected per scan, known as a Raman 
transect, and spatial discrimination of spectral information is accomplished by assigning 
scattering signal from different points to different rows of the CCD camera. Thus a single 
Raman transect provides simultaneous acquisition of spectra at many points along a line, 
rather than sequential acquisition of the same data by point mapping. The illumination 
line can then be translated across the sample in a direction perpendicular to the laser line, 
and in this way an image with a spectrum at each pixel can be generated from several 
parallel transects (Figure 1.4B). While individual measurements in serial imaging may boast 
diffraction-limited spatial resolution, the overall spatial resolution of the image is governed by 
the focused laser spot size (or width of a line focus laser) and the accuracy of the motorized 
sample stage. 
The main advantage of serial imaging techniques is that, with a full Raman spectrum 
associated with each pixel, all spectral features can be used to analyse chemical distribu-
tion within a sample. The main disadvantage of serial imaging is the low speed of image 
acquisition. The weakness of the Raman signal means that a relatively long time is required 
for each individual scan, and hence the scanning time for an entire image is considerable, 
e.g. several hours for a 100 x 100 pixel image. In this case, line focus imaging provides a 
much faster recording speed than the point illumination scheme, as spectral data along a full 
spatial dimension can acquired simultaneously. Thus, there is a trade-off between spatial 
resolution, chemical resolution, and measurement time when comparing direct and serial 
imaging techniques. A comprehensive study comparing DRI with both point and line focus 
hyperspectral imaging found that line focus mapping is the fastest method for acquiring 
spectral information at a reasonable spatial resolution (~1 /im) [49]. However, even with 
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Figure 1.4: High spatial resolution serial Raman imaging techniques: A Point and B line focus mapping 
demonstrated for a 25 x 25 grid on an A549 cell in culture. Scale bar = 5 nm. 
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that method, it can take several hours to acquire a Raman image, which is unsuitable for 
the analysis of dynamic living systems [50]. Serial imaging approaches can also be disad-
vantaged by low image fidelity, with point-mapping images degraded by pixilation artefacts 
[51] and line-mapping images by banding [52]. Despite these limitations, hyperspectral Ra-
man imaging is a mature technology with many diverse applications. Point-mapping has 
been used for label-free detection of mitochondrial distribution in fixed HeLa cells [53], to 
identify pyknotic nuclei in oxidatively stressed fibroblasts [3], to image the distribution of 
condensed nuclear chromatin in human cells at different stages of mitosis [54], to image 
protein and DNA distribution in apoptotic cells [55], for elucidation of NADH dynamics 
[56], and to probe cell-biomaterial interactions, namely polymer microsphere degradation 
within fixed macrophages [57]. Line-focus imaging has been used to study the spatial dis-
tribution of phosphate mineral species in mature and newly generated mammalian cortical 
and trabecular bone [58], to identify trends in mineralization during development of mouse 
calvaria [59], to investigate the differences between healthy and diseased [60] or damaged 
bone [52], to study calcium phosphate bone implant coatings [61], and to identify trends 
in mineralization within cultures of mouse calvarial osteoblasts [62]. 
The analysis of single living cells in culture with Raman micro-spectroscopy requires bal-
ancing the trade-off between spatial resolution, chemical resolution, and measurement time. 
Ideally, an approach which maximizes information content while minimizing measurement 
time is desirable — that is, the rapid acquisition of broadband Raman scattering signal from 
an entire cell in the least amount of time. DRI is unsuitable because it provides images of 
limited chemical resolution rather than full Raman bio-molecular fingerprints. Point mea-
surements of single living cells using a dot laser focused to diffraction-limited spot size provide 
high information content, but at such high spatial resolution, point spectra of subcellular 
organelles can be obtained with features dominated by only a single biochemical compo-
nent {e.g. cholesterol [3], phosphatidylchohne [9]). Thus point-to-point measurements may 
exhibit large spectral variation, necessitating the automated collection of hundreds or thou-
sands of spectra to completely characterize a heterogeneous cellular system. However, as 
mentioned, point and line imaging both involve very long measurement times (~1-15 hours 
or more) [3, 54], and are only suitable for fixed and/or dried cells rather than live cell culture 
systems. 
An alternative to mapping/imaging techniques is to use single 'point' Raman micro-
spectroscopy with non-diffraction hmited spatial resolution. By using a laser with a large 
spot size, the scattering signal from a large subcellular region is represented in each Raman 
spectrum, and so only a small number of measurements are required to analyse a cell. One 
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option is to use a de-focused laser with circular beam profile, similar to that used in DRI. 
However, de-focusing the laser substantially reduces the excitation intensity, and hence the 
Raman scattering intensity, thus requiring long measurement times. Our research group has 
developed a dedicated Raman micro-spectroscopic system optimized for the rapid, real-time 
analysis of single living cells [13]. Our approach involves the use of a high power NIR-
785 nm line focus laser with an elliptical beam profile (~10 ^m x 20 fim spot size with a 
x63 water immersion objective) which offers spatial resolution similar to that of diffraction 
limited FTIR micro-spectroscopy [4]. A similar approach could be taken by de-focusing 
a high-power NIR dot laser with a beam expander; however, the severe reduction in laser 
power at the sample would require long measurement times in order to obtain high-fidelity 
Raman signals (our system does not contain a beam expander). With our approach, typical 
data collection time per cell is ~5-10 minutes, depending on the signal integration time and 
the number of spectra required per cell (typically one to five), which in turn depends on cell 
type, size and morphology (Figure 1.5). A previous member of our group, Dr Chris Owen, 
conducted a series of experiments during his PhD and found that even long-term (> 1 hour) 
exposure to the high-power NIR laser on our system did not unduly influence the health 
and viability of live cell culture systems [17]. Spectra from different cellular locations can 
then be ensemble-averaged to produce a representative spectral biochemical fingerprint of 
a cell. Compensation for the sacrifice in spatial resolution is the collection of high-quality 
Raman spectral data from single living cells in only a few minutes. Rapid data acquisition 
minimises possible interference from cellular changes, while simultaneously maximizing the 
number of cells sampled under the same in vitro conditions. Thus, our approach facilitates 
the spectral analysis of a population of living cells in only a fraction of the time required for 
the collection of one high spatial resolution map of a single, fixed cell. Previous applications 
of this approach to analysis of live cell culture systems are discussed later in this chapter. 
1.4.6 Advantages of R a m a n micro-spectroscopy over other techniques 
Biological assays, histology, (immuno-)fluorescence confocal microscopy, reverse transcriptase 
polymerase chain reaction, flow cytometry, immunoblotting, autoradiography, and electron 
microscopy all require invasive processing steps (trypsinization, fixation, staining, etc.) and 
so are unsuitable for studying live cell culture systems in vitro. Some optical and spectro-
scopic techniques, such as fluorescence laser scanning confocal microscopy (LSCM), can be 
used to study single living cells, but require the use of synthetic fluorescent tags in order to 
identify the presence and location of intracellular bio-molecules, as the auto-fluorescence of 
natural fluorophores is often weak and non-specific. These tags, often very large molecules. 
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Figure 1.5: Live cell analysis with a line focus laser with large (non-diffraction limited) spot size (~10 lum 
X 20 /xm, elliptical beam profile). This approach only requires collection of a few spectra to 'map' a cell 
(typically 1 -5 spectra per cell, ^^30-40 second integration time per scan). An A549 cell in live culture is 
shown along with the sites of spectra acquisition (ellipses). Scale bar = 5 /xm. 
may induce undesirable biochemical perturbations and/or pharmacological/toxicological ef-
fects. In addition, such tags only probe a small range of subcellular or membrane-bound 
components, and do not provide complete biochemical characterization of cellular biopoly-
mers. Other problems limiting applications of fluorescence LSCM include sub-optimal la-
beling, photo-damage of samples induced by short-wavelength excitation, and fluorophore 
photon bleaching [5]. 
FTIR spectroscopy and imaging, like their Raman counterparts, are biochemical char-
acterization techniques which provide molecular-level information based on the absorption 
(rather than inelastic scattering in Raman) of electromagnetic radiation by molecules of a 
sample. Since FTIR spectroscopy and imaging are derived from the intrinsic molecular vi-
brational energy levels of a material, no external markers, dyes, or labels are required to char-
acterize biological samples. However, excitation with broadband IR beams for spectroscopy 
or tuned, wavelength-specific beams for imaging generally provide spatial resolution (~10-
20 /im) which is significantly inferior to that offered by diffraction-limited Raman micro-
spectroscopy (~1 yUm). The biggest limitation of FTIR for analysis of biological samples is 
due to the strong absorbance of water throughout the infrared region. Water absorbance 
interferes with IR spectra, and requires artefact inducing correction such as fixation and 
dehydration of samples, or omission of distorted spectral regions. In addition, collection of 
FTIR spectra normally requires very thin samples, which often necessitates invasive micro-
toming of biological samples. Alternatively, attenuated total reflectance (ATR) FTIR can 
be used to analyze sample surface properties. However, this technique requires contact with 
an ATR crystal, which can physically damage delicate biological samples. 
By its very nature as a non-contact optical technique, Raman spectroscopy offers a num-
ber of advantages over conventional biological techniques, including rapid, potentially real-
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time, non-destructive and non-invasive (depending on excitation laser wavelength) analysis 
of biological samples in the absence of fixatives or labels. The weak Raman scattering of 
water interferes only minimally with Raman signals from hydrated or aqueous biological sam-
ples, which offers significant advantages over FTIR vibrational spectroscopy for biomedical 
applications. It is generally accepted that NIR excitation (~700-1064 nm) is required for 
non-invasive analysis of biological samples, as visible wavelength excitation of such samples 
is often plagued by fluorescence, and UV excitation can damage biological samples through 
photo-degradation. The analysis of live systems permits the study of the same biological 
sample at multiple time points, thereby reducing the need for replicate/parallel samples 
commonly used in biological studies. In practice, however, such an approach is technically 
complex, and would require construction of an expensive, environmentally-controlled (tem-
perature and humidity) chamber around the Raman microscope, to ensure sterile and stable 
conditions during measurements and between time points. Because of the obstacles associ-
ated with this approach, virtually all live cell investigations with Raman micro-spectroscopy 
have instead focused on the analysis of separate/parallel replicate samples grown in consis-
tent culture conditions at different time points. This compromise relies on the ubiquitous 
cell biology assumption that similar preparations of cells and/or tissue constructs grow and 
behave similarly in culture. But this approach is not without benefits, as it permits in-
dependent biochemical characterization of the same sample (rather than separate, parallel 
samples for each time point) after Raman analysis, which is invaluable for both validation 
and correlation of Raman spectral results with those obtained using gold standard biological 
techniques. 
1.4.7 Biological applications of R a m a n micro-spectroscopy 
Modern vibrational spectroscopy has developed into a powerful tool for biomedical research. 
The extension of microprobe and fibre optic technologies to spectroscopic imaging, as well 
as improvements in optical filter technology and detector sensitivity, have facilitated the 
widespread application of vibrational spectroscopy to the study of biological samples (pro-
teins, cells and tissues) in the laboratory and chnical settings. Applied Raman spectroscopy, 
in particular, has experienced a "renaissance" in the past two decades, fuelled by significant 
technological advances, and a growing interest in developing practical academic and commer-
cial applications. In this overview, the key developments which paved the way for biological 
Raman micro-spectroscopy are discussed, along with its application to the biochemical anal-
ysis of cells and tissues. More comprehensive coverage of this field can be found in a number 
of excellent review articles [5, 63, 64, 65, 66, 67, 68]. 
44 
C h a p t e r 1: In troduct ion 
Historical development 
Biological applications of vibrational spectroscopy (FTIR and Raman) were first explored in 
the 1960s, as scientists developed methods to interpret the vibrational spectra of biological 
molecules {e.g. proteins, nucleic acids, phosphohpids, carbohydrates), identified character-
istic IR and Raman frequencies of organic compounds, and investigated structure-spectra 
correlation in both IR and Raman spectroscopy [69]. Lasers replaced the mercury arc as 
the source of Raman excitation in the 1960s, providing vastly superior performance and 
ease of use [6]. The advent of Raman micro-spectroscopy in the 1970s enabled the anal-
ysis of micro-scale features of heterogeneous biological samples, with the added benefit of 
correlating molecular chemical information with the structure and morphology of the tissue 
sample producing the Raman spectrum. However, the photo-degradation and overwhelming 
fluorescence encountered with UV and visible lasers, respectively, hindered the analysis of bi-
ological samples with Raman micro-spectroscopy [4]. These issues, along with the weakness 
of the Raman effect, were major impediments to the application of Raman spectroscopy for 
routine biochemical analysis. As a result, growth in FTIR spectroscopy and its applications 
to biology outpaced that of Raman until the 1980s. 
The two major technological advances in Raman instrumentation which occurred in the 
mid- to late-1980s were FT-Raman spectroscopy [38, 70] and the use of multi-channel CCD 
detectors with dispersive Raman spectrographs [71, 72]. Both technologies offered NIR 
excitation, which effectively reduced fluorescence interference. The user-friendly FT-Raman 
systems and fast dispersive systems enabled non-specialists to explore interdisciplinary ap-
plications of Raman spectroscopy, including those in biology and medicine. Continuing 
advances in optical technology such as fibre optic probes, compact diode lasers, efficient 
laser rejection filters, gratings, and compact imaging spectrographs have further enhanced 
biological applications of Raman spectroscopy [21]. In addition, the substantial increase 
in computing power witnessed in the past 20 years has greatly facilitated collection and 
sophisticated analysis of high-dimensional spectral data. These developments culminated in 
the generation of high-performance, commercially-available integrated Raman spectrometers 
which incorporated laser, spectrometer, sampling accessories, and software into a complete 
system. These systems were reliable, easy to use, and paved the way for the modern Raman 
revolution. 
CCD-based dispersive Raman spectroscopy is more commonly used for biomedical ap-
plications than FT-Raman spectroscopy. Dispersive systems generally produce spectra with 
greater signal to noise ratio (SNR) and permit much faster acquisition times than capable 
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with FT-Raman systems. Dispersive Raman systems are also more versatile than FT-Raman 
systems, allowing more laser options (UV, visible, and NIR), improved wavelength coverage 
of Raman-shifted light, alternative Raman imaging configurations (global, sequential point 
and line-focus imaging for dispersive systems versus sequential point imaging only for FT-
Raman systems), and yield spectra which are shot-noise rather than detector noise limited 
[6]. The combination of NIR diode lasers and detectors optimized for NIR scattering per-
mit the use excitation wavelengths shorter than the 1064 nm used in FT-Raman systems. 
Although fluorescence rejection is not as prominent, scattering efficiency is higher for lasers 
emitting at 785 nm or 830 nm than those operating at 1064 nm {e.g. the — scattering 
enhancement is approximately 3.5 times for 785 nm relative to 1064 nm), and CCD detector 
efficiency drops off dramatically as excitation wavelength increases. Once the benefits of 
this combination were realized, NIR lasers (particularly at 785 nm and 830 nm) became the 
standard excitation source for biological applications of Raman spectroscopy. 
Research and applications 
Raman signals can be used as bio-molecular fingerprints to characterize the biochemical 
composition and architecture of tissues, populations of cells, single cells and subcellular 
organelles, and to study cellular biochemistry in vitro. Biological applications of enhanced 
Raman (RRS, SERS, CARS), and Raman imaging techniques (DRI, point and line-focus 
mapping) were discussed in previous sections. The following section is devoted to biological 
applications of spontaneous, non-resonant Raman micro-spectroscopy. 
An excellent overview of in vitro and in vivo tissue characterization by Raman spec-
troscopy can be found in [5]. The analysis of tissue biochemistry and structure with Raman 
micro-spectroscopy can be performed on live or freshly excised tissues, or samples which have 
been fixed, frozen, and/or sectioned. In the case of bulk (i.e. unsectioned) samples, confocal 
Raman micro-spectroscopy can be used for non-invasive characterization of tissue compo-
nents beneath the surface. In this case, the use of NIR lasers minimises light absorption by 
tissues and enables deeper tissue penetration, in some cases more than 1 mm beneath the 
surface. In order to probe tissue composition and architecture beyond this limit, samples 
must first be fixed and embedded in a hard resin for sectioning. 
Raman micro-spectroscopy has been used to for spectroscopic characterization of both 
normal and diseased tissue states. A large number of studies have focused on optical detection 
and diagnosis of disease, with the aim of identifying spectroscopic markers of cancer in tissue 
samples both in vitro and in vivo. Stone et al. was able to classify epithelial cancers by 
correlating their Raman spectral signatures with their histopathological grade [73]. Deinum 
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et al. achieved histological classification of atherosclerotic lesions from Raman spectra of 
human coronary arteries [74]. Benign and malignant cancers have been studied in breast 
[75], oral [76], ovarian [77], lung [78], and brain [79, 80] tissues. The composition and 
hydration of normal and diseased human skin has been extensively studied by Caspers et al. 
[81, 82]. In addition, Raman micro-spectroscopy and imaging have been applied extensively 
to the analysis of mineralized and calcified tissues (bone, teeth, etc.), and are reviewed in 
detail in Chapter 6. 
Raman micro-spectroscopy has been used to examine populations of cells in suspension 
to study cellular proliferation [83], biochemical changes associated with carcinogenesis and 
necrosis [84], and to identify multi-drug resistance phenotype in cancer cell lines [85]. Al-
though interesting spectral information has been obtained from cell suspensions, single-cell 
spectra offer important information concerning specific biological functions, cellular inter-
actions with its microenvironment (with other cells, drugs, biomaterials, etc.), as well as 
variation within a population. 
The analysis of single living cells in suspension has been accomplished by combining 
Raman micro-spectroscopy with optical tweezers, a technique known as laser tweezers Raman 
spectroscopy (LTRS) [86]. This approach has been used to study heat denaturation in single 
micro-organisms [87], and to identify spectral differences between neoplastic and normal 
eukaryotic cells [88]. Raman spectra of single fixed, dried, cytospun, and living cells, grown 
or deposited on an appropriate Raman-transparent substrate {e.g. CaF2, MgF2), have been 
collected to study the biochemical composition of cellular organelles [9, 89], to distinguish 
between different prostatic cancer cell lines [90], and to study cellular processes such as 
apoptosis [91]. 
Puppels et al. pioneered the use of Raman micro-spectroscopy for biochemical analysis 
of single living cells in culture [7]. They studied differences between spectra of nuclei and 
cytoplasm in live human granulocytes, and deduced information on the secondary structure 
of proteins, and DNA: protein ratio in cell nuclei. Puppels et al. were also the first to show 
that NIR excitation is critical for the analysis of live cells in culture, as they detected cellular 
degradation with 514.5 nm excitation but not with 660 nm excitation [92]. Notingher et 
al. also demonstrated that UV and visible wavelength lasers can lead to cell death, even at 
low laser powers {e.g. 5 mW) and short irradiation times (5-20 minutes), but no damage 
was detected after 40 minutes of irradiation with 115 mW of 785 nm excitation [13]. These 
observations were attributed to cellular damage induced by higher energy photons of UV 
and visible light {i.e. higher energy than NIR light); for example, it is well known that high 
energy UV light can lead to irreversible double-stranded breaks in DNA, which promptly 
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leads to cell death. 
Raman spectra are sensitive to changes in molecular composition, and can therefore be 
used as cell-specific biochemical signatures to discriminate between different cell phenotypes 
[41, 88, 90, 16]. Non-invasive phenotyping with Raman micro-spectroscopy has also been 
used to identify cancerous cell phenotypes [85] to aid in disease detection, diagnosis [90], as 
a biosensor to monitor cellular response to drugs for pharmaceutical testing [18], and as a 
basic cytology tool to investigate cellular organelles [53], biochemistry [56], and apoptosis 
[91]. The application of Raman micro-spectroscopy to tissue engineering is a new and exciting 
prospect. Notingher et al. used Raman micro-spectroscopy to monitor mRNA-translation 
during embryonic stem cell differentiation [15], while Jell et al. investigated enhanced 
differentiation of foetal osteoblastic progenitor cells with bioactive glass dissolution ions 
[19]. Non-invasive spectral analysis shows tremendous potential for selection of cells for 
tissue engineering, monitoring cell growth, differentiation, cell-biomaterial interactions, the 
production of extracellular matrix, and the development of organized tissue structures in live 
cell culture systems. 
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Materials and Methods 
This chapter provides a general outline of the materials and methods employed in applying 
Raman micro-spectroscopy to the analysis of live cell culture systems. Experiment-specific 
details are included in the pertinent chapters. The important aspects of the research include 
cell culture conditions, cell biology for validation and correlation of spectral results with 
gold standard biological techniques, instrumentation and experimental techniques for Ra-
man micro-spectroscopy, and chemometric data analysis (signal processing and multivariate 
statistical analysis). 
2.1 Cell cu l tu re 
Standard cell culture techniques were used to prepare cultures of primary cells and im-
mortalized cell lines (transduced/transfected or cancerous) for analysis with Raman micro-
spectroscopy. Details of cell sources, cell culture media, supplements {e.g. serum, L-
glutamine, antibiotics, antimycotics, etc.) cell seeding densities and culture conditions for 
each experiment are included in the pertinent chapters. 
Standard cell culture preparations involve seeding cells on sterile, polystyrene-based tissue 
culture plastic, thermanox, glass coverslips, etc. These substrates are unsuitable for cellular 
analysis with Raman micro-spectroscopy, as the Raman signal from the dense polymer or 
glass substrate overwhelms the much weaker Raman scattering from cellular biopolymers, 
often by several orders of magnitude. To facilitate Raman data collection, cells can be grown 
on substrates such as CaFg [90], MgFg [16], fused-silica [15], etc. which have much lower 
Raman signals. Previous investigations in our laboratory by Notingher et al. [13] and Owen 
[17] into the suitability of various substrates as cell culture coverslips for Raman micro-
spectroscopy identified MgF^ as the best candidate, due to its low Raman signal and low 
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solubility in water. Notingher et al. further demonstrated that MgFg has no adverse effects 
on cell attachment, morphology, and viability [16]. Hence MgFg (Global Optics, UK) was 
selected as the substrate for all experiments discussed herein. For each experiment, MgF2 
coverslips were cleaned in ethanol, autoclaved, and UV-treated to ensure sterilization prior 
to cell seeding. 
2.2 Cell biology 
Gold standard biological techniques were used to confirm cellular changes {e.g. cell cycle 
stage, differentiation, phenotype, etc.) and to correlate these with Raman spectral changes. 
This involved analysis of independent samples run in parallel to those analysed with Ra-
man micro-spectroscopy. The techniques used in the investigations presented in this thesis 
include; flow cytometry, histo-/cyto-chemical staining, immunocytochemistry (ICC), and 
immunoblotting. The specific details of these techniques and analyses are included in the 
Materials and Methods sections of the relevant chapters. 
2.3 R a m a n micro-spectroscopy 
Excellent descriptions of the general properties of CCD-based dispersive Raman spectrome-
ters with NIR excitation can be found in [4, 6, 72], Raman spectra for all of the experiments 
discussed herein were measured with a dedicated Renishaw In Via (Renishaw, Wotton-under-
Edge, Gloucestershire, UK) dispersive spectrometer system optimised for rapid, real-time 
analysis of live cell and tissue culture systems, described in detail by Notingher et al. [16]. 
All Raman spectroscopy experiments reported in this thesis were performed by the author. 
A diagram of the system featuring its main components is included in Figure 2.1. The spec-
trometer was connected to a Leica DM-LM (Leica, Wetzlar, Germany) microscope, fitted 
with a Prior® motorised stage (accurate to within ±1 fim laterally and axially) and temper-
ature control module (accurate to within ±0.1°C). A Renishaw high power NIR 785 nm diode 
line focus laser (~300 mW at source, ~120 mW before objective) was used for excitation. 
The use of NIR laser excitation mitigates problems of photo-degradation and fluorescence 
commonly encountered with UV and visible excitation of biological samples, respectively. 
Previous research in our laboratory by Owen [17] and Notingher et al. [16] revealed that this 
laser wavelength and power have no detrimental effects on cell viability or phenotype, even 
with prolonged exposure. Other researchers have used similar laser wavelengths and power 
to examine biological cells [3, 83, 90, 93] and tissues [59, 94, 95]. 
The system's beam expander was removed to maximise the laser power at the sample, 
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F i g u r e 2.1: Schematic d iagram of the CCD-based dispersive R a m a n micro-spectroscopy system used in the 
experiments presented herein. The main system components are indicated. 
and hence the Raman scattered intensity. For analysis of live cell culture systems, the laser 
was focused on individual cells by a x63 (NA = 0.9) long-working distance (2 mm) water 
immersion Leica objective. Raman spectra of live cells were measured in either DMEM 
or PBS supplemented with 1% A/A maintained at 37°C (alternatively, COg independent 
medium can be used). The spatial resolution of the instrument (with x63 objective) was 
determined by the elliptical shape of the line focus laser spot and other spectral parameters 
{e.g. 50 ^m spectrometer slit width and CCD height of eight pixels). The lateral resolution 
was estimated by measuring the intensity profile along the sharp edge of a poly dimethyl 
siloxane (PDMS) sample at 1 jim step increments [15]. The region illuminated at the 
focal plane was roughly elliptical in shape, with minor axis estimated as x = 10 jj,m, major 
axis y — 20 /im. Axial resolution was determined by measuring vertical step scans above 
the surface of the same PDMS sample, and was estimated to be 2 = 30 /xm. This spatial 
resolution is on the same order of the diffraction-limited spatial resolution offered by FTIR, 
(~10-20 /im) spectrometer systems equipped with a 1064 nm Nd-YAG laser [6]. Thus the 
interrogated focal volume is ellipsoidal in shape, with an approximate value of y = ^irabc = 
3140 /im^, where a, b are the minor and major equatorial radii, and c is the polar radius 
of the ellipsoidal volume. While this spatial resolution is much lower than the potentially 
submicron (~1 fim^) diffraction-limited spatial resolution of dispersive Raman spectrometers 
equipped with UV, visible, and NIR dot lasers, this live cell culture approach (described in 
Chapter 1) utilizing a large laser spot size facilitates rapid collection of Raman scattering 
from live cells in only a few minutes. By collecting Raman scattering signal from a large focal 
volume, this approach is similar in principle to that of FTIR spectroscopy, which provides 
spatially-averaged information from regions whose dimensions are defined by the aperture of 
the system (ranging from as low as 10 x 10 /um^ [96] to more than 100 x 100 nxn^). 
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The Raman back-scattered radiation (180° collection geometry) was collected by the 
same objective, passed through a 785 nm holographic notch filter (HNF) to block Rayleigh 
(elastic) scattering and reflected laser light, and then focused by an entrance slit into a spec-
trometer equipped with a 1200 lines/mm grating, and finally detected by a multi-channel 
{e.g. 576 x 384 pixels), thermo-electrically cooled (Peltier cooled to —70°C), deep-depletion 
CCD detector. The width of the spectrograph sht is adjustable (0 /xm - 100 /xm) and in-
fluences the throughput (and hence signal strength) and spectral resolution of the system. 
For the experiments presented herein, the spectrometer slit was set to 50 /im, unless oth-
erwise stated. Spectral resolution, estimated from the full-width half maximum (FWHM) 
of He-Ne lines, was typically ~ l - 2 cm""\ Raman spectra were typically collected over the 
flngerprint region (550-1850 cm~^ for cell spectra, 400-1900 cm"^ for bone nodule spectra). 
The extended scans utilised Renishaw's SynchroScan technology, rather than static scans, 
since the static wavenumber range (~400 cm"^) of the grating was inadequate to cover the 
full fingerprint region. The Synchroscan technology enables measurement of high resolution 
spectra with wider wavelength range than can be accommodated by a single CCD expo-
sure, and produces broad-band spectra free of stitching artefacts. Signal integration time 
was typically 40 seconds per spectrum, which corresponds to approximately 150 seconds of 
real time due to the nature of Renishaw's Synchroscan technology for extended scans larger 
than the static grating range. For bone nodule spectra, an integration time of 100 seconds 
corresponds to approximately 375 seconds of real time per spectrum. 
In order to ensure a robust and stable environment for Raman measurements, the spec-
trometer system was set up on an anti-vibration table, and experiments were conducted in 
a dark room to eliminate ambient light, and to provide better isolation from noise and dust. 
2.4 D a t a analysis: chemometr ics 
The derivation of chemical information from data is known as chemometrics [97], and in-
cludes all steps of the analytical process, namely pre-processing {i.e. signal processing), 
univariate analysis, and both qualitative and quantitative multivariate mathematical tech-
niques. Raman spectra are essentially chemical signals describing the normal molecular 
modes of vibration of molecules within an interrogated region of a sample. As illustrated in 
Figure 1.1, Raman spectra of biological cells contain thousands of individual Raman shifts 
originating from molecular vibrations in various cellular biomolecules. This leads to complex 
spectra with tens or hundreds of overlapping peaks which characterise the bio-molecular 
composition of a biological cell. The most informative Raman spectral region is the so-called 
52 
C h a p t e r 2: Mater ia l s a n d M e t h o d s 
'fingerprint' region (~600-1800 where most of the characteristic Raman-active vibra-
tions of cellular biopolymers occur. The high dimension and complexity of Raman spectra 
of biological materials necessitates objective, automated data analysis techniques capable of 
extracting the maximum level of information from the entire spectral region (of interest), 
with a minimum level of supervision and biased user-input. Multivariate statistical tech-
niques can be used to derive metrics for both qualitative and quantitative data analysis, 
and are effective in identifying key trends in large, high-dimensional data sets. To ensure 
robust and reliable multivariate analyses, Raman spectral data must be pre-processed with 
signal processing filters to remove unwanted information {e.g. noise, background signal, etc.) 
and to correct spectra for systematic error arising from instrument or experimental param-
eters, in order to generate a standardised data set in which individual spectra are directly 
comparable. 
The following sections describe the chemometric methods (signal processing routines and 
multivariate analysis techniques) used in this thesis to analyse Raman spectra from biolog-
ical cells and tissues. A sequence of figures describing the effects of signal processing filters 
and multivariate analysis on Raman spectra are also included. The specific processing fil-
ters and multivariate analysis techniques employed in each experiment are indicated in the 
Materials and Methods sections of each chapter. Many of these techniques were developed 
for analytical chemistry applications and other sciences, and are not specific to the analysis 
of Raman spectra. For a more comprehensive and rigorous treatment of these techniques, 
and their applications to biological Raman spectroscopy, the reader is directed to several 
excellent texts, book chapters and tutorial articles [95, 97, 98, 99, 100, 101, 102, 103, 104]. 
All Raman data were processed and analysed with software developed in-house for the Mat-
lab (The Mathworks Inc., USA) environment, and with the multivariate statistical analy-
sis toolbox PLS-toolbox (Eigenvector Research, Inc., USA). The in-house Matlab software 
toolbox was initially developed by Dr loan Notingher, and included Matlab codes for im-
porting data, converting to spectral data type, intensity correction, background removal via 
Maquelin's projection method, SNV normalisation, mean-centre processing, and PCA. Addi-
tional codes written or modified by the author were designed to enhance the functionality of 
the toolbox, and included Matlab codes for Modpoly backgound correction, Savitsky-Golay 
smoothing and differentiation, PCA smoothing, EMSC normalisation, spectral alignment 
for wavenumber axis calibration, and spectral modelling via least squares fitting. Finally, 
Matlab programs for LDA and factor analysis via multivariate curve resolution (MCR) were 
implemented from the commercially available PLS-toolbox. 
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2.4.1 Digi ta l signal process ing of R a m a n spectra 
Cosmic rays were deleted on-line using the manual cosmic ray correction feature in the 
Renishaw WiRE 2.0 (Windows based Raman Environment) software environment. A raw 
data Raman spectrum collected from a single live cell in culture is included in Figure 2.2. 
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F i g u r e 2.2: Raw data Raman spectrum collected from a single live cell in culture. 
Calibrat ion 
Raman spectra contain a wealth of information on the molecular structure of a sample. The 
specific Raman shifts (cm"^) of peaks indicate which molecular moieties — chemical bonds, 
functional groups, etc., are present, while peak intensities reflect their relative molecular 
concentration with respect to one another. It is therefore critical that both abscissa and 
ordinate axes of Raman spectra are calibrated properly to ensure accurate data interpretation 
and robust comparison between samples. 
Prior to data collection, the ordinate (wavelength) axis was calibrated to the sharp, nar-
row Raman peak at 520.5 cm"^ of a silicon sample supphed by Renishaw. Following data 
collection, spectra were passed through a signal processing filter which aligns spectra via a 
linear shift to the sharp Raman vibration of phenylalanine (consistently observed at 1003 
cm"^ on the cahbrated system), which is observed in the vast majority of biological Raman 
spectra and in all of the samples analysed in this thesis. This routine fits a parabola to the 
band maximum and two neighboring data points, and the maximum of the parabola is taken 
as the band position [105]. The program also standardizes the Raman shift (cm"') axis with 
a linear interpolation algorithm to ensure that all spectra are aligned to the same reference 
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position (Figure 2.3). This pre-processing step avoids potential problems such as spectral 
broadening of peaks which can result from averaging mis-aligned spectra, and is crucial to 
accurate analysis of difference Raman spectra. For samples that did not contain a pheny-
lalanine peak at 1003 cm~^ {e.g. PBS), the program merely standardizes the wavenumber 
axis. 
2 cm-'' shift 
Post-alignment 
Pre-alignment 
600 800 1000 1200 1400 1600 1800 
Raman shift (cm"^) 
F i g u r e 2.3: Spectral alignment: spect ra were aligned to the sharp phenylalanine peak a t 1003 c m " and 
t runca ted to the 600-1800 cm"^ spectral region. Shown are a Savitsky-Golay smoothed spect rum before 
(blue) and after (red) alignment and s tandardizat ion of the wavenumber axis. The spect ra are offset for 
clarity. Inset: A shift of approximately 2 cm~^ was required to align this part icular spec t rum with respect 
to the reference position of the sharp phenylalanine vibration. 
For cahbration of the intensity axis, several spectra of a fluorescent green glass sample 
were collected immediately prior to data acquisition. The mean spectrum (Figure 2.4) was 
used as an external standard to correct spectra (Figure 2.5) for variations in intensity due to 
fluctuations in laser power, instrument response and optical throughput. This approach, first 
implemented in our laboratory by Dr loan Notingher, generates a broad-band instrument 
response profile with an intensity-correction factor for each wavenumber in the desired spec-
tral range, and is a valid alternative to the more familiar tungsten-halogen lamps often used 
for intensity calibration [106]. The same approach has previously been used by Notingher 
et al. [16], Owen et al. [18], and Jell et al. [19] to process Raman spectra of single living 
cells, and is important to account for day-to-day spectral variation (caused by fluctuations 
in laser intensity, optical throughput of the system, changes in sample preparations, etc.) 
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and long-term experiments. 
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Figure 2.4: Intensity calibration spectra. A Mean calibration spectra collected from a fluorescent glass 
sample on experimental (green) and reference (blue) days. B Intensity correcton factors calculated from 
intensity ratios of experimental and reference calibration spectra reported in A. 
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Figure 2.5: Intensity correction of Raman spectra. A Raw data spectrum. B Raw da ta (blue) and intensity-
corrected (red) spectra. 
Baseline and background removal/correction 
Backgrounds in Raman spectroscopy are common and arise from luminescence processes 
{e.g. fluorescence, phosphorescence), non-laser induced emissive processes {e.g. room light, 
sunlight, blackbody radiation, chemiluminescence), or Raman scattering from impurities, 
substrates, solvents, or optics [97]. Background correction or removal facilitates qualita-
tive interpretation of spectral data, and multivariate analyses can be extremely sensitive to 
background variation or baseline differences between spectra. Automated routines which 
employ a broad background approximation across the entire spectrum are more objective, 
robust, and easier to implement than user-defined curves (polynomials and cubic splines). 
Commonly used background correction methods include the use of a high-pass filter, spectral 
curve-fitting, and differentiation of spectra data [100]. 
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In this thesis, different background and basehne correction algorithms were used to pro-
cess biological Raman spectra, depending on the intended multivariate analysis. Background 
removal was accomplished by application of a Savitsky-Golay filter to compute 2"'' deriva-
tive Raman spectra [107]. Alternatively, the modpoly algorithm described by Lieber and 
Mahadevan-Jansen (5*^  order polynomial, 1000 iterations) [108] was used to eliminate flu-
orescence and other background effects by modeling the broad-band signal with a 4'"'' or 
5^ ^ order polynomial (Figure 2.6). This algorithm subtracts a least-squares fit polynomial 
from a spectrum and used an iterative correction to eliminate negative intensity values, and 
establishes a zero-baseline for each spectrum individually. Subtraction of the signal due to 
cell culture media {e.g. DMEM) or buffer {e.g. PBS) was accomplished using the projection 
method described by Maquelin et al. [93], which uses vector algebra to isolate the signal 
from cell and medium. Finally, correction of the background signal, rather than removal, was 
performed using extended multiplicative signal correction (EMSC) [109]. The open-source 
EMSC program was modified to incorporate fifth-order wavelength-dependent spectral vari-
ations to account for background effects. A user interface Matlab program (written by the 
author) was also generated to set EMSC parameters and to convert and scale spectral data 
to the correct format for EMSC processing. The advantage of this approach is that back-
ground corrections for individual spectra are computed with respect to a common spectrum 
{e.g. the mean spectrum) derived from the entire data set (Figure 2.7). 
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Figure 2.6: Background removal with the Modpoly algorithm. A Intensity-corrected spectrum (from Fig-
ure 2.5) prior to background subtraction (red) and the modified polynomial computed using the Modpoly 
algorithm (green). B Raman spectrum with zero-baseline following background subtraction. 
Smoothing 
The Raman effect is a weak process, and the SNR of Raman spectra is generally an order of 
magnitude (or more) lower than that of FTIR spectra [68]. Consequently, Raman spectra 
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Figure 2.7: Extended multiplicative signal correction (EMSC) normalisation. A Intensity-corrected spectra 
collected from 186 alveolar type II (ATII) cells at different time points, 558 total spectra (see Chapter 4 
for details). B Reference spectrum for EMSC correction: mean of input spectra in A. C EMSC-corrected 
ATII cell spectra. Note how the algorithm defines a common baseline for all spectra based on the mean 
reference spectrum. D Intensity-corrected spectrum (from Figure 2.5) before (red) and after (grey) EMSC 
normalisation. 
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of biological samples {e.g. cells and tissues) which possess small Raman scattering cross-
sections often yield low-intensity, noisy spectra. Furthermore, removal of strong background 
signals cannot remove the statistical/shot noise imparted by the background, and increases 
the relative error (i.e. decreases the SNR) [97]. Boxcar averaging, high-frequency Fourier 
filtering, sliding average filters, Savitsky-Golay polynomial smoothing, and wavelet filtering 
are all commonly used de-noising techniques [99]. In the current experiments, smoothing 
of individual spectra was performed using a Savitsky-Golay filter (Figure 2.8), which is 
a low-pass filter commonly used in spectral analysis. This algorithm involves a moving 
window polynomial (typically quadratic or quartic) fitting function that preserves the relative 
height and width of data peaks as well as signal area. Since it employs a least-squares 
fitting technique, filtering is fast and straightforward using matrix inversion for obtaining 
the polynomial coefficients. The input parameters are the frame size of the window and 
polynomial order. Input parameters for processing of spectra were typically 5 points, 2""^  
order polynomial for non-derivative spectra, and 21 points, 2'"* order polynomial for 2"^  
derivative spectra. Multivariate smoothing was used in some cases to remove noise common 
to an entire data set by compressing the data with a principal components analysis, and 
then re-constructing the data from the first few principal components (PCs), and discarding 
the higher order PCs which describe the noise in the system. 
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F i g u r e 2.8: Smoothing spectra with a Savitsky-Golay filter: an EMSC-corrected spectrum before (grey) and 
after (green) smoothing. The spectra are offset for clarity. 
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Normalisation 
Normalisation is one of the most important processing steps for analysis of high-dimensional 
spectra data. Raman spectral intensity variations can have detrimental effects on quantita-
tive multivariate analysis. Such variation can arise from changes in incident laser intensity, 
interrogated volume, instrumental throughput, sample fluorescence, opacity, refractive index, 
absorptivity and density. Some of these effects can be mitigated with the aforementioned 
intensity axis calibration and removal/correction of background signal. Further intensity 
variations can be corrected by one of several normalization routines, including normalization 
to an internal [3, 14] or external standard {i.e. standardization to a single reference band), 
vector normalization [53, 88], scaling to unity variance of first-derivative spectra [15], stan-
dard normal variate (SNV) transformation [5, 16], and EMSC [68]. The normalisation 
routines applied to biological Raman spectra within this thesis include: the SNV transfor-
mation, which sets the average intensity to zero and standard deviation to one for each 
spectrum; vector normalization, in which each spectral vector is divided by the vector norm; 
normahzation to maximum unity intensity (internal standard); and EMSC, which corrects 
for additive (varying slopes and curved baseline interference, absorptivity, etc.) and mul-
tiplicative (interrogated volume changes) effects by regressing each spectrum on the mean 
spectrum of the data set [110]. 
2.4.2 Mult ivariate analysis 
Multivariate analysis techniques can be used for both qualitative and quantitative data anal-
ysis of high-dimensional spectral data. These methods include both unsupervised and su-
pervised techniques, which can be used to investigate clustering, classification, and modeling 
of Raman spectral data. 
Principal Components Analysis (PCA) 
PCA is a linear mathematical transform, also known as the Karhunen-Loeve transform, which 
expressed each spectrum in a data set as a linear combination of orthogonal basis functions, 
called principal components (PCs) [111]. PCA applied to biological Raman spectra generates 
PCs and scores. The PCs are vectors which contain spectral features corresponding to the 
main molecular species responsible for the statistical variation between spectra (with respect 
to the mean spectrum, if the data is mean-centered (Figure 2.9)), and score values describe 
the contribution of PCs to the original data. These vectors are the eigenvectors of the data 
covariance matrix, with the greatest variance captured by PCI, the second greatest variance 
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by PC2, etc. This algorithm is often used for dimensionality reduction, by expressing high-
dimensional data in terms of a smaller number of PCs. Data compression is achieved by 
retaining only the PCs that describe the most significant variance, while discarding higher-
order PCs which account for noise. In this thesis, pre-processed and mean-centered Raman 
spectra were analysed using a singular value decomposition PCA algorithm. 
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F i g u r e 2.9; In mean centre processing, t he mean spec t rum from a d a t a set is subt rac ted f rom each individual 
spect rum. A D a t a before and B after mean centre processing. 
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F i g u r e 2 .10: PCA: A R a m a n spectral d a t a for PCA, after t r ea tment with signal processing filters for 
intensity correction, EMSC normalization, Savitsky-Golay smoothing, and spectral alignment. T h e P C A 
algorithm decomposes spect ra into a set of mathemat ica l basis vectors, i.e. principal components (PCs). B 
Scores on FC1~PC6 describe the contr ibution of each P C to the original spectra. C P C 1 - P C 6 . 
PCA is an unsupervised technique commonly used to investigate clustering of samples 
within a data set. PC-score plots, in which the scores on one PC are plotted against another, 
may be analysed to indicate whether or not spectra are related. If grouping or clustering 
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of spectra is observed in these plots, then there exist systematic differences in the spectra 
[112]. Examination of the PCs can be used to determine the biochemical species which are 
responsible for the discrimination between sample groups. PCA of Raman spectra has been 
used to study the differences between normal and neoplastic haematopoietic cells [88], and to 
identify multi-drug resistance phenotype in cancer cell lines [85]. PCA has also been used to 
generate contrast in Raman hyperspectral images of human cells [9], and for hyperspectral 
images of human bronchial tissue based on K-means cluster analysis of PC scores [94]. 
Linear Discriminant Analysis (LDA) 
A more detailed description of LDA can be found elsewhere [113]. LDA is a supervised 
classification algorithm for discrimination of sample groups which incorporates class mem-
bership of data. The algorithm computes linear discriminant functions, which are directions 
in the spectral space that maximise the ratio of between-class variance to within-class vari-
ance according to Fisher's criterion. Projecting the data along these functions produces 
maximal group separation. The main limitation of LDA is that the number of variables (e.g. 
points per spectrum) has to be smaller than the number of samples. This condition is rarely 
fulfilled for high-dimensional spectral data sets, and so PCA is used as a data compression 
method, with the scores of the significant PCs taken as input for generation of the LDA 
model [5]. The supervised step, the selection of PC scores to include for the LDA model, 
can be determined by examining the scree plot of singular values [58] or using Wilk's Lambda 
method and 95% F-test inclusion criterion [93]. LDA model classification accuracy can be 
assessed by partitioning the data set into training and test data, or by using leave-one-out 
cross-validation, whereby the class of a spectrum is predicted using an LDA model built 
from the full data set excluding the spectrum in question; the method is repeated, with each 
spectrum left out in turn, so that each spectrum is predicted once. PCA-based LDA has 
been used to discriminate between spectra of different prostatic adenocarcinoma cell lines 
[90], and between different bone cell phenotypes used in tissue engineering [16]. 
The LDA program in the PLS-toolbox was used for the LDA analysis, and scree plots used 
to determine the significant PCs. Classification accuracy was assessed using leave-one-out 
cross-validation. Although PCA-LDA classification is a supervised technique, a program was 
complied to automate the analysis and remove the supervision step. The program computes 
separate LDA models for sequentially larger sets of PCs (n = 1,2, . . . iV — 1, where N is the 
number of spectra in the analysis) and determines the optimal number of PCs which produce 
the LDA model with highest classification accuracy. 
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Factor analysis 
The PCs generated by PCA of biological Raman spectra are abstract mathematical vectors, 
and in general do not represent pure biochemical components, but rather combinations of 
both positive and negative spectral peaks from multiple components. Factor analysis (FA) 
is a multivariate analysis technique which can be used as an extension of PCA to obtain 
a more interpretable form of the PC vectors [97]. In this approach, the eigenvectors {i.e. 
PCs) generated in the covariance matrix diagonalisation are "rotated" (linearly combined by 
weighted addition or subtraction) to give "factors" that describe the spectral signatures of 
biomolecular species which describe the differences between spectra of sample groups. PC 
score values are also rotated, so that factor scores indicate the relative amount of each factor 
present in the original spectra. The advantages of using FA as an analysis tool is that it has 
an inherent signal-averaging effect and has the ability to resolve spectral components that are 
present in spectra of different samples. Factor analysis has been used to identify biochemical 
differences between FT-Raman spectra of tumorigenic and non-tumorigenic cells [41], to 
identify biochemical components for Raman hyperspectral imaging of breast tissue [95], 
and in several Raman line-mapping investigations of mineralised tissues [52, 58, 59]. The 
multivariate curve resolution program in the PLS-toolbox was used to rotate the significant 
PCs using a constrained iterative alternating least squares solver subject to non-negativity 
constraints. 
Spectral modelling by least-squares fitting 
PCA-based factor analysis is a mathematical transformation that effectively compresses high-
dimensional spectra onto a reduced set of basis spectra derived directly from the data. 
Factors describing spectra of single biochemical components permit the semi-quantitative 
determination of how spectral contributions of those factors vary between the data. Some 
factors, however, contain correlated spectral features from multiple biochemical components, 
and investigating biochemical differences between samples based on these factors is much less 
straightforward. 
In contrast to factor analysis, spectral modelling imposes a pre-selected set of basis spec-
tra on the data. In this approach, the basis vectors — spectra of biochemical components 
{e.g. nucleic acids, proteins, lipids, carbohydrates) are fit to biological Raman spectra us-
ing a non-negative least-squares fitting procedure (Figure 2.12). In most cases the basis 
spectra are collected from pure chemical compounds. Alternatively, morphological modeling 
involves measuring in situ basis spectra of the major morphological features of the sample 
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Factors = w * PCs 
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F i g u r e 2 .11: A-Iultivariate factor analysis. A Principal component (PC) loading vectors, P C 1 - P C 6 from 
Figure 2.10C. B Factors generated by eigenvector rotat ion of PCs 1-6, computed by multivariate curve 
resolution (MCR). T h e rotat ion is performed using a rota t ion- t ransformat ion matr ix w, computed with a 
constrained iterative al ternat ing least squares solver subject to non-negativity constraints. 
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using a high spatial resolution confocal Raman spectrometer. Morphological modeling has 
been used to study human breast tissue [114], colonic carcinoma cells [95], and to determine 
the composition of human coronary arteries [115], while spectral modeling with pure chem-
ical compounds and/or extracted cellular components has been used to characterize single 
living human breast epithelial cells [116], to study spectral changes due to proliferation in 
suspensions of live cells [83], to study spectra of individual cellular organelles within high 
spatial resolution Raman maps of fixed [8], and dried [9] cells, and to study the biochemical 
composition of human bronchial tissue [94]. 
FC = Spectrum * (Basis spectra)-"" 
Model fit = FC * Basis spectra 
c 3 
CO 
C/3 
c 0) 
Mean ATI I 
spectrum 
Model fit 
1  jwaJ 
uJW 
Component spectra 
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Raman shift (cm" ) 
1400 
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F i g u r e 2.12: Spectral modelling by least squares fitting. The mean spectrum of a set of EMSC-normalised 
Raman spectra collected from a sample of ATll cells was modelled by fitting with a set of basis spectra repre-
senting cellular biochemical components: DNA, RNA, actin, collagen, human serum albumin, chymotrypsin, 
glycogen, cholesterol, phosphatidyl choline, and a 5th order polynomial (to model the background). The fit 
coefficients (FC) for the model spectrum were calculated using a least-squares solver subject to non-negativity 
constraints, and the model spectrum generated by scaling the basis spectra with the FCs. Shown are the 
mean ATI I cell spectrum (blue), the model fit (red), and weighted component spectra which sum to give the 
model fit spectrum. Spectra are offset for clarity. 
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The spectral modeling of cellular Raman spectra presented in this thesis was similar to 
the approach used by Owen et al. to evaluate changes in nucleic acids and lipids during 
drug-induced apoptosis of live cancer cells [18]. The biochemical components used to gen-
erate the set of basis spectra were the same as those used in that study (all from Sigma 
Ltd., UK), and included nucleic acids (calf thymus DNA and bakers yeast RNA), proteins 
(human serum albumin to model high a-helix content protein, chymotrypsin to model high 
/3-pleated sheet content protein, actin and collagen), lipids (phosphatidyl choline and choles-
terol) and carbohydrates (glycogen). For spectroscopic measurements, the pure compounds 
were dissolved in dHgO, except the lipids that were immersed in PBS. The spectra of cellular 
biochemical components were pre-processed in the same fashion as cellular spectra prior to 
least-squares fitting. Fitting of non-baselined EMSC-processed spectra was accomplished 
using an original Matlab program (written by the author), which incorporated a 5"" order 
polynomial in the set of basis spectra to model the background signal. The signal contribu-
tion of various biochemical components to cellular Raman spectra was assessed by examining 
the fit coefficients generated by the least-squares fitting routine. The quality of the fitting 
was assessed by comparing model spectra to the empirical data by examining residuals, and 
by computing the correlation coefficient (R) between each original spectrum and its model 
spectrum. The correlation coefficient provides a statistical measure of the similarity between 
spectra [68], and was used here as a goodness-of-fit parameter (R=l for identical spectral 
profiles). 
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Chapter 3 
Non-invasive spectral analysis of 
cell cycle dynamics 
In this chapter, Raman micro-spectroscopy is used to characterise biochemical cell cycle 
dynamics within single living cells in vitro. Previous characterization of the mammalian cell 
cycle using Raman micro-spectroscopy involved analysis of suspensions of viable cells and 
individual fixed and/or dried cells. Cell suspensions do not provide cell-specific information, 
and fixing/drying can introduce artefacts which distort Raman spectra, potentially obscuring 
both qualitative and quantitative analytical results. These difficulties can be circumvented 
by taking advantage of the non-invasive nature of Raman micro-spectroscopy. 
Raman spectra of human osteosarcoma cells synchronized in Gq/Gi , S, and G2/M phases 
of the cell cycle were obtained and multivariate statistics applied to analyze the changes in 
cell spectra as a function of cell cycle phase. Multivariate analysis by PCA identified spectral 
differences between cells in different phases, indicating a decrease in relative cellular lipid 
contribution to Raman spectral signatures from Gq/Gi to G2/M , with a concurrent relative 
increase in signal from nucleic acids and proteins. Supervised LDA of spectra was used to 
classify cells according to cell cycle phase, and exhibited 97% discrimination between Go/Gi -
phase cells and Gg/M-phase cells. The non-invasive analysis of live cell cycle dynamics 
with Raman micro-spectroscopy demonstrates the potential of this approach to monitoring 
biochemical cellular reactions and processes in live cells in the absence of fixatives or labels. 
3.1 In t roduc t ion 
Cell cycle dynamics are intimately involved in all aspects of health and disease, and have 
justly received significant interest in biomedical research. Changes in cell cycle mechanics 
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induced by drug administration in vitro are routinely investigated to aid in pharmaceutical 
development, including identification of anti-cancer agents which disrupt cell cycle machin-
ery [117]. Recently, scientists have explored cell cycle changes induced by cell-biomaterial 
interactions to develop biocompatible and bioactive tissue engineering scaffolds which sup-
port and enhance cell adhesion, proliferation, and differentiation [118, 119, 120]. Current 
histological, cellular and molecular techniques available to study cell cycle biochemistry in 
culture are invasive, requiring fixation and/or exogenous fiuorescent labelling {e.g. flow cy-
tometry) [5]. Many research fields would benefit from the development of new techniques 
which permit non-invasive, in situ monitoring of living cells. 
The ability of Raman micro-spectroscopy to resolve molecular detail on the micron scale 
makes it a suitable method to elucidate the intricate dynamics of the cell cycle. The eukary-
otic cell cycle is a highly regulated, complex process divided into a number of phases: Gq, 
Gi(gap 1), S, G2(gap 2), and M. The two gap phases (Giand G2) separate DNA synthesis in 
S phase, and chromosome segregation and cell division in M phase (mitosis) [121]. Go is a 
resting state which Gi cells may enter if conditions for DNA synthesis are unfavourable; cells 
in Go may re-enter the Gi phase of the cell cycle in response to mitogenic stimuli [122]. The 
growth of cell populations is asynchronous, meaning that cells do not pass through different 
cell cycle phases at the same time. Chemical treatments such as serum starvation and cell 
cycle inhibitors can be used to synchronise cell cultures, enabling biologists to study cellular 
changes which occur during the cell cycle [123]. Serum starvation causes cells to exit the cell 
cycle and enter the Gq resting phase [124], while chemical cell cycle inhibitors can be used 
to block entry into S phase {e.g. aphidicolin, an inhibitor of DNA-polymerase [125]) or to 
arrest cells in metaphase of mitosis {e.g. nocodazole, which disrupts tubulin polymerisation 
[126]). Chemical inhibitors may be administered to adherent cells in culture, and their ef-
fects are reversible upon washout and re-incubation with serum-supplemented medium. The 
current gold-standard for assessing cell cycle synchronisation is flow cytometry, which pro-
vides information on the distribution of cells in different cell cycle stages based on cellular 
DNA content, BrdU (anti-5-Bromo-2'-deoxyuridine) incorporation into nuclear DNA, and 
expression of cell cycle stage-specific proteins {e.g. cyclin E in Gi, and cyclin B1 in G2) 
[127]. However, this technique requires suspensions of (normally fixed) cells stained with 
a DNA-bound fluorescent dye, and cannot be applied in situ on adherent cells growing in 
culture. 
Both infrared (IR) absorption spectroscopy and Raman micro-spectroscopy have been 
used to analyze pre-synchronized viable cell suspensions [128, 83] and single fixed and dried 
cells [129, 54] to characterize spectral patterns related to the cell division cycle. Strong 
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water absorption can interfere with IR spectra, requiring potentially artefact-inducing [12] 
fixation and dehydration of samples [130], or omission of distorted spectral regions [128]. The 
weak inelastic scattering of aqueous media makes Raman micro-spectroscopy amenable and 
uniquely-suited to cell cycle analysis of living cells in situ. However, to date this advantage 
has not been exploited. 
Here, Raman micro-spectroscopy is used to characterise the biochemical changes related 
to cell cycle dynamics within single living cells. Raman spectra of human osteosarcoma 
(MG63 cell line) cells synchronized in Gq/Gi , S, and Gg/M phases of the cell cycle were col-
lected and multivariate statistics applied to analyze the changes in cell spectra as a function 
of cell cycle phase. Specifically, principal components analysis (PCA) was used to examine 
cell cycle dependent variations in Raman spectral signatures, and linear discriminant analy-
sis (LDA) was applied as a supervised classification algorithm to differentiate between cells 
synchronized in different cell cycle phases. The results presented here illustrate the potential 
of Raman micro-spectroscopy as a sensitive and powerful tool for non-invasive biochemical 
analysis of live cellular systems. 
3.2 Mater ia l s and M e t h o d s 
3.2.1 Cell culture 
MG63 (human osteosarcoma cell line) cells (ECACC, UK) were grown to 70% confluence 
before seeding onto sterilised magnesium fluoride (MgFg) coverslips (Global Optics, UK) 
at a density of 1 x 10^ cells/cm^ for 24 hours. Cells were cultured in Dulbecco's modified 
Eagle's medium (DMEM) supplemented with 10% foetal bovine serum (FBS), 1% antibi-
otic/antimycotic (all from Invitrogen) in a 5% CO2 incubator at 37°C. 
3.2.2 Cell synchronisat ion 
Cell cycle inhibitors were used to synchronize MG63 cells in Go/Gi , S, and Gg/M phases 
of the cell cycle as described previously [131]. At 70% confluence, cells were synchronized 
in Go/Giby serum starvation (0.1% FBS serum) for 48 hours. For S-phase block, Gq/Gi-
synchronized cells were incubated with 10% FBS supplemented DMEM containing 2 fj,g/mL 
aphidicolin (Sigma), an inhibitor of DNA-polymerase [125], for 24 hours to synchronize 
cells at the Gi/S transition point, after which the aphidicohn block was washed off and 
the cells incubated for 5 hours with 10% FBS medium to stimulate synchronized entry into 
S phase of the cell cycle. Gg/M block was accomplished by treating Go/Gi-synchronized 
cells with 10% FBS medium containing 0.2 ^g/mL nocodazole (Sigma), an agent which 
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disrupts tubulin polymerization, for 27 hours [126]. Flow cytometry was used to assess 
cell cycle synchronization. Optimal G2/M synchronization efficiency was achieved using a 27 
hour incubation period with nocodazole, rather than a 30 hour time point used in previous 
studies [132]. 
3.2 .3 F low c y t o m e t r y 
Flow cytometric analysis of DNA content was used to assess cell cycle synchronization as 
described previously [127]. Briefly, cell suspensions (~1 x 10® cells) were washed three times 
in phosphate-bufi^ered saline (PBS, Gibco/Invitrogen), fixed in 70% ice-cold ethanol whilst 
vortexing, and stored at 4°C. The cells were centrifuged for 5 minutes at 400 x g and the pellet 
re-suspended in 0.5 mL PBS, and 300 /iL propidium iodide (PI, Sigma, 50 //g/mL). To ensure 
a fluorescence signal proportional to DNA content, 50 PLL RNase-A (Sigma, 100 /ig/mL) was 
added to remove cellular RNA. The samples were then covered and incubated for 30 minutes 
at room temperature. DNA content histograms were collected using a FACSCalibur flow 
cytometer (Becton Dickenson; Franklin Lakes, NJ, USA), which was calibrated using the 
DNA histogram-profile of asynchronous control cells. Cell cycle markers were added to DNA 
content histograms using the CellQuest Pro software to determine the percentage of cells in 
Go/Gi , S, and G2/M phases of the cell cycle. Flow cytometry measurements were performed 
on at least three independently synchronized cell populations for each treatment group. 
3.2.4 R a m a n micro-spectroscopy 
Raman spectra were measured with a Renishaw InVia spectrometer connected to a Leica 
microscope, described in detail in Chapter 2. Before Raman analysis, the cell culture medium 
was removed and the cells rinsed twice with PBS. Spectra of live cells were measured in PBS 
maintained at 37°C. A high power 785 nm diode line focus laser (~120 mW power at the 
sample) was used for excitation. The laser was focused on individual cells by a x63 (NA 
= 0.9) long working distance (2 mm) water immersion objective. Under these conditions, 
the laser illuminates an elliptical region at the focal plane, with approximately 10 j^ m x 20 
jim lateral spatial resolution. The spectrum of each cell was calculated as the average of 
four or five spectra (depending on cell size and morphology) measured at difl'erent lateral 
positions to ensure a complete mapping of the cell. Each point spectrum was integrated for 
40 seconds, giving a total spectral integration time of 160-200 seconds per cell. 
Fifteen cells per cell cycle group were analyzed with Raman micro-spectroscopy. To 
reduce the influence of system variability, and to hmit the potential of artificial data clustering 
[16], cell spectra were measured on three separate days, with five cells per treatment group 
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analyzed per day. Spectra were collected from a glass reference sample each day to correct 
for instrument response. The spectrum of PBS buffer was measured each day, with signal 
integration time of 300 seconds. 
Reference cellular components, phosphatidyl choline (lipid), DNA (nucleic acid), and 
actin (protein) were purchased from Sigma Ltd. (UK) and used without further preparation. 
The spectra of the dry samples were measured for comparison with the principal component 
loading vectors generated by PC A. 
3.2.5 D a t a aiiEilysis 
Signal processing 
Raman spectra were pre-processed and analyzed in Matlab (The Math Works, Natick, MA) 
using software routines described in Chapter 2. The PBS contribution to the signal was sub-
tracted using the projection method described by Maquelin et al [93], and the background 
was corrected using the Modpoly algorithm described by Lieber and Mahadevan-Jansen 
(5*^  order polynomial, 1000 iterations) [108]. The wavenumber axis of each spectrum was 
then standardised and aligned to the sharp phenylalanine peak at 1003 cm~\ and the mean 
spectrum for each cell was calculated from the aligned group of 4-5 spectra per cell. Av-
erage spectra for each treatment group were calculated from the 15 mean cell spectra per 
group, which were individually smoothed using a Savitsky-Golay filter (5 points, 2""^  order 
polynomial) [107], and then normalised using the standard normal variate (SNV) trans-
formation [5]. For PCA, spectral differentiation of the aligned, PBS-corrected spectra was 
used to remove the background, instead of the Lieber and Mahadevan-Jansen method. Sec-
ond derivative spectra were computed using a Savitsky-Golay filter (21 points, 2""^  order 
polynomial) and then normalised using the SNV transformation. 
Multivariate analysis 
The mean-centred, second derivative Raman spectra were analyzed using a singular value 
decomposition PCA algorithm. PC score plots were used to identify clusters within the data, 
and the PCs were analysed to extract biochemical information from the spectral differences 
between cells in different phases of the cell cycle. Significant PCs were then used to generate 
an LDA model, and the cell synchronization results obtained by flow cytometry were used to 
calculate the prior probabilities of each cell cycle group. Classification accuracy was assessed 
using leave-one-out cross-validation, whereby the class of a spectrum is predicted using an 
LDA model built from the full data set excluding the spectrum in question. This method 
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was repeated, with each spectrum left out in turn, so that each spectrum was predicted once. 
3.3 Resul t s 
3.3.1 F low c y t o m e t r y 
Flow cytometry was used to assess cell cycle synchronization induced by serum starvation and 
cell cycle inhibitors aphidicolin and nocodazole. DNA content histograms which describe the 
percentage distribution of cells in Gq/Gi , S, and G2/M phases of the cell cycle are included 
in Figure 3.1. Serum starvation rendered cells quiescent in Go/Gi with 94% accuracy, and 
mitotic block with nocodazole synchronized 77% of cells in G2/M. Synchronization at the 
Gi/S-transition point with aphidicolin synchronized 94% of cells in Gq/Gi (n=5, data not 
shown), and subsequent washout with re-stimulated growth successfully synchronized 68% of 
cells in S phase. Given the difficulty associated with S-phase synchronization, these results 
compare favourably with MG63 synchronization results reported in the literature [131, 133], 
and are higher than contact-inhibition synchronization achieved in previous Raman cell cycle 
studies [83]. The distribution of asynchronous cells was approximately 60% Gq/Gi , 15% S 
phase, and 25% Gg/M (n=3). 
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Figure 3.1: Flow cytometry analysis of MG63 cell synchronisation. Representative DNA content histograms 
are shown for A cells blocked in G o / G i b y serum starvation (n=4), B cells synchronised in S phase with 
aphidicolin, washout and re-stimulated growth (n=3), and C cells arrested in G2/M with nocodazole (n=3). 
Cell cycle markers used to estimate the percentage distribution of cells in each phase are also included. 
3.3.2 Cell morphology 
MG63 cell morphology varied at different points of the cell cycle. Gq/Gi cells were elongated, 
whereas S and G2/M cells showed a gradual progression to a more rounded morphology. Cells 
round up during mitosis as the cytoskeleton rearranges, but Gg/M arrest by nocodazole, 
an anti-microtubule agent which disrupts the cellular cytoskeleton, may contribute to the 
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rounding of Gg/M cells [126]. Pictures representative of cell morphology for each cell cycle 
group are included in the insets of Figure 3.2. 
3.3.3 R a m a n cell spectra 
The average normalised Raman spectra of MG63 cells synchronized in Go/Gi, S, and 
Gg/M phases of the cell cycle (after pre-processing) are shown in Figure 3.2. The spec-
tra of MG63 cells reported here are similar to previously published Raman spectra of MG63 
cells [16], and consist of peaks corresponding to molecular vibrations of all cellular com-
ponents {i.e., nucleic acids, proteins, lipids, and carbohydrates). A detailed table of peak 
assignments is included in Appendix A (Table A-1). 
600 800 1000 1200 1400 1600 1800 
Raman shift (cm" ) 
F i g u r e 3.2: Average processed Raman spectra of MG63 cells (middle black lines represent averages, shaded 
areas s tandard deviation): spectra are labelled as Go/Gi , S phase, and G2/M , based on cell cycle treatment. 
The spectra have been shifted vertically for clarity. Representative pictures of synchronised cells are included 
in the insets (scalebar — 10 /um). 
3.3.4 Unsuperv i sed P C A 
The scree plot of singular values generated by the PCA indicated the first six PCs accounted 
for the main sources of variance, a conclusion supported by the low signal-to-noise ratio 
(SNR) observed in the higher PCs. 
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PCA was used to compress the high-dimensional spectral data to scores on the first 
six PCs. The PCs contain spectral features corresponding to the main molecular species 
responsible for the statistical variation between spectra. Principal component 1 (PCI) was 
dominated by lipid spectral features, with peaks at 717, 877, 980, 1265, 1301, 1440, 1660 
cm" \ all of which describe molecular vibrations in lipids. These features are highlighted in 
Figure 3.3, where PCI is compared to the second derivative Raman spectrum of phosphatidyl 
choline (P-Ch), a model lipid. A statistically significant correlation (Rpci=0.85) between 
PCI and P-Ch was obtained by calculating the correlation coefficient (R), which provides 
a statistical measure of the similarity between spectra (identical spectral profiles exhibit a 
correlation coefficient of unity, i.e. R=l ) . PC3 displayed prominent features found in spectra 
of nucleic acids {e.g. DNA, with peaks at 729, 786, 1095, 1260, 1375, 1490, and 1578 cm"') 
and cellular proteins {e.g. actin, with peaks at 620, 854, 1003, 1033, and 1125 cm"'). These 
marker peaks are indicated in Figure 3.4, where PC3 is compared to the sum of the second 
derivative Raman spectra of DNA and actin (to model nucleic acid and protein, respectively). 
Statistical comparison of these two spectral vectors yielded a correlation of Rpca—0.62. PC2 
and PC4-PC6 had lower SNR and contained little information. Furthermore, the scores on 
PC2 revealed clustering according to the day of spectral acquisition: spectra measured on 
the same day tended to cluster together, with sub-clusters of segregated cell cycle groups. 
Despite every effort taken to minimise spectral variation, day-to-day spectral variation can 
occur due to instrumental factors or variation in sample preparation. Previous Raman cell 
biology studies have also reported significant day-to-day spectral variation [93, 83]. The 
segregation of the effects of day-to-day spectral variation into a single PC makes it easier 
to filter out these influences on the data, which otherwise might affect data interpretation. 
It also justifies collection of cell spectra from all phases on each experimental day in order 
to compensate for day-to-day variation, and thereby prevent artefactual clustering of cell 
spectra {i.e. clustering of spectra based on noise or daily system variation) [16]. 
In generating PCs, the PCA algorithm assigns score values on each PC to each spectrum, 
where a score value represents the contribution of a PC to a spectrum. PC score plots can 
be used to identify clustering of data within the PC model. Clustering of cell cycle groups 
was observed by plotting the scores on PCl versus scores on PC3 (Figure 3.5). Gq/Gi and 
G2/M cells were separated with only a few G^/M-blocked cells grouping near the Gq/Gi cell 
cluster (Figure 3.5A). Plotting the scores of S phase synchronized cells (Figure 3.5B) revealed 
that they he in a broad band between the Go/Gi and Gg/Mcell clusters, with much larger 
variance than the other cell groups. 
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F i g u r e 3.3: Comparison of P C I with the second derivative spectrum of phosphatidyl choline (P-Ch). Com-
mon peaks are indicated, and the spectra have been shifted vertically for clarity. 
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F i g u r e 3.4: Comparison of PCS with the vector sum of the second derivative spectra of DNA and actin. 
Common peaks are indicated, and the spectra have been shifted vertically for clarity. 
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3.3 .5 S u p e r v i s e d L D A 
The significant PC scores were used to generate an LDA classification model in order to 
differentiate between cells synchronized in different cell cycle phases. The scores on PC2, 
which described day-to-day spectral variation, were not included in the LDA model. The 
LDA prior probabilities of each cell cycle group were calculated using the cell synchronization 
data obtained using flow cytometry. In a standard LDA, the prior probability of class k, 
7r(A:), is found simply by calculating its frequency within the training data, i.e. ^ for 
the current data. However, this assumes 100% synchronization efficiency of the chemical 
treatments, which is not the case. Instead, the cell cycle distribution data from Figure 3.1 
should be incorporated to calculate the prior probability for the Gq/Gi phase class as 
7r(Go/Gi) = ^ (Go/Gi%) -H ^ (S%) 4- ^ (G2/M%) 
(94.1%) 4- (27.9%) -t- (6.2%) 
= 0.4273. 
This expression describes the probability that an arbitrary spectrum belongs to a Gq/Gi-
phase cell, by incorporating the probabihty of analysing a Gq/Gi phase cell within the 
Go/Gi-synchronized culture (94.1%), and within the S phase-synchronized (27.9%) and 
Gg/M -synchronized (6.2%) cultures. Similarly, the prior probabilities for S and Gg/M phase 
classes were calculated as 
7i"(S) = ^ (2.0%) -I- ^ (68.1%) -I- ^ (16.6%) = 0.2890 
7r(G2/M) = (3.9%) + (4.0%) -k (77.2%) = 0.2837 
Two linear discriminant functions (LDl and LD2) were generated from the scores on P C l -
PC6 (exclusive of PC2). These scores were then projected onto LDl and LD2 to produce an 
LDA score plot (Figure 3.6). 
The results of the LDA model cross-validation are reported in Table 3.1. The rows of the 
table show the total number of spectra measured for each cell type, while the columns indicate 
the number of spectra the LDA predicted as belonging to each cell group. The number of 
spectra correctly predicted is shown in bold, and non-bold entries represent misclassifications. 
The overall predictive accuracy of the algorithm was calculated and expressed in terms 
of sensitivity and specificity for each cell cycle group. LDA model classification accuracy 
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was highest for cells synchronized in Go/Gi(93%), with only one cell misclassified as an 
S phase cell. Classification accuracy was lower for cells synchronized in S phase (67%), 
with five cells misclassified. The predictive power was lowest for Gg/M phase cells (60%), 
with five cells misclassified as S phase cells and one as a Go/Gi phase cell. Overall, 73% 
of the cells were correctly classified, with most errors occurring due to misclassification of 
cells synchronized in G^/M phase as S phase cells. With only one misclassification between 
Go/Gi and Gg/Mcell populations, the PCA-LDA model exhibits excellent 97% spectral 
discrimination between Go/Gi and G2/M phase cells. In addition, the model demonstrated 
89% spectral discrimination between quiescent Gq/Gi phase cells and actively cycling cells 
in S or Gg/M phases. 
Raman-predicted 
cell cycle stage 
Cell Cycle Block S phase G2/M 
Go/Gi 14 1 0 
S phase 3 10 2 
G2/M 1 5 9 
Sensitivity (%) 93 67 60 
Specificity (%) 87 80 93 
T a b l e 3.1: Cell cycle classification accuracy of three-group LDA model as assessed by leave-one-out cross-
validation. 
78 
Chapter 3; Non- invas ive spectra l analys is of cell cyc le d y n a m i c s 
3.4 Discussion 
Spectra of cells from MG63 cultures synchronized in Go/Gi , S, and Gg/M phases of the cell 
cycle were collected to study changes in Raman spectra of live MG63 cells as a function 
of cell cycle phase. The flow cytometry results (Figure 3.1) revealed excellent levels of cell 
cycle synchronization, indicating that the synchronized populations analyzed with Raman 
micro-spectroscopy contained high-proportions of cells within the correct target phase. Once 
cell cultures were synchronized, the use of a line focus laser with a large spot-size {i.e. not 
diffraction-limited) facilitated rapid collection of spectra from single living cells within a 
matter of minutes. 
The Raman spectra of synchronized MG63 cells reported here (Figure 3.2) indicate minor 
spectral variations between cell cycle groups. The similarity between spectra of cells in 
Go/Gi, S, and G2/Mis expected, given that the cells were from the same cell line and differed 
only in cell cycle phase, and also because spectral changes were monitored on the level of the 
entire cell, rather than subjective targeting of specific sub-cellular regions (e.g. cell nuclei). 
The small standard deviations within each cell cycle group suggest cell populations with a 
high degree of homogeneity, in agreement with the flow cytometry results. 
Principal components analysis (PGA) was used to identify the spectral peaks which 
account for the variance between spectra of cells synchronized in different cell cycle phases. 
PCI (Figure 3.3) and PCS (Figure 3.4) described significant trends within the data, with PCI 
describing changes in cellular lipid and PC3 changes in DNA and protein. The observation 
of biochemical-specific spectral peaks in the PCs was supported by statistically significant 
correlation between the PCs and the spectra of reference cellular components (PCI and P-
Ch, Rpci=0.85, and PCS and DNA -|- actin, Rpc3=0.62). In general, PCs computed in a 
PGA do not represent pure biochemical components, but rather combinations of peaks from 
multiple components [90]. This explains the presence of extra peaks in the PCs and why 
the correlation coefficients are less than one: the significant correlation Rpci=0.85 indicates 
that PCI mostly describes lipid features, which account for the highest variance within the 
dataset, but also contains some additional information about molecular vibrations of other 
cellular components. PCS captures the smaller variance due to changes in nucleic acids and 
proteins (Rpc3=0.62), as well as some additional biochemical components. Discrepancies 
between the PCs and reference spectra, and hence lower correlation coefficients, may also be 
due in part to the comparison of solid state spectra of the dry reference components with the 
PCs derived from solution phase spectra. The fact that more changes in cellular lipids were 
detected than in DNA and protein is not surprising, for two reasons: cells contain much more 
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lipid than DNA, and the results presented here represent spectral changes on the level of the 
entire cell; and it is likely that it is specific types of protein rather than total protein content 
which changes as cells advance through the cell cycle [112]. However, these findings differ 
from an earlier study by Notingher et al. [14], where changes in the levels of DNA accounted 
for the most significant differences between the spectra of A549 adenocarcinoma cells from 
a confluent monolayer and spectra of rounded cells on top of the monolayer. Those findings 
were interpreted as spectral differences between cells resting in Go/Gi and those actively 
dividing in S/Gg/M phases of the cell cycle, respectively. However, contact inhibition alone 
generally yields low levels of synchronization, and the degree of synchronization was not 
assessed, nor was the cell cycle phase of individual cells confirmed. These discrepancies may 
be due to analysis of cell clusters and confiuent cell layers rather than single individual cells. 
PC A also serves as an unsupervised clustering algorithm to examine grouping of data. 
PGA assigns score values on each PC to each spectrum, where a score value represents the 
contribution of a PC to a spectrum. PC score plots can be used to determine whether 
or not spectra are related: clustering or grouping of spectra within these plots indicates 
systematic differences between the spectra. The clustering of cell cycle groups in the P C l -
PC3 score plot (Figure 3.5) suggests that cluster heterogeneity increases as synchronization 
efficiency decreases; the increasing variance (i.e. cluster spread) in cell cycle populations from 
Go/Gi to Gz/Mto S phase reflects the lower efficiencies of G2/M and S phase synchronization. 
The cluster positions (Gq/Gi —^  S ^ G2/M) reveal a decrease in score value on PCI and 
an increase in score value on PCS, which implies a decrease in cellular lipid content and 
increases in cellular nucleic acid and protein content as cells progress through the cell cycle. 
A previous study in which suspensions of viable, synchronized cells were investigated with 
Raman micro-spectroscopy to characterize spectral patterns related to the cell division cycle 
also reported similar trends [83]. 
The clustering in the PC1-PC3 score plot (Figure 3.5) is similar to the cell cycle depen-
dent variations in Fourier transform IR (FTIR) micro-spectra of single HeLa cells recently 
reported by Boydston-White et al. [112]. In that study, good spectral discrimination be-
tween Go/Gi, S, and G2/M phase cells was achieved with PCA applied only to the amide 
I region (1598-1702 cm~^) of cell nucleus spectra. The PCA presented here was not con-
fined to a narrow spectral band, and so discrimination is based on spectral features from 
multiple biochemical components over the entire spectral fingerprint range (600-1800 cm'^). 
The fact that this cell cycle trend is preserved despite the use of different mammalian cell 
hnes (MG63 versus HeLa), vibrational spectroscopic techniques (Raman micro-spectroscopy 
versus FTIR), and sample preparation conditions (live cells versus formalin-fixed and dried 
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cells) illustrates the potential of vibrational spectroscopy as a robust and powerful tool for 
non-invasive cellular biochemical analysis. 
The significant PC scores from the PCA were used to generate a supervised LDA model 
to classify cells according to cell cycle phase. The LD1-LD2 plane (Figure 3.6) represents 
the optimal spectral subspace for group discrimination. The LDA separated Go/Gi phase 
cells from S and G2/M phase cells along the direction of LDl, reducing the overlap between 
clusters of G q / G i and G2/M phase cell populations observed in the PC1-PC3 score plot (Fig-
ure 3.5A). The LDA also decreased the spread of the diffuse cluster of S-phase synchronized 
cells. These results can be attributed to the fact that LDA model discrimination is based on 
score values on five PCs (PCI, PC3-PC6), whereas the PC1-PC3 plane only represents a 
small subset of the larger PC-space from which the functions LDl and LD2 were computed. 
The PCA-LDA model exhibited excellent 97% spectral discrimination between Go/Gi 
and G2/M phase cell populations. The high efficiency of Go/Gi(94%) and Gg/M (77%) 
synchronization combined with the high sensitivity of Raman spectral characterization en-
ables reproducible detection of cell cycle specific differences between these extremes of the 
cell cycle. Furthermore, the model also demonstrated a high-level of spectral discrimina-
tion (89%) between G q / G i phase cells and actively cycling cells in either S or G2/M phases. 
These results refiect the high synchronization efficiency of serum starvation and hence in-
creased homogeneity of the G q / G i cell population over the S and G 2 / M phase groups. This 
is also evident when all three cell cycle groups are considered separately: classification ac-
curacy for Go/Gi group (93%) is much higher than that observed for either S-phase (67%) 
or G2/M (60%) cells. A decrease in synchronization efficiency leads to a loss in predictive 
power, due to increased cluster overlap and higher levels of data label uncertainty. While 
the PCA results indicate spectra of S-phase cells display features intermediate to those of 
Go/Gi and G2/Mcell spectra, the LDA projection (Figure 3.6) appears to merge the S and 
G2/M phase clusters, obscuring class distinction which leads to lower prediction accuracy. 
The LDA model classification accuracy was assessed using cross-validation (Table 3.1) 
did not decrease with decreasing synchronization efficiency, i.e. G o / G i > G2/M > S, as 
expected. This trend was expected based on the observation that cluster heterogeneity in 
the PC1-PC3 plane appeared to increase with decreasing synchronization efficiency, and 
given that the accuracy of classification algorithms generally decreases as cluster hetero-
geneity increases. However, the LDA model prior probabilities explain the observed trend: 
although the synchronization efficiency for G2/M phase arrest (77%) is higher than that for 
S phase synchronization (68%), the prior probabihty for the S phase class, 7r(S) = 0.2890, 
is slightly greater than the prior probabihty for the G2/M phase class, 7r(G2/M) = 0.2837. 
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Thus LDA classification accuracy decreased with prior probability, rather than synchroniza-
tion efficiency. Also, it is possible that the population of S phase cells within the five-
dimensional PC-space (PC1-PC6 exclusive of PC2) may in fact be less heterogeneous than 
the G2/M phase cell population, at least within the current model. In this case, examining 
the data in the two-dimensional PC1-PC3 plane could produce a distorted representation of 
the overall structure of the data clusters. This interpretation is supported by the LDA score 
plot (Figure 3.6), where the S phase cell population is actually less heterogeneous than the 
GG/M phase cluster, if cluster heterogeneity is estimated by the average Euclidean distance 
of the data from the cluster centroid in the LD1-LD2 plane. 
3.5 F u t u r e work 
The main goal of this and other Raman-based research of the cell cycle is to predict using 
PCA and/or LDA the cell cycle phase of a single living cell based solely on it's Raman 
spectrum. The research presented in this chapter is the first step in building a library of 
spectra and multivariate statistical models with which to make predictions for unknown 
samples. One limitation with the current LDA model is that it requires unequivocal initial 
labelling of spectra as G q / G i , S, or G G / M phase cell spectra. Initial labelhng does not 
incorporate class prior probabilities, which account for imperfect cell synchronization. As the 
exact cell cycle phase of each individual cell was not determined, the initial labelling is based 
on the cell synchronization treatment administered, rather than on true/verified cell cycle 
phase. Thus the supervisor for the LDA model is imperfect, and has to contend with some 
degree of "label noise". In this case, it is possible that some misclassified Gg/Mphase cells 
were actually in S phase of the cell cycle, and hence correctly classified, but are considered 
misclassified because they were initially labelled as G2/M phase cells. A similar argument 
holds for misclassified G O / G I and S phase cells. Thus, the use of data which does not 
permit unambiguous initial labelling is likely to be a contributing factor to LDA model 
misclassifications. Future development of fully supervised classification models which can 
incorporate label noise in the training data, or removal of initial label noise by way of 
fluorescence staining to confirm the cell cycle status of individual cells [112] may lead to 
improvements in cell cycle-related spectral discrimination and classification in larger samples 
of synchronized cells. 
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3.6 Conclusions 
In this study the high sensitivity and non-invasive sensing capabihties of Raman micro-
spectroscopy were used to characterize biochemical dynamics related to the cell division 
cycle within live, synchronized cells. By analysing live cells in situ, the possibility of arte-
facts arising from fixation and desiccation were avoided. The high levels of chemical syn-
chronization enabled spectra of individual cells from the target phases to be collected and 
subsequently analyzed using multivariate statistics. Small biochemical differences between 
cells were detected and used to classify cells based on their Raman spectral signatures. This 
research demonstrates the potential for Raman micro-spectroscopy to non-invasively assess 
cell-cycle related changes {e.g. retardation, impairment, apoptosis) induced by pharmaco-
logical treatments of cells grown in vitro, or by cell interactions (attachment, differentiation, 
and proliferation) with biomaterial substrates. 
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Chapter 4 
Spectral monitoring of alveolar 
epithelial type II cell differentiation 
This chapter investigates the biomolecular characterisation of pulmonary alveolar type II 
(ATII) cell differentiation in vitro using Raman micro-spectroscopy. ATII cells are progen-
itor cells for alveolar type I (ATI) cells in vivo, and spontaneously differentiate towards an 
ATI-like phenotype in culture. Both undifferentiated and differentiated primary human ATII 
cells were analysed, and Raman spectral changes correlated to cellular changes in morphol-
ogy and marker protein synthesis (surfactant protein C, alkaline phosphatase, caveolin-1). 
The spectra of undifferentiated ATII cells contained strong phospholipid vibrations, aris-
ing from alveolar surfactant stored within cytoplasmic lamellar bodies (Lbs). Differentiated 
ATI-like cells yielded spectra with significantly less lipid content. Factor analysis revealed 
a phospholipid-dominated spectral component as the main discriminator between ATII and 
ATI-like phenotypes. Spectral modelling of the data revealed a significant decrease in the 
spectral contribution of cellular lipids — specifically phosphatidyl choline, the main con-
stituent of surfactant, as ATII cells differentiate. These observations were consistent with 
the clearance of surfactant from Lbs as ATII cells differentiate, and were further supported 
by cytochemical staining for Lbs. These results demonstrate the first spectral characteri-
zation of primary human ATII cells, and provide insight into the biochemical properties of 
alveolar surfactant in its unperturbed cellular environment. 
4.1 Introduction 
The unique environment of pulmonary alveoli is established and maintained by two highly 
specialized epithelial cell types, alveolar type I (ATI) and type II (ATII) cells. ATI cells 
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dominate the alveolar epithelial lining, covering over 90% of the alveolar surface area [134]. 
ATII cells perform a multitude of indispensable functions, the most important being the 
production, storage and secretion of surfactant, a phospholipid-rich, multi-functional lubri-
cant which reduces alveolar surface tension. Surfactant prevents alveolar collapse during 
ventilation, aids in the maintenance of fluid homeostasis within the alveolus, and has also 
been linked to host defence through the binding of surfactant proteins to pathogens [135]. 
Surfactant produced by ATII cells is stored in cytoplasmic organelles called lamellar bodies 
(Lbs), a distinguishing feature of type II cells. 
ATII cells are also alveolar progenitor cells, and are believed to be the sole progenitor 
for ATI cells in vivo [136]. In vitro, primary ATII cells lose their distinctive phenotype and 
express phenotypic features characteristic of ATI cells [137]. The spontaneous differentiation 
is characterized by morphological changes, such as surfactant clearance, i.e. a decrease in 
the number of surfactant-containing Lbs, and changes in the expression of specific marker 
proteins, such as a decrease in surfactant protein C (SPC), which is unique to the ATII cell 
phenotype [135]. The parallels between mechanisms of ATII cell differentiation in vivo and 
in vitro have yet to be fully defined, and so the in vitro derived phenotype of differentiated 
alveolar epithelial cells is generally referred to as ATI-like. 
Electron microscopy techniques have previously been used to identify the main morpho-
logical and ultrastructural changes during ATII cell differentiation [138], while expression 
of important markers such as surfactant proteins (SPC, SPA, etc.), caveohn-1 and intra-
cellular adhesion molecule-1, have been investigated with immunofiuorescence confocal mi-
croscopy, reverse transcriptase polymerase chain reaction, flow cytometry and immunoblot-
ting [137, 139]. These morphological and immunocytochemical techniques provide insight 
into the differentiation process; however they are invasive, requiring exogenous labelling 
and/or cell fixation or extraction, and therefore, are unsuitable for studies on living cells. 
The non-invasive sensing capability of Raman micro-spectroscopy in combination with its 
compatibility with aqueous systems makes this technique uniquely suited to the biochemical 
analysis of single living cells in vitro [7]. Raman spectra are sensitive to changes in molecular 
composition, and can therefore be used as cell-specific biochemical signatures to discrimi-
nate between different cellular phenotypes [16, 88]. Thus, Raman micro-spectroscopy offers 
the potential to non-invasively characterize biochemical changes in the phenotype of stem 
cells during differentiation. This technique has previously been used to monitor mRNA-
translation during embryonic stem cell differentiation [15], and to study enhanced differen-
tiation of foetal osteoblastic progenitor cells with bioactive glass dissolution ions [19]. 
Witherden and Tetley previously developed a novel procedure for isolation of human 
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ATII cells which results in high ATII cell purity (~95%) [140]. Using this protocol, the 
undifferentiated type II phenotype can be maintained for approximately one week in standard 
immersion cell culture [141], and the ATII to ATI-like cell transition occurs over a period 
of approximately 8-14 days (unpublished observations). In this chapter, the non-invasive 
biochemical characterization of in vitro differentiation of primary human ATII cells with 
Raman micro-spectroscopy is presented. Raman spectra of live ATII cells were measured 
at different points during a differentiation time-course. Cellular changes in morphology and 
marker protein synthesis (SPC, alkaline phosphatase, caveolin-1) were monitored to verify 
the ATII to ATI-like transition of primary cells, and to correlate spectral changes with 
changes in cellular phenotype. ATII cell spectra were analysed with several well-known 
chemometric techniques including principal component analysis (PCA), factor analysis, and 
spectral modelling to identify spectral markers describing important biochemical changes 
which occur during ATII cell differentiation. 
4.2 IVIaterials and IVEethods 
The analysis of primary human ATII cell differentiation with Raman micro-spectroscopy was 
a collaborative project involving Dr. Sarah Kemp and Prof. Teresa Tetley of the National 
Heart and Lung Institute (NHLI), Imperial College London. The sensitive isolation procedure 
of ATII cells was conducted by Dr. Sarah Kemp, who also assisted with cytochemical 
characterisation and immunoblot analysis of ATII cells. All Raman spectroscopy experiments 
and data analysis were performed by the author. 
4.2.1 Isolation and culture of ATII cells 
Primary human alveolar epithelial cells were isolated from normal region of lung tissue fol-
lowing lobectomy for carcinoma. . The ATII cells were isolated as described previously [141]. 
Briefly, the tissue was perfused repeatedly with 0.15 M NaCl to remove leukocytes before 
digestion with trypsin (2.5 /iL/mL HBSS; Sigma, Poole, UK) for 45 minutes at 37°C. The 
tissue was finely chopped in newborn calf serum (NCS; Invitrogen, Paisley, UK), filtered and 
the ATII cells isolated by differential adhesion of contaminating cells. For characterization 
via marker protein synthesis, the non-adherent ATII cells were cultured (0.75 x 10® cells/mL 
media) on collagen type-I coated plates in defined cell culture-1 (DCCM-1) medium (Bio-
logical Industries, Kibbutz, Israel) containing 10% NCS, 100 U/mL penicillin, 100 /ig/mL 
streptomycin, 2 mM glutamine. For characterization by Raman micro-spectroscopy, ATII 
cells were cultured (0.20 x 10® cells/mL media) on collagen type-I coated MgFg coverslips 
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(Global Optics, Bournemouth, Dorset, United Kingdom) in DCCM-1, with supplements as 
above. ATII cells were plated at a lower seeding density on MgFg to facilitate the collection 
of spectra of single, individual ATII cells. 
4.2.2 Alkaline phosphatase staining 
Staining for alkaline phosphatase (ALP) was performed as described previously [141]. 
Washed cells were incubated with alkaline phosphatase stain (10 mg naphthol-AS-bisphosphate 
in 40 yuL dimethylsuphoxide, made up to 10 mL with 0.625 M MgCl and 0.125 M amino 
methyl propanol in distilled water and filtered immediately before use) for 20 minutes at 
37° C and washed with distilled water before viewing. Intense, pink staining identifies ATII 
cells. 
4.2.3 Immuno cytochemistry 
Cell monolayers were washed, fixed in paraformaldehyde (40 //L/mL PBS; Invitrogen), and 
pre-treated by heat to facilitate antigen retrieval (15 minutes at 90°C in target retrieval 
solution; Dako, Ely, UK). Cells were probed with an antibody to pro-surfactant protein-C 
(pSPC, 1 jig/mL rabbit polyclonal; Chemicon (Milhpore), Chandlers Ford, UK) antibodies 
or an isotype specific control at the same concentration. Immunoreactivity of the antibody 
was detected using an indirect streptavidin-biotin method (LSAB kit; Dako) and horse radish 
peroxidase (HRP). Bound antibody was detected as a brown stain. 
4.2.4 Caveolin-1 immunoblott ing 
Confluent cells were lysed in sample bufl^ er (250 mM Tris, pH 6.8; 100 ^L/mL glycerol; 40 
/iL/mL SDS (sodium dodecyl sulfate); 20 /xL/mL 2-mercaptoethanol; 0.1 ijL/mL bromophe-
nol blue) and immediately boiled for 10 minutes. Samples were centrifuged (5 minutes, 7500 
g) before analysis of equal amounts of protein. The amount of protein was determined by lysis 
of additional equivalent wells of cells with PBS containing 20 ^L/mL TX-lOO and analysis by 
a BCA (bicinchoninic acid) assay (Sigma). Proteins were resolved using a NuPAGE 10% Bis-
Tris gel (Invitrogen) with MES (2-(N-morpholino) ethane sulfonic acid) running bufi^ er and 
transferred to a nitrocellulose membrane. The membrane was blocked (50 mg/mL skimmed 
milk powder in Tris NaCl; 1 //L/mL tween-20) for 1 hour at room temperature before being 
probed with an antibody to caveolin-1 (1:2000, rabbit polyclonal; Transduction Laboratories, 
Lexington, KY), overnight at 4°C. Proteins were detected by incubation with HRP conju-
gated anti-rabbit IgG (Dako) and visualized using enhanced chemiluminescence (Visualizer; 
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Upstate (Millipore), Chandlers Ford, UK). Human umbilical vein epithelial cells (HUVECS) 
were used as a positive control. 
4.2.5 Osmium tetroxide staining of lamellar bodies in ATII cells 
Staining of Lbs within primary ATII cells was performed as described previously [142]. 
Briefly, the cells were rinsed in PBS (pH 7.3) and fixed with glutaraldehyde (15 /uL/mL 
PBS) for 15 minutes. The cells were then washed twice and treated with osmium tetroxide 
(10 mg/mL PBS; Sigma) for 90 minutes at room temperature. The cells were then washed 
twice and incubated in tannic acid (10 mg/mL PBS, pH 6.8; Sigma) overnight. After washing 
with PBS (pH 6.8), the cells were examined and photographed under light microscopy. 
4.2.6 Raman micro-spectroscopy 
Raman spectra were measured with a Renishaw In Via spectrometer connected to a Le-
ica microscope, as described in Chapter 2. Spectra of living ATII cells were measured in 
Dulbecco's modified Eagle's medium (DMEM; Sigma) with 1% antibiotic/antimycotic (In-
vitrogen) maintained at 37°C with a heated stage. Cells were serum-starved overnight for 
synchronisation in the Gq/Gi phase of the cell cycle to minimise cell cycle related spectral 
variance (Chapter 3). Spectra of the fingerprint region (550-1850 cm"^) were recorded at a 
resolution of -^1-2 cm"\ with 40 seconds integration time per spectrum. Raman spectral 
characterization of ATII cell phenotype was assessed at three time points post-seeding: early 
(days 3-4), middle (days 10-11), and late (days 17-18). Two-day time points were used to 
facilitate Raman analysis of sufficient numbers of cells. 
4.2.7 D a t a analysis 
Signal processing 
Raman spectra were intensity-corrected for instrument response to minimise the effects of 
day-to-day spectral variation [16], and normalized with extended multiplicative signal cor-
rection (EMSC) [109]. Spectra were smoothed using a Savitsky-Golay filter (5 points, 2"'' 
order polynomial) [107], and the wavenumber axis of each spectrum was standardised and 
aligned to the sharp phenylalanine peak at 1003 cm~\ and truncated to the 600-1800 cm~^ 
spectral region. Where spectra have been baseline-corrected, the Modpoly algorithm de-
scribed by Lieber and Mahadevan-Jansen (5'^  order polynomial, 1000 iterations) [108] was 
used to eliminate fluorescence and other background effects. 
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Multivariate analysis 
Multivariate PCA, factor analysis, and least-squares spectral modelling were described in 
detail in Chapter 2. Pre-processed Raman spectra were analysed using a singular value 
decomposition PCA-algorithm to identify the biochemical differences between spectra of 
primary ATII cells at different stages of differentiation. Multivariate factor analysis was 
then applied using the PCA results in order to obtain a more interpretable form of the PC 
loading vectors. Multi-variate curve resolution (MCR) was used to rotate the significant PCs 
using a constrained iterative least squares solver subject to non-negativity constraints. 
A non-negative least-squares fitting procedure was used to estimate the signal contri-
bution of biochemical components to the Raman spectral signatures of primary ATII cells. 
Each mean ATII cell spectrum was modelled by a linear combination of "basis" spectra, 
i.e. spectra of representative cellular biochemical components [89]. Details of the reference 
biochemicals used in spectral modelling were included in Chapter 2. Briefly, the basis com-
ponents included spectra of nucleic acids (DNA and RNA), proteins (actin, human serum 
albumin, chymotrypsin and collagen), carbohydrates (glycogen), lipids (phosphatidyl choline 
and cholesterol), and a 5"" order polynomial (to model the background signal). The quality 
of the fitting was assessed by comparing model spectra to the empirical data by examining 
residuals, and by computing the correlation coefficient (R) between each original spectrum 
and its model spectrum. The correlation coefficient provides a statistical measure of the 
similarity between spectra [68], and was used here as a goodness-of-fit parameter (R=l for 
identical spectral profiles). 
4.3 Results 
4.3.1 Characterization of ATII cell phenotype 
Early time-point ATII cells (d3-4) were small and cuboidal in shape, grouped together to 
form small islands of cells when cultured on MgFa coverslips, and demonstrated positive 
staining for numerous Lbs (Figure 4.1 A) — the main morphological feature of ATII cells. 
These cells formed monolayers when cultured on tissue culture plates, and demonstrated 
intense positive staining for ALP (Figure 4.2A) and pSPC (Figure 4.2B), both markers for 
the ATII phenotype. Cells cultured on MgFg coverslips were slightly larger than those on 
tissue culture plates, most likely because they were plated at a lower seeding density and 
thus had more room to spread out. ATII cells cultured on MgF2 also stained positive for 
ALP and pSPC markers (Figure B-1, Appendix B). 
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F i g u r e 4.1: Morphology of primary ATII cells cultured on MgFg coverslips. Light microscope images of 
ATII cells stained with osmium tetroxide and tannic acid for the presence of Lbs. Shown are typical staining 
pictures of cells collected at the A early time-point (d3-4), B middle time-point (d lO- l I ) , and C late time-
point (dl7-18). The dark osmiophilic granules indicate cytoplasmic Lbs. Scalebar = 20 /jm. 
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F i g u r e 4.2: Characterisation of primary ATII cells. A Positive ALP and B pSPC staining of human ATII 
cell monolayers. C Western blot of caveolin-1 (a- and /3-iso-forms) expression from ATII cells over 18 days. 
HUVEC represents the positive control for caveolin-1. Scalebar = 50 /xm. 
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Over the 18-day culture period, the ATII cells flattened and spread out, demonstrating a 
roughly circular, elevated, central perinuclear region, surrounded by large, thin, and feature-
less cytoplasmic attenuations [138]. In some regions the squamous cells formed a continuous 
epithelial monolayer, but several individual, isolated cells were also present. The clearance 
of cellular surfactant during differentiation was evident by the reduction in the number of 
cells containing Lbs as well as the number of Lbs per cell (Figure 4.1). This is consistent 
with the secretion of surfactant from ATII cells into the cell culture media, as demonstrated 
in previous in vitro investigations of ATII cell differentiation [143]. Late-culture ATII cells 
(d 17-18) contained few Lbs, and when present, were observed throughout the perinuclear 
region but were scarcely observed in the flattened, peripheral attenuations. The decrease 
in staining intensity for both ALP and pSPC (Figures 4.2A and B) over time indicates an 
increase in the number of differentiated cells in culture. Positive expression of the ATI-like 
phenotype was confirmed by examining caveolin-1 protein expression by immunoblotting 
(Figure 4.2C). Caveohn-1 is a major structural protein of caveolae, plasma membrane in-
vaginations involved in membrane transport, which are features of ATI cells, but are absent 
or only weakly expressed in ATII cells [139]. The western blot indicates low caveolin-1 levels 
for early culture cells (day 4), and higher expression for late culture cells (days 11 and 18). 
The decrease in caveolin-1 expression from day 11 to day 18 may be due to fewer numbers 
of cells at the late time point, possibly reflecting loss of cells through cell death or loss of 
phenotype over time in vitro. 
4.3.2 Spectral variability within single living ATII cells 
For each cell, Raman spectra were measured at different positions to study spectral varia-
tion with respect to spatial location. Significant spectral heterogeneity was observed between 
spectra collected from the nucleus and cytoplasm of early-culture ATII cells (Figure 4.3). Cy-
toplasm spectra {e.g. spectrum 1, Figure 4.3) were very intense and dominated by molecular 
vibrations from phospholipids (Table 4.1) [144]. The high signal intensity and prominent 
phospholipid features are due to the presence of Lbs, cytoplasmic organelles densely packed 
with surfactant, which is rich in phosphatidyl chohne. The strong similarity between this 'Lb 
spectrum' and the Raman spectrum of phosphatidyl choline is also highlighted in Figure 4.3. 
In contrast, spectra collected from cellular regions including the nucleus [e.g. spectrum 2, 
Figure 4.3), had much lower intensity and resembled typical, protein-dominated cell spectra 
with minor contributions from nucleic acids and lipids [54, 3]. Spectra 1 and 2 exhibit 
clear differences in several bands specific to lipids, amino acids, and nucleotides, as well as 
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F i g u r e 4.3: A Raman spectra collected from the cytoplasm (spectrum 1) and nucleus (spectrum 2) of an 
early-culture (d3-4) ATII cell. The spectrum of phosphatidyl choline (PCh) is included for comparison with 
spectrum 1. The spectra have been corrected for instrument response, baseline-corrected, the wavenumber axis 
standardised and aligned, and the PCh spectrum scaled to represent equal maximum intensity to spectrum 
1. B Light microscope picture of an early-culture ATII cell. C Same cell as in B , with sites of spectral 
acquisition labelled 1 and 2. Ellipses indicate the region probed by each scan. The spectra are offset for 
clarity. The correlation coefficient between spectrum 1 and the PCh spectrum is R = 0.97. Scalebar = 5 /um. 
Raman shift (cm Lipid peak assignment 
717 
875 
1062,1122 
1082 
1266 
1301 
1440 
1656 
1740 
choline headgroup: CN+ (CHg)^ stretch 
C-C-N+ symmetric stretch 
out-of-phase and in-phase modes of all-trans chain 
gauche conformation 
C=C-H in-plane bend of the cis -CH=CH- linlcage 
in-phase CHg twisting mode 
CH bending modes, including CH2 scissors and CH3 
degenerate deformation of hydrocarbon chains 
C=C stretch of the cis -CH=CH- linkage 
of unsaturated lipid chains 
carbonyl C = 0 ester stretch 
Table 4.1: Assignments for prominent Raman shifts arising from molecular vibrations in cellular lipids. 
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bands which contain information from some or all of these biopolymers, including symmetric 
PO^ stretch (1095 cm~^), C-H deformation (1440 cm"^), amide I (1656 cm~^) and amide 
III (1250-1350 cm"^) envelopes [89]. For example, the broadening of the 1656 cm"^ C=C 
stretching band from unsaturated lipid chains compared to the pure PCh spectrum is due 
to amide I modes of proteins (C=0 stretching mode, peptide linkage), which feature much 
more prominently in spectrum 2, where the 1656 cm"^ band is broader and weaker than in 
spectrum 1. 
The variation in Raman spectra with respect to spatial location reflects the significant 
compartmentalisation of surfactant phospholipids within cytoplasmic Lbs. The high degree 
of spectral variation observed here is in contrast to the results of Chan et al, who re-
ported very small variability between spectra collected at different sites within single living 
haematopoietic cells [88]. These findings validate our approach to collect several spectra per 
cell to ensure that Raman signatures are based on Raman scattering from the entire cellular 
volume. The intra- and inter-cellular spectral variation is further highlighted in Figure 4.4, 
which demonstrates that similar spectral heterogeneity was observed in separate ATII cells. 
4.3.3 Biomolecular characterization of single living ATII cells 
Early-culture ATII cells had typical dimensions of approximately 20 fim x 30 fxm, meaning 
that three spectra were adequate to probe a single cell. Middle and late-culture ATII cells 
were much larger, with the main cellular features confined to a central perinuclear region. 
Perinuclear spectra exhibited features of proteins, lipids and nucleic acids, but lacked the 
intense lipid peaks which dominated the spectra of early-culture ATII cells. Spectra collected 
from thin cytoplasmic attenuations were extremely weak, noisy, and did not display signif-
icant features above the signal of the DMEM culture medium (Figure B-2, Appendix B). 
Therefore, only the perinuclear regions of larger, flattened ATI-like cells were analysed. This 
approach helped to expedite live cell analysis and preserve signal quality. Furthermore, the 
perinuclear regions of such cells were similar in size to full, early-culture ATII cells, and could 
be scanned with three spectra. 
For each cell, the spectral measurements were averaged, with the mean Raman spectrum 
representing the cell's biomolecular fingerprint. The average processed Raman spectra of 
ATII cells from each of the three time points are shown in Figure 4.5A. Solid black lines 
denote average spectra, which represent the mean of 183, 204, and 171 spectra collected 
from 61 early culture ATII cells (spectrum 1), 68 middle time point cells (spectrum 2), and 
57 late time point cells (spectrum 3), respectively. The grey lines represent ± one standard 
deviation from the mean. All of the spectra exhibit similar general features, and consist of 
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F i g u r e 4.4: Raman spectra collected h o m the cytoplasm (spectra 1 and 2) and nucleus (spectrum 3) of 
two different early-culture (d3-4) ATII cells (A and B) , illustrating the high degree of spectral heterogeneity 
with respect to spatial location within ATII cells. The spectra have been corrected for instrument response, 
baseline-corrected, the wavenumber axis standardised and aligned, and are offset for clarity. Light microscope 
pictures of the live cells in culture are included, and the sites of spectral acquisition indicated (ellipses). 
Scalebar = 5 /um. 
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peaks corresponding to molecular vibrations of all cellular biopolymers. Detailed tables of 
peak assignments are included in Table A-1, Appendix A. The small standard deviations 
within each group indicate that Raman spectral characterization of ATII cell phenotypes 
were highly reproducible. 
Of note is that the magnitude of the intra-group variance was smaller than the inter-group 
differences for both early and late time points. This is highlighted in Figure 4.5B, where 
the standard deviation plots for early (spectrum b) and late (spectrum c) time points are 
compared to the absolute value of the difference spectrum between early and late time point 
ATII cells (spectrum a). The absolute value of the early - late difference spectrum was taken 
for comparison purposes, as the standard deviation plots are strictly non-negative. The grey 
bars in Figure 4.5B highhght spectral regions where the inter-group differences (between early 
and late time point cells) are significantly greater than the intra-group variances. Figure 4.6 
is a scatter plot of the intensity values of select peaks from early (black lines) and late (red 
lines) time point ATII cell spectra and their average ± standard deviation intensity values. 
All indicated peaks have significantly different (p <C 0.05) mean intensities as determined by 
t-test analysis. 
4.3.4 Principal components-based factor analysis 
PCA was performed on the pre-processed, average Raman spectra of ATII cells. The first six 
PCs were identified as the main descriptors of spectral variance (accounting for 83%), while 
the remaining PCs were noisy and each accounted for less than 1% of the total variance. 
The PCs are abstract vectors, containing both positive and negative peaks from multiple 
biochemical components. PCI, for example, displayed prominent lipid features, and was 
very similar to the difference spectrum between the mean spectra of early and late time-
point ATII cells presented in Figure 4.5 (R=0.84, Figure B-3, Appendix B). The clustering 
of early and late time point ATII cells into distinct groups within the PC1-PC2 score plot 
(Figure 4.7) indicates significant differences between these two groups of cells. 
The significant PCs were rotated in a constrained factor analysis to obtain physically 
realistic factors which represent biochemical species that differ between the spectral profiles 
of ATII and ATI-like cells. Two main factors, describing phosphoUpid and protein spectral 
components, are shown in Figure 4.8. The phospholipid factor (spectrum 1, Figure 4.8) 
strongly resembles the "Lb spectrum" collected from the cytoplasm of early-culture (d3-4) 
ATII cells {e.g. spectrum 1, Figure 4.3, R=0.98). The protein factor (spectrum 2, Figure 4.8) 
mostly describes cellular proteins, and a significant correlation (R=0.98) was obtained with 
a model protein spectrum generated by least-squares fitting of the protein factor with the 
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Figure 4.5: A Average Raman spectra of individual ATI I cells measured at early (d3-4, spectrum 1), middle 
(dlO-11, spectrum 2), and late (dl7-18, spectrum 3) time points. The spectra represent the mean of 183, 
204, and 171 spectra collected from 61, 68 and 57 cells, respectively (3 spectra per cell). The solid black 
lines indicate the average spectra and the grey lines delineate one standard deviation from the mean. Spectra 
have been offset for clarity. B The absolute value of the difference spectrum (spectrum a) between the mean 
of early and late time point ATII cells, along with the s tandard deviation of early (spectrum b) and late 
(spectrum c) time point spectra. Spectra have been offset for clarity. The grey bars highlight spectral regions 
where the inter-group differences (between early and late time point cells) are significantly greater than the 
intra-group variance. 
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F i g u r e 4.6: Scat ter plot showing intensity values of select peaks with the most significant differences between 
early (black lines) and late (red lines) t ime point ATII cell spectra. T h e average peak s t rength and s tandard 
deviations are also included (offset along the x-axis to reduce clut ter) . 
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F i g u r e 4.7: P C 1 - P C 2 score plot. Scores of early (d3-4) and late (d l7-18) t ime point ATII cells. 
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protein basis spectra used in spectral modelling (Figure B-4). The four additional factors did 
not describe pure-component spectra, but rather correlated spectral features from multiple 
components {e.g. protein and lipid, protein and nucleic acids), minor peak shifts and residual 
noise. 
600 800 1000 1200 1400 
Raman shift (cm~^) 
1600 1800 
F i g u r e 4.8: Factors generated f rom eigenvector rotat ion. Factor 1 describes changes in cellular phospho-
lipids during ATII cell differentiation, and is extremely similar to the cytoplasmic Lb spec t rum displayed in 
Figure 4.3 (Ri=0 .98) . Factor 2 describes protein-related differentiation changes, and demons t ra ted signifi-
cant correlation with a model protein spec t rum generated by least-squares f i t t ing Factor 2 wi th a basis set 
of protein spect ra (R2=0.98). Factors have been baseline corrected and normalised to max imum intensity 
values, and are offset for clarity. 
The score values generated in the factor analysis were plotted to investigate clustering of 
the data (Figure 4.9). Overlap of time point clusters indicates that each group represents a 
mixed population of ATII and ATI-like cells. The small degree of overlap between clusters 
of early and late time point cells (less than 10%) indicates that most early culture cells 
express the ATII phenotype, and most late time point cells express the differentiated ATI-
like phenotype. The close proximity of the middle time point cluster to the late time point 
cluster suggests that most of these cells have already differentiated and express the ATI-
like phenotype. However, the scattering of roughly one-quarter of the middle time point 
cells throughout the early time point cluster indicates that the differentiation process is not 
homogeneous, and that some cells differentiate faster than others. 
98 
Chapter 4: Spectra l moni tor ing of a lveolar epi thel ia l t y p e II cell d i f ferent iat ion 
. V s « . * 0 „ • 
O d3-4 
O d10-11 
• d17-18 
0.3 
0.2 
0.1 
(03 
o o 
o 
00 
oO 
d P 
o 
o 
o 
% ° § o 
° o 
o o O 
O OO 
o 
o 
o 
o 
o 
o 
- o 
0.1 0.2 0.3 0.4 
Phospholipid factor scores 
0.5 0.6 
Figure 4.9: Factor scores plot. Phospholipid factor scores versus protein factor scores, generated by con-
strained eigenvector rotation. The time point clusters indicate a decrease in lipid and an increase in protein 
contribution to the Raman signal of ATII cells during differentiation in vitro. 
4.3.5 Spectral model l ing 
The mean spectra of ATII cells were individually fit with a set of basis spectra to investi-
gate changes in spectral contributions of cellular biochemical components during ATII cell 
differentiation. An example of the fitting results is displayed in Figure 4.10, where the mean 
spectrum of early time point cells is plotted along with the model-predicted spectrum and 
residual. The quality of the fit is indicated by the small residual spectrum and high cor-
relation coefficient R=0.996. The small number and magnitude of negative peaks in the 
residual spectrum indicates minimal over-estimation in the contribution of reference spectra. 
Positive residual peaks point to some un-modelled signal, likely due to lipids and proteins 
(small positive peaks at 717 cm'^ and 815, 1325, 1607 cm"\ respectively). High quality 
modelling results were obtained for all 61 early time point cells (R = 0.995 ± 0.002, where R 
denotes the mean), 68 middle time point cells (R = 0.994 ± 0.003), and 57 late time point 
cells (R = 0.995 ±0.002). All correlation coefficients were statistically significant. Additional 
spectral modelling results for mean middle and late time point cell spectra are included in 
Figure B-5, Appendix B. 
The model fit coefficients are weighting/scaling factors which, when normalised to unity 
sum, indicate the relative percent signal contribution of each component to the original 
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F i g u r e 4 .10: Spectral modelling of ATII cells with R a m a n micro-spectroscopy: T h e mean spec t rum of the 
61 early t ime point cells (black), the model fit (grey), and the residual spec t rum (R=0.996). 
Raman spectrum (Table 4.2). The results are grouped together in terms of component 
classification, i.e. nucleic acids, proteins, carbohydrates and lipids, rather than individual 
components. Thus the coefficients for DNA and RNA were added to indicate the total nucleic 
acid composition, the separate protein fit coefficients added together to give the overall 
protein composition, etc. This grouping is necessary because the basis components contain 
overlapping spectral features {i.e. are not orthogonal), and hence similar components such as 
DNA and RNA are not completely spectrally resolved [18, 145]. Differences in normalised fit 
coefficients of components between time points were tested for statistical significance using 
the Kruskal-Wallis test. 
Time point Nucleic acid 
(%) 
Protein 
(%) 
CHO (%) Lipid (%) 
Early (d3-4) 11.8 ±2.0 51.8 ±7 .7 8.5 ± 1.5 27.9 ± 8.8 
Middle (dlO-11) 10.8 ±2 .0 61.2 ±5.6* 9.2 ± 1.3 18.8 ± 6.9* 
Late (dl7-18) 8.4 ±2 .4 63.0 ± 4.6" 9.5 ± 1.0 19.1 ± 5.9" 
Table 4.2: Relative percent signal contribution of model basis components to the R a m a n spectra of early, 
middle, and late t ime point AT2 cells. CHO = carbohydrate . * and ** denote statistically significant 
differences between Ear ly /Middle and Ea r ly /La t e t ime points, respectively, computed using Kruskal-Wallis 
test (p < 0.05). 
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4.4 Discussion 
The appHcation of Raman micro-spectroscopy to distinguish between different cell types 
and phenotypes has been reported by several research groups [85, 88, 90, 16]. Multivariate 
analysis techniques have made possible systematic (and often unsupervised) analysis of large, 
high-dimensional spectral data sets, and can identify important sources of spectral variation 
across a broad frequency range. Few studies have focussed on the analysis of live cells, 
or on phenotypic discrimination of stem/progenitor cells and their differentiated progeny. 
A previous study by Notingher et al. [15] demonstrated the potential of Raman micro-
spectroscopy for biomolecular characterization of live embryonic stem cells, and identified 
spectral markers describing mRNA translation as indicators of stem cell differentiation. In 
this chapter, the non-invasive sensing capability of Raman micro-spectroscopy was exploited 
to characterize the differentiation of live, primary human ATII cells in vitro. 
Cellular changes in morphology (Figure 4.1) and marker protein synthesis (Figure 4.2) 
were consistent with known differentiation pattern of ATII cells [137, 141], confirming that 
the ATII phenotype was dominant among early culture cells (d3-4), and that most of the 
cells express the ATI-like phenotype by the middle time point (dlO-11). Thus, spectrum 1 
in Figure 4.5 represents the spectral profile corresponding to the ATII phenotype, while the 
ATI-like phenotype is associated with spectral profiles 2 and 3. 
For the Raman spectra of ATII cells (Figure 4.5), the differences at the various time 
points in the differentiation process manifest themselves mostly as changes in phospholipid 
vibrations (717, 1062, 1082, 1301, 1740 cm~^). Investigation of spectral heterogeneity re-
vealed that a phospholipid-dominated spectral component (spectrum 1, Figure 4.3), com-
monly measured from the cytoplasm of early-culture ATII cells but absent in late-culture 
cells, was primarily responsible for these differences. Changes in several other bands ascribed 
to proteins or multiple components were also detected, most notably the medium band at 
937 cm~^ with contributions from C-C a-helix protein stretch, C-C-N+ symmetric stretch 
in lipids, and C-O-C glycosidic linkage of carbohydrates; the CHg deformation in proteins 
at 1340 c m ' ^ the 1440 cm"^ band encompassing C-H bending modes in all cellular biopoly-
mers; and the 1665-1680 cm"^ band which includes the protein amide I mode as well as the 
1656 cm"^ C=C stretch of the cis "CH=CH- linkage of unsaturated lipid chains [76, 16]. 
The observed changes in ATII cell spectra were consistent with the spectral factors gen-
erated by the unsupervised PCA and subsequent constrained eigenvector rotation. Two 
independent factors, one describing cellular phospholipids and the other cellular proteins 
(Figure 4.8), were identified as the main discriminating factors between spectra of ATII and 
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ATI-like cells. The profile of the phopholipid factor (spectrum 1, Figure 4.8) was similar 
to the Lb spectrum (spectrum 1, Figure 4.3), and the intense phosphohpid vibrations (Ta-
ble 4.1) provide some insight to the properties of the surfactant stored in the Lbs of live ATII 
cells. Alveolar surfactant is rich in saturated phospholipids {e.g. dipalmitoyl phosphatidyl 
choline, DPPC), but vibrations characteristic of unsaturated lipid chains at 1266 cm~^ and 
1656 cm~^ confirm the presence of unsaturated phospholipids {e.g. phosphatidyl glycerol) 
within Lbs of ATII cells. Furthermore, the skeletal C-C stretch modes in the 1000-1150 
cm~^ region are known to be sensitive to the conformation of the hydrocarbon chains [146]. 
The bands at 1062 cm~^ and 1122 cm"^ are assigned to the all-trans chain configuration, 
while the band at 1082 cm"^ is attributed to the gauche conformation. The ratio of the 
trans-to-gauche intensity for Factor 1 (and the Lb spectrum) is intermediate of that previ-
ously reported for fully saturated DPPC and for unsaturated dioleoyl phosphatidyl choline 
(DOPC) [147], indicating that the conformational order of the hydrocarbon chains within 
Lbs is intermediate of that for pure saturated and unsaturated phospholipid vesicles, which 
is consistent for a vesicle containing both saturated and unsaturated phospholipids. 
The phospholipid factor also contained some minor protein features (1003, 1336 cm"\ 
amide I broadening of the 1656 cm"^ band), which likely arise from both surfactant proteins 
(SP-A, B, C, and D) and non-surfactant cellular proteins. Apart from the much higher 
intensity of the choline peak at 717 cm~^ observed here, the phospholipid factor is very 
similar to the cluster-averaged spectrum of cellular vesicles recently reported by Krafft et al. 
[89], collected from a high spatial resolution Raman map of a fixed human lung fibroblast. 
The protein factor (spectrum 2, Figure 4.8) described mainly a-helix proteins rather 
than /3-sheet content, inferred from the presence of peaks characteristic of the a-helix protein 
structure (937, 952 cm'^), the absence of key /3-sheet protein vibrations (760, 975 cm~^), and 
an amide I centre frequency of ~1658 cm"* [76, 16, 148]. The protein factor also contained 
minor signal contributions from lipids (717, 1082, 1122 cm"^) and carbohydrates (855, 937, 
1045 cm~^), indicating that these minor spectral features are correlated to the main protein 
features. 
The factor scores plot (Figure 4.9) illustrates how the spectral contribution of these 
phospholipid and protein factors change as ATII cells differentiate. Spectra of early time 
point (d3-4) cells were characterized by high phospholipid content relative to protein, while 
late time point cells (dl7-18) yield spectra with much higher protein: lipid ratios. The 
decrease in phospholipid signal contribution to ATII cell spectra correlates well with the 
clearance of phosphoHpid-rich surfactant from Lbs as ATII cells differentiate (Figure 4.1). 
This observation is further supported by the spectral modelling results (Table 4.2), which 
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indicate a significant 9% relative decrease in the Raman signal contribution from cellular 
lipids from ~28% to ~19% as ATII cells differentiate {p < 0.05 for both early/middle and 
early/late time point comparisons). Of this decrease, 8% is attributed to a decrease in 
phosphatidyl choline, and only 1% to cholesterol. The reduction of spectral signal from 
lipids is offset by a significant 10% relative increase in the signal contribution from cellular 
proteins, from ~52% in early culture cells to approximately 62% in middle/late culture 
cells {p < 0.05 for both early/middle and early/late time point comparisons). The negative 
correlation between relative signal contribution of lipids and proteins to the spectra of ATII 
cells was further confirmed by plotting the protein model fit coefficients against those for 
lipids for all primary ATII cells analyzed (Figure B-6). Thus, the model-predicted spectral 
contribution from phospholipids can be used as a spectroscopic marker for the identification 
of cellular phenotype {i.e. ATII vs ATI-like), and hence differentiation state of primary ATII 
cells in vitro. 
This experiment complements previous ATII cell differentiation studies by offering a non-
invasive, spectroscopic perspective of the biochemical changes which live ATII cells undergo 
as they differentiate towards an ATI-like phenotype. It also complements a coherent anti-
Stokes Raman scattering (CARS) vibrational imaging study by Nan et al, in which they 
demonstrated selective, high-speed imaging of lipid droplets in unstained, live cells [35]. 
CARS is a nonlinear optical process which provides resonant enhancement of the weak spon-
taneous Raman scattering signal, typically by a factor of ~ 10®. The chemical selectivity, 
speed and real-time imaging features of CARS microscopy make it an attractive alternative 
to fiuorescence microscopy for cellular imaging. Using CARS, Nan et al. were able to gen-
erate chemical images describing the cellular distribution of lipids by tuning the excitation 
laser to interrogate a lipid vibration at 2845 cm^\ By collecting chemical images at different 
time points, the authors investigated the dynamics of hpid droplets during the differentia-
tion of 3T3-L1 fibroblast cells to adipocytes. The results revealed an initial clearance of hpid 
droplets in the early stages of differentiation, followed by an unsynchronised re-accumulation 
of lipid droplets at later stages. This is in contrast to the results for ATII cells presented in 
this chapter, where no re-accumulation of Lbs was observed at later stages of differentiation. 
Both of these studies demonstrate the versatility of vibrational spectroscopy as a powerful, 
non-invasive tool for live cellular analysis. 
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4.5 Future work 
The focus of the current study was to non-invasively characterise the in vitro differentia-
tion of single, living ATII cells based on the collection of Raman scattering from the entire 
cellular volume. This was facilitated by using a high-power NIR line-focus laser offering 
non-diffraction limited spatial resolution to excite Raman scattering from large subcellular 
regions. Raman micro-spectroscopy can also be used to study specific cellular organelles, e.g. 
mitochondria [53], nucleus and endoplasmic reticulum [89], as well as the composition and 
physical properties of phospholipids within model protein-surfactant systems. In particular, 
the lipid acyl chain methylene and methyl C-H stretching modes in the high wavenumber 
region (2800-3200 cm"^) can provide valuable information on the conformation of hydrocar-
bon chains, inter-chain interactions, intra-chain isomerizations, and phospholipid headgroup 
packing order [149]. Takai et al. have previously demonstrated the application of con-
focal Raman micro-spectroscopy to characterise the lipid structure of triacylglycerol-based 
cytotoxic granules within single living human lymphocytes [150]. Thus there is significant po-
tential in the application of Raman micro-spectroscopy to non-invasively analyse the compo-
sition and physical properties of surfactant phospholipids stored in Lbs within the cytoplasm 
of live ATII cells at different stages of differentiation. In a comprehensive lipidomic analysis 
of surfactant produced by primary human ATII cells, Postle et al. demonstrated that ATII 
cell differentiation has a profound effect on composition of surfactant phospholipids, espe-
cially on acyl chain length [151]. The application of confocal Raman micro-spectroscopy with 
diffraction-limited spatial resolution to probe individual Lbs (typically 1-2 in diameter) 
would complement existing ultrastructural information on Lbs within fixed ATII cells [152]. 
This line of future research could also be applied to the development of synthetic surfactant 
systems, whereby Raman micro-spectroscopy data on the unperturbed cellular system could 
aid in the design of functional, biologically-relevant, and therapeutic surfactants [153]. 
4.6 Conclusions 
The results of this chapter demonstrate that Raman micro-spectroscopy can be used to 
characterize and identify phenotypic differences between alveolar epithelial cells at different 
stages of differentiation in vitro. The spectral profile of undifferentiated, ATII cells exhibited 
intense phospholipid peaks, corresponding to the presence of surfactant Lbs in the cytoplasm. 
In contrast, the spectra of differentiated, ATI-like cells demonstrated significantly less lipid 
character. Multivariate spectral analysis results were correlated to cytochemical staining 
patterns to systematically detect spectroscopic markers indicating a reduction in cellular 
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surfactant during differentiation. PCA-based factor analysis identified a phospholipid spec-
tral component as the main discriminator between the spectra of ATII and ATI-like cells, and 
a decrease in the contribution of this factor to ATII cell spectra during differentiation was 
observed in the factor scores. Spectral modelling revealed a significant 9% decrease in rela-
tive phospholipid Raman signal contribution as ATII cells differentiate. These observations 
are consistent with the clearance of surfactant from cytoplasmic Lbs in the transition from 
the ATII to ATI-like phenotype. This study demonstrates the advantage of Raman micro-
spectroscopy over invasive cytochemical techniques, emphasizing the non-invasive analysis 
of single living stem/progenitor cells in the absence of fixatives or labels. 
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Chapter 5 
Raman spectral phenotyping of 
pulmonary alveolar epithelial cells 
The focus of the following chapter is to demonstrate the application of Raman micro-
spectroscopy for the non-invasive spectral phenotyping of various pulmonary alveolar ep-
ithelial cells. In this study, the phenotype of primary ATII cells characterised in the previ-
ous chapter is compared with that expressed by A549 and TTl cell lines. Cancerous A549 
cells are commonly used as a cell culture model for ATII cells, while the recently estab-
lished immortalised TTl cell line serves as a model for ATI-like cells. Spectra of A549 and 
TTl cells were compared with those of primary ATII and ATI-like cells collected during a 
differentiation time-course. Several well-established chemometric techniques were used to 
identify spectral markers describing the biomolecular and hence phenotypic differences be-
tween primary cells and cell lines. The results indicate that spectra of A549 and TT l cells 
are characterised by significantly lower phospholipid content than those of ATII cells, owing 
to fewer phospholipid-rich Lbs in the cytoplasm of A549 and TT l cells. Furthermore, we 
found that the spectra of A549 and TT l cells resemble the spectra of ATI-like cells more so 
than those of ATII cells. The variation between ATII, A549 and TT l cell spectra permitted 
excellent discrimination of lung cell phenotypes, facilitating phenotypic classification of cells 
based on their Raman spectral signatures with 99% accuracy. These results suggest that 
TTl cells are an appropriate model for ATI-like cells, but question the suitability of A549 
cells as a model for the ATII phenotype. 
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5.1 Introduction 
Cell biology plays a central role in many branches of biomedical science. Research into 
diseases such as cancer often rely on identifying drugs that disrupt cellular processes {e.g. 
the cell cycle [117]), influence cell growth or metabohsm [154], or induce cell death {i.e. 
apoptosis) [155]. The traditional view of tissue engineering involves the growth of cells 
on three-dimensional bioactive-bioresorbable scaffold materials, in order to repair or replace 
damaged or diseased tissue [156]. Stem cell {e.g. haematopoietic stem cells for myocardial 
repair [157]) and other cell-based therapies {e.g. chondrocytes for autologous cartilage trans-
plant [158]) within regenerative medicine also rely on understanding how cells differentiate 
and interact with other cells and tissues. Studying cellular behaviour and manipulating cel-
lular processes requires vast and reliable sources of cells with which to conduct experiments 
to test and refine hypotheses. Indeed, the type and source of cells are contentious issues 
and spark debate in many fields, the most well-known being the use of embryonic stem cells 
[159]. In most cases, the use of appropriate cells is crucial — cancer cells for cancer research, 
stem cells to investigate differentiation and pluripotency, and tissue-specific cells in tissue 
engineering. For example, with respect to tissue engineering of cartilage and bone, chondro-
cytic and osteoblastic cells, respectively, are required to ensure the production of the proper 
proteins which characterise the extracellular matrix of the target tissue. Primary stem, pro-
genitor, and differentiated/lineage-specific {e.g. osteoblasts for bone tissue formation) cells 
are often regarded as ideal for studying cell growth and behaviour in vitro. However, the 
use of primary cells is not without complications: the availability of primary cell or tissue 
samples may be unreliable, primary cells can be difficult to extract and isolate, and may be 
difficult to culture in vitro. Some primary cells, e.g. osteoblasts and chondrocytes, have a 
finite life-span in culture, and can lose their phenotype with increasing time in culture or 
passage number [160]. 
To overcome the limitations of primary cells, cell lines are often used to model the be-
haviour of a specific type of cell. Cell lines are typically derived from cancerous tissue or 
by immortalisation of primary cells through retroviral transfection or transduction, whereby 
cells are treated with an immortalising agent {e.g. simian virus 40 (SV40) large tumor 
antigen) to obtain long life-span cultures [161, 162]. For example, osteoblast-like cell lines 
commonly encountered in bone tissue engineering include osteosarcoma-derived MG63 [163] 
and Saos-2 [164] cell lines, and SV40-transfected human alveolar bone cells [162]. Both 
cancerous and transformed cell lines are generally easier to culture than primary cells, have 
a high rate of proliferation, long-life span, and maintain their phenotype in culture. How-
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ever, the major disadvantage of cell lines relates to whether the phenotype they express is 
consistent with the true phenotype of normal, primary cells [165, 166]. Although cell lines 
obtained by transduction often express phenotypes that are closer to the primary cell phe-
notype than cancerous cell hnes [167], no model is perfect, and therefore it is important to 
identify the limitations of cell lines as models for primary cells. 
The human A549 adenocarcinoma cell line is commonly used in lung cell biology as a 
model for human alveolar type II (ATII) epithelial cells. The A549 cell line was derived 
from a solid type II pneumocyte lung tumour by Giard et al. in 1972 [168], and possesses 
characteristic features of ATII cells, including synthesis of phospholipids, the presence of 
cytoplasmic lamellar bodies (Lbs), and apical microvilli [169]. Since then, the A549 cell 
line has been widely used as a model for ATII cells to study the regulation of pulmonary 
surfactant systems [170], and also as a monolayer culture to mimic ATI cells for the study 
of solute transport [171]. However, despite the attention A549 cells have received, the 
A549 cell architecture and barrier properties are quite distinct from those of an ATII or ATI 
cell [172]. Furthermore unlike primary ATII cells, cultured A549 cells do not undergo a 
transition to express a phenotype similar to that of an ATI cell. These differences, along 
with inconsistencies within the hterature regarding expression of ATII-specific markers by 
A549 cells, question the suitabihty of this cell line as an appropriate model for primary ATII 
cells [173]. 
Non-invasive phenotyping with Raman micro-spectroscopy has been used to identify can-
cerous cell phenotypes [85] to aid in disease detection, diagnosis [90], as a biosensor to mon-
itor cellular response to drugs for pharmaceutical testing [18], and as a basic cytology tool 
to investigate cellular organelles [53], biochemistry [56], apoptosis [91], and differentiation 
[15]. The combination of Raman micro-spectroscopy with optical tweezers, laser tweezers 
Raman spectroscopy (LTRS), enables the acquisition of Raman spectra of individual cells 
in suspension [174]. This approach has recently been used for phenotypic discrimination 
between normal and neoplastic haemopoietic cells [88], and shows promise for the develop-
ment of a non-invasive LTRS-based flow cytometry system for cell sorting, whereby sorting 
is based on inherent cellular biochemical signatures rather than surface phenotype or fluo-
rescent labels. 
In this chapter, Raman micro-spectroscopy is used to non-invasively characterise the A549 
cell phenotype. The spectral profiles of A549 cells were compared with those of primary ATII 
cells collected in the previous chapter to identify biochemical differences between these two 
cell phenotypes, in order to assess the suitabihty of the A549 cell line as a model for primary 
ATII cells. This chapter also deals with the phenotypic characterisation of an immortalised 
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type I cell line (TTl — transduced type I), recently derived and characterised by Kemp 
et al. [175]. A549 and TTl cells were tested for expression of ATII specific (Lbs, ALP, 
SPC) and ATI-like specific (caveolin-1) markers to correlate Raman spectral profiles with 
cellular phenotype. Several well-established chemometric techniques were used to compare 
the spectra of ATII, A549 and TTl cells, including PCA, LDA, factor analysis and spectral 
modelling to identify spectral markers describing the biochemical differences between primary 
undifferentiated ATII, differentiated ATI-like, and A549 and TTl cell lines. 
5.2 Materials and M e t h o d s 
5.2.1 Cell culture 
Primary human ATII cells were isolated and cultured by Dr. Sarah Kemp, as described in 
the previous chapter. Human A549 lung carcinoma cells (American Type Culture Collec-
tion; Manassas, VA, USA) were grown to 70% confluence before seeding cells onto sterilised 
MgF2 coverslips at a density of 1.0 x 10^ cells/cm^). Cells were cultured in Dulbecco's mod-
ified Eagle's medium (DMEM, Sigma) supplemented with 10% foetal bovine serum (FBS; 
Invitrogen), 1% antibiotic/antimycotic (Invitrogen) in a 5% COg incubator at 37°C. 
5.2.2 Immortal isat ion of primary ATII cells 
Purified ATII cells were immortalised as described by O'Hare et al. [161]. Briefiy, midcon-
fiuent, proliferating ATII cell cultures were retrovirally transduced with the catalytic subunit 
of human telomerase (hTERT) and a temperature sensitive mutant of simian virus 40 large 
tumor antigen (U19tsA58). Cells that were successfully transduced were cultured in the 
same media as the ATII cells, supplemented with 0.5 mg/mL G418 (Sigma). 
5.2.3 Cytochemistry: ALP, pro-SPC and Lb staining, and caveolin-1 im-
munoblott ing 
Staining of A549 and TTl cells for ALP, pro-SPC (pSPC), Lbs, and immunoblotting for 
caveolin-1 followed the protocols discussed for primary ATII cells in the previous chapter. 
5.2.4 R a m a n micro-spectroscopy 
Raman spectra of A549 and TTl cells were collected with the same spectrometer settings 
and following the same protocols estabfished for ATII cells in the previous chapter. All cells 
were serum-starved overnight for synchronisation in the Go/Gi phase of the cell cycle to 
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minimise cell cycle related spectral variance (Chapter 3). Spectra collected from early (days 
3-4), middle (days 10-11), and late (days 17-18) time point ATII cells were compared to 
spectral profiles of A549 and T T l cells. 
5.2.5 D a t a analys i s 
All Raman data were processed and analysed with software developed in-house for the Mat-
lab (The Mathworks Inc., USA) environment, and with the multivariate statistical analysis 
toolbox PLS-toolbox (Eigenvector Research, Inc., USA). Spectra were intensity-corrected for 
instrument response to minimise the effects of day-to-day spectral variation, and normalised 
with extended multiplicative signal correction (EMSC) [109]. Spectra were smoothed using 
a Savitsky-Golay filter (5 points, 2""' order polynomial), and the wavenumber axis of each 
spectrum was standardised and aligned to the sharp phenylalanine peak at 1003 c m " \ and 
truncated to the 600-1800 cm"^ spectral region. Where spectra have been baseline-corrected, 
the Modpoly algorithm described by Lieber and Mahadevan-Jansen (5"' order polynomial, 
1000 iterations) [108] was used to eliminate fluorescence and other background effects. 
Principal component analysis (PCA) and Factor analysis 
Pre-processed Raman spectra were vector normalised and analysed using a singular value de-
composition PCA-algorithm written in Matlab. PC loading vectors were visually inspected 
to identify biochemical trends in the data, and PC score plots were generated to explore 
clustering of cell populations. Multivariate curve resolution was then used to rotate the sig-
nificant PCs subject to non-negativity constraints to generate factors describing the spectral 
signatures of biochemical components that differ between spectra of ATII, A549 and T T l 
cells. 
Linear discriminant analysis (LDA) 
Supervised LDA was used to discriminate between ATII, A549 and T T l cells based on 
their Raman spectral signatures. Scores from PCA were used as input for the LDA model. 
Classification accuracy was assessed using leave-one-out cross-validation, whereby the class 
of a spectrum is predicted using an LDA model built from the full data set excluding the 
spectrum in question. This method was repeated, with each spectrum left out in turn, so 
that each spectrum was predicted once. 
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Spectral modelling 
ATII, A549 and TTl cell spectra were modelled by non-negative least-squares fitting with a 
set of biochemical basis spectra [89], as described in the previous chapter. Fitting coefficients 
were used to estimate the signal contribution of cellular biochemical components to the 
Raman spectral signatures of ATII, A549 and TTl cells. Correlation coefficients were used 
to assess the quality of model fitting, and as a statistical measure of the similarity between 
spectra of different cell types. 
5.3 Results 
5.3.1 Characterisation of ATII, A549 & T T l cell phenotypes 
The growth pattern and characterisation of primary ATII cells was discussed at length in the 
previous chapter. Briefly, early time point (d3-4) ATII cells were cuboidal, stained positive 
for ATII-specific cell markers Lbs (Figure 5.1), ALP, pSPC, and only weakly expressed 
caveolin-1, a marker for the ATI-like cell phenotype (Figure 5.2). With increasing time 
in culture, cells adopted a flattened morphology with raised perinuclear region and thin 
cytoplasmic attenuations. The staining pattern shifted to strong expression of caveolin-1 
and weak expression of ALP, pSPC and Lbs in middle (dlO-11) and late (dl7-18) time 
point ATII cells, confirming the spontaneous differentiation of ATII cells to an ATI-like 
phenotype in vitro. Henceforth, the term "ATII cells" will be used to refer to early culture 
(d3-4) primary ATII cells, and "ATI-like cells" to refer to middle (dlO-11) and late (dl7-
18) time point ATII cells, unless otherwise indicated. The focus of the current chapter is to 
discuss the morphological, biochemical, and spectral characterisation of A549 and TTl cells, 
in relation to the previous results obtained for primary ATII cells. 
Both A549 and TTl cells grew rapidly in culture, and no differences in cell growth, mor-
phology and expression of ALP, pSPC, and Lbs were observed between the MgFg and tissue 
culture substrates. A549 cells were typically small and cuboidal in shape, and demonstrated 
positive staining for numerous Lbs (Figure 5.ID), although Lb staining was not as intense or 
uniform as observed in early ATII cells. The morphology of TTl cells was similar to that of 
ATI-like cells, although TTl cells were less squamous in appearance, and thin cytoplasmic 
attenuations were less prevalent. Staining for Lbs was weaker in TTl cells than in both A549 
and ATII cells (Figure 5.IE). Staining for ATII-specific markers revealed that neither A549 
nor TTl cells expressed ALP or SPC (Figures 5.2A, 5.2B), while immunoblotting revealed 
that the level of caveolin-1 expression by TTl cells was similar to that of ATI-like cells, 
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F i g u r e 5.1: Morphology of ATII, A549 and T T l cells cultured on MgF2 coverslips. Light microscope images 
of cells stained with osmium tetroxide and tannic acid for the presence of Lbs. Shown are typical staining 
pictures of A early (d3-4), B middle (dlO-11), and C late (d 17-18) time point primary ATII cells, D A549 
and E T T l cells. The dark osmiophilic granules indicate cytoplasmic Lbs. Scalebar = 20 fim. 
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Figure 5.2: Characterisation of ATII, A549, and T T l cells. A ALP and B pSPC staining of cell monolayers. 
C Western blot of caveoUn-1 (a- and /3-isoforms) expression from ATII, A549 and T T l cells. HUVEC 
represents the positive control for caveolin-1. Scalebar = 50 nm. 
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and caveolin-1 expression by A549 cells was extremely weak or negative (Figure 5.2C, and 
personal observation of additional TTl and A549 cell preparations, Figure C-1, Appendix C). 
5.3.2 Spectral variability wi th in single ATII, A 5 4 9 &: T T l cells 
Similar patterns of spectral heterogeneity were observed in ATII, A549 and TTl cells. Cy-
toplasm spectra exhibited more lipid character than spectra collected from cell nuclei, which 
were dominated by protein and nucleic acid spectral features. The strong phospholipid vi-
brations (Table 4.1, Chapter 4) observed in cytoplasm spectra are due to the presence of 
surfactant-containing Lbs in all three cell types. However, these vibrations were much more 
intense in cytoplasm spectra of ATII cells than in those of A549 and TTl cells (Figure 5.3), 
owing to the higher concentration of phospholipid-rich Lbs in the cytoplasm of ATII cells. 
Correlation coefficients between the spectrum of phosphatidyl choline (PCh) and ATII cy-
toplasm spectra {e.g. R=0.97 for spectrum a of Figure 5.3) were typically much higher than 
those between PCh and A549 and TTl cytoplasm spectra (R=0.88 and 0.82 for spectra b 
and c of Figure 5.3, respectively). 
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F i g u r e 5.3: Typical Raman spectra collected from the cytoplasm of early-culLure ATII cell (a), A549 cell 
(b), and T T l cells (c). The spectra have been corrected for instrument response, EMSC normalised, baseline-
corrected, the wavenumber axis standardised and aligned, and vector normalised. Light microscope pictures 
of the cells from which the spectra were collected are included, along with an ellipse to designate the region 
probed by each scan. The spectra are offset for clarity. Scalebar = 10 jj,m. 
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5.3.3 Biomolecular characterisat ion of ATII , A549 &: T T l cells 
Biomolecular characterisation of ATII and ATI-hke cells was discussed at length in the 
previous chapter. Briefly, three spectra were collected from each ATII cell and the perinuclear 
region of ATI-like cells, and cell-specific measurements were averaged to produce a single 
representative biomolecular fingerprint for each cell. A549 and TTl cells were slightly larger 
than ATII cells, and so mean A549 and TTl cell spectra were computed from between three 
and five measurements per cell, depending on cell size and shape. 
The average processed Raman spectra of ATII, A549 and TT l cells are shown in Fig-
ure 5.4. Solid black lines denote average spectra, which represent the mean of 183, 250, 
and 222 spectra collected from (a) 61 ATII cells, (b) 57 A549 cells, and (c) 56 TTl cells, 
respectively. The small standard deviations (grey lines) within each group indicate that Ra-
man spectral characterisation of ATII, A549 and TTl cell phenotypes is highly reproducible. 
All of the spectra exhibit similar general features, and consist of peaks corresponding to 
molecular vibrations of all cellular biopolymers. Peak assignments are listed in Table A-1, 
Appendix A. All data demonstrated good SNR and no data were discarded. 
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F i g u r e 5.4: Average Raman spectra of (a) ATII, (b) A549 and (c) T T l cells. The spectra represent the mean 
of 183, 250, and 222 spectra collected from 61, 57 and 56 cells, respectively. The solid black lines indicate the 
average spectra and the grey lines delineate one standard deviation. Spectra have been offset for clarity. 
The plots exploring the intra-group and inter-group spectral variance are presented in 
Figure 5.5. In both comparisons between primary ATII cell spectra and those of A549 
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(Figure 5.5A) and TTl (Figure 5.5B) cell lines, the inter-group differences (as represented by 
the absolute value of the difference spectrum between the group means) were larger than the 
intra-group variances (as represented by the standard deviation of each group). The absolute 
value of difference spectra was taken for comparison purposes, as the standard deviation plots 
are strictly non-negative. The grey bars in Figures 5.5A and B highlight spectral regions 
where the inter-group differences (between ATII/A549 and ATII/TTl cells, respectively) 
are significantly greater than the intra-group variances. These plots also indicate that the 
spectral variation between primary ATII cells and immortalised TTl cells are greater than 
those between ATII and A549 cells. 
5.3.4 Principal C o m p o n e n t s Analys is ( P C A ) 
Principal components analysis (PCA) was performed on the full data set including spectra 
from primary ATII and ATI-like cells, as well as A549 and TT l cell lines. The data was 
compressed onto a set of PC basis vectors, with PC score values representing spectral coor-
dinates. Plotting the data in the new PC coordinate system facilitates the identification of 
data clusters, as a means to compare the spectra of different types of cells. The PC1-PC2 
score plot is included in Figure 5.6, and demonstrates the resolution of cellular phenotype 
afforded by the first two principal components, which accounted for 65% of the spectral 
variance (54% for PCI, 11% for PC2). To avoid cluttering within the PC1-PC2 score plot, 
the PC scores of ATII and ATI-like cells only are included in Figure 5.6A, while those of 
ATII, A549 and TT l cells are included in Figure 5.6B. 
Data clustering by PCA provides a qualitative comparison of cellular spectra. To quan-
titatively compare the spectral profiles of A549 and TTl cells lines with those of primary 
ATII cells, the pair-wise correlation coefficients between each A549 cell spectrum and pri-
mary ATII cells from each time point were computed, and the mean ± standard deviation 
correlation coefficient for each then calculated. This process was repeated for TT l cells, 
and the results, based on a total of 10,602 and 10,416 correlation coefficients for A549 and 
TTl cells, respectively, are summarised in Table 5.1. Differences in correlation coefficients 
calculated between spectra of A549 and TTl cell lines with early, middle, and late time point 
ATII cell spectra were tested for statistical significance using the Kruskal-Wallis test. 
5.3.5 Factor Analys is 
While some biochemical information can be extracted from the PCs, these are abstract 
mathematical vectors which contain positive and negative peaks from multiple biochemical 
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Figure 5.5: A The absolute value of the difference spectrum (spectrum a) between the mean of ATII and 
A549 cells, along with the standard deviation plots of ATII (spectrum b) and A549 (spectrum c) cell spectra. 
B The absolute value of the difference spectrum (spectrum d) between the mean of ATII and T T l cells, along 
with the standard deviation plots of ATII (spectrum e) and T T l (spectrum f) cell spectra. Spectra have 
been offset for clarity. The grey bars highlight spectral regions where the inter-group differences (between 
ATII/A549 and ATII /TTl cells, respectively) are significantly greater than the intra-group variances. 
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F i g u r e 5.6: PC1-PC2 score plots. A Scores of primary ATII cells (early Lime point, d3-4) and ATI-like 
cells (middle dlO-11, and late d l7-18 time points). B Scores of primary ATII (early time point d3-4) cells 
and A549 and T T l cells. All cells were included in the PCA, and thus are all represented in the same 
PC-coordinate system, and axes limits are the same for both graphs. 
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Primary ATII cells 
Early (d3-4) Middle (dlO-11) Late (d 17-18) 
A549 0.986 ± 0.01 0.989 ± O.OOgt 0.989 ± 0.008^ 
TTl 0.984 ±0.01 0.991 ± 0.006* 0.990 ± 0.007* 
Table 5.1: Mean ± standard deviation correlation coefficients comparing A549 and T T l cell spectra to 
the spectra of primary ATIl cells (all time points). The results aie based on 10,602 and 10,416 correlation 
coefficients computed for A549 and T T l cell spectra, respectively. In this approach, each A549 and T T l 
cell spectrum is individually compared to each ATII cell spectrum, f and | denote statistically significant 
difference between correlation coefficients between A549 and T T l cell spectra with spectra from middle/late 
time point ATII cells versus early time point ATII cells, respectively, computed using Kruskal-Wallis test 
( p < 0.05). 
components, and hence are difficult to interpret. Factor analysis is an extension of PCA 
whereby the PC loading vectors are rotated to identify the spectral signatures of biomolecular 
species which describe the differences between spectra of sample groups. 
To obtain the input data for the factor analysis, PCA was used to directly compare the 
spectra of ATII, A549 and TT l cells, and retained the first six PCs as the main descriptors of 
spectral variance (accounting for 86%). The remaining PCs were noisy and each accounted 
for less than 1% of the total variance. It is worth noting that PCI mostly described spectral 
differences between ATII and TT l cells, demonstrated by the high correlation coefficient 
between PCI and the difference spectrum between the mean spectra of ATII and TT l cells 
(R=0.97). PCI was also quite similar to the main obtained in the PCA comparing ATII and 
ATI-like cells presented in the previous chapter (R=0.97), indicating that the main source 
of spectral variance between ATII, A549 and TTl cells was very similar to that between 
undifferentiated ATII and differentiated ATI-like cells. 
The factor rotation produced separate phosphohpid and protein factors (Figure 5.7) 
which resemble those obtained in the previous chapter (R=0.96 and R=0.98, respectively). 
The phospholipid factor (spectrum a) describes the differences in phosphohpid character 
of cytoplasm spectra collected from ATII, A549 and TTl cells, along with some minor 
signal contribution from proteins (symmetric ring breathing mode of phenylalanine at 1003 
cm"^). Significant correlations were also obtained between this factor and the cytoplasm 
spectrum collected from early culture ATII cells {e.g. spectrum a. Figure 5.3, R=0.98) and 
the spectrum of PCh (Figure 4.3, Chapter 4, R—0.95). Spectral modelling of the protein 
factor (spectrum b) with the protein basis spectra produced a very accurate fit (R=0.99). 
Minor spectral features of nucleic acids (O-P-0 stretch of DNA at 786 c m ' ^ guanine and 
adenine stretches at 1575 cm~^) and phospholipids (carbonyl C=0 stretch at 1740 cm"^) were 
also observed in this factor. The additional factors did not describe pure component spectra, 
but rather correlated spectral features from multiple components {e.g. protein and hpid, 
protein and nucleic acids), minor peak shifts and residual noise (Figure C-2, Appendix C). 
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Figure 5.7: Factors generated from eigenvector rotation. Factor (a) describes cellular phospholipids, and 
is extremely similar to the spectrum collected from the cytoplasm of early culture ATII cells (spectrum a. 
Figure 5.3, R=0.98). Factor (b) is a protein spectrum, and demonstrated significant correlation with a model 
protein spectrum generated by least-squares fitting with a basis set of protein spectra (R=0.99). Factors have 
been baseline-corrected and normalised to maximum intensity values, and are offset for clarity. 
The factor scores describe the contribution of the phosphohpid and protein factors to the 
spectra of ATII, A549 and TT l cells (Figure 5.8). The cluster arrangements indicate that 
ATII cells have a higher phospholipid factor: protein factor ratio than TTl and A549 cells, 
and that the cellular proteins described by the protein factor contribute more to the spectra 
of A549 cells than to those of ATII and TT l cells. Overlap of cell clusters indicates that 
these two factors alone are incapable of completely resolving cellular phenotype. 
5.3.6 Linear Discriminant Analys is (LDA) 
The PC and factor score plots are convenient graphical representations of how the data 
are structured with respect to the first two PCs and factors, respectively. The inability of 
each to adequately resolve the separate cellular phenotypes is likely due to the relatively low 
information content incorporated in each plot {e.g. only 65% for PC score plot). LDA, like 
factor analysis, is an extension of PCA, which incorporates class membership of data (in this 
case cell type) to achieve maximal group separation. To determine whether ATII, A549 and 
T T l cells could be distinguished solely by their Raman spectra, an LDA classification model 
was generated using the scores on the first 25 PCs (accounting for 92.5% of the spectral 
variance). The PC scores were then projected onto two linear discriminant (LD) functions 
LDl and LD2 to produce an LDA score plot (Figure 5.9), which revealed excellent separation 
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Figure 5.8: Factor score plot. Phospholipid factor scores versus protein factor scores, generated by con-
strained eigenvector rotation. The cell clusters indicate that ATI I cell spectra have higher phospholipid 
content than A549 and T T l cells, and that the signal contribution of the protein factor to A549 cell spectra 
is higher than that for ATI I and T T l cells. 
of data clusters. The use of 25 PCs produced optimal discrimination, and inclusion of more 
than 25 PCs produced inferior results, most likely due to the addition of noise present in the 
higher PCs. 
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Figure 5.9: LDA scores plot. LDA scores were computed by projecting the 25 PC scores onto linear 
discriminant functions LDl and LD2, providing maximal group separation. 
The results of the LDA model cross-validation are reported in Table 5.2. The rows of the 
table show the total number of spectra measured for each cell type, while the columns indicate 
the number of spectra the LDA predicted as belonging to each cell group. The number of 
spectra correctly predicted is shown in bold, and non-bold entries represent misclassifications. 
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The overall predictive accuracy of the algorithm was calculated and expressed in terms of 
sensitivity and specificity for each cell group. With only two misclassifications of TT l cells 
as A549 cells, the results indicate excellent spectral discrimination between ATII, A549 and 
TT l cells, with the LDA model demonstrating 99% sensitivity and specificity. 
Raman-predicted 
phenotype 
Phenotype ATII A549 TT l 
ATII 61 0 0 
A549 0 57 0 
TT l 0 2 54 
Sensitivity (%) 100 100 96 
Specificity (%) 100 98 100 
Table 5.2: Phenotype classification accuracy of the PCA-based LDA model as assessed by leave-one-out 
cross-validation. 
5.3.7 Spectral model l ing 
Factor analysis is a mathematical transformation that effectively compresses the high-dimensional 
spectral data onto a reduced set of basis spectra derived directly from the data. Factors 
describing spectra of single biochemical components [e.g. phospholipids or proteins, as in 
Figure 5.7) permit the semi-quantitative determination of how spectral contributions of those 
factors vary between the data. Some factors, however, contain correlated spectral features 
from multiple biochemical components {e.g. proteins and DNA), and investigating biochem-
ical differences between samples based on these factors is much less straightforward. 
In contrast to factor analysis, spectral modelling imposes a pre-selected set of basis 
spectra on the data. In this case, the contribution of each model component to the spectra 
is assessed by analysing the fit coefficients generated by a least-squares fitting routine. The 
mean spectra of individual ATII, A549 and TTl cells were fitted with the set of basis spectra 
to investigate differences in spectral contribution of cellular biochemical components between 
ATII, A549 and TTl lung cell phenotypes. An example of the fitting results for each cell 
group is displayed in Figure 5.10, where the mean spectra of ATII, A549 and TTl cells 
are plotted along with the model-predicted spectra and residuals. The quality of the fits 
is indicated by the small residual spectra and high correlation coefficients (R=0.996, 0.997, 
0.994 between mean and model spectra for ATII, A549 and TT l cells, respectively). Similar 
modelling results were obtained for all 61 early time point ATII cells (R = 0.995±0.002, where 
R denotes the mean), 57 A549 cells (R = 0.995±0.003), and 56 TTl cells (R = 0.993±0.002), 
with all correlation coefficients statistically significant. 
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Figure 5.10: Spectral modelling of ATII, A549 and T T l cells with Raman micro-spectroscopy: The mean 
spectra of ATII, A549, and T T l cells are shown in black, the model fits in grey (R=0.996, 0.997, and 0.994), 
and residual spectra in black. Spectra are offset for clarity. 
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To determine the signal contributions of the model biochemical components to the spectra 
of ATII, A549 and TT l cells, the model fit coefficients for each individual cell were normalised 
to unity sum, and the mean ± standard deviations calculated for each cell type (Table 5.3). 
As in the previous chapter, the results are grouped together in terms of component classi-
fication (nucleic acids, proteins, carbohydrates and lipids), to recognise the non-orthogonal 
nature of the basis spectra [18, 145]. The results indicate that the signal contribution from 
lipids is highest for ATII cell spectra (~27.9%), intermediate for A549 cell spectra (~21.7%) 
and lowest for TTl cell spectra (~15.7%). Protein signal levels, although similar between 
A549 and TT l cells (~61%), were significantly lower for ATII cell spectra (^51.8%). Other 
significant differences were detected in nucleic acid signal contribution between TT l cells 
and both ATII and A549 cells, and in carbohydrate signal levels between A549 cells and 
both ATII and TTl cells. Differences in normalised fit coefficients of components between 
cell phenotypes were tested for statistical significance using the Kruskal-Wallis test. 
Cell type Nucleic acid (%) Protein (%) 
CHO (%) Lipid (%) 
ATII (d3-4) 11.8 ±2 .0 51.8 ±7 .7 8.5 ±1.5 27.9 ±8 .8 
A549 11.6 ±3 .5 61.1 ±5.7* 5.5 ± 2.4** 21.7 ±9.0** 
TT l 15.0±2.l t t 61.0±3.9t 8.4 ± 1.5 15.7 ±5.9^ 
Table 5.3: Relative percent signal contribution of model basis components to the Raman spectra of ATII, 
A549 and T T l cells. CHO=carbohydrate. *, j, and $ denote statistically significant diff'erences between 
ATII/A549, ATII /TTl , and A549/TT1 cells, respectively, computed using Kruskal-Wallis test {p < 0.05). 
5.4 Discussion 
Hundreds of cell types have been characterised using Raman micro-spectroscopy, the vast 
majority being cancerous and immortalised rather than primary cells. The motivation behind 
this trend is presumably the convenience and stability of immortal cell culture systems, 
and to avoid difficulties associated with primary cells {e.g. availability of samples, lengthy 
and difficult isolation procedures [140], sensitive culture conditions [176] and spectral and 
phenotypic variation between samples of primary cells [96]). Cell lines provide robust cellular 
systems with which scientists have developed the experimental and analytical tools enabling 
non-invasive cytochemical analysis by Raman micro-spectroscopy. But the importance of 
primary cells in several research fields {e.g. stem cell therapy, tissue engineering, etc.) and 
the establishment of reliable, reproducible protocols for primary cell isolation, such as the 
one used here for ATII cells, mean that primary cellular systems will undoubtedly play a 
more prominent role in the future development of bio-cellular applications of Raman micro-
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spectroscopy. In this chapter, Raman micro-spectroscopy was used to assess the suitabihty 
of cancerous and immortahsed cell lines as models for primary pulmonary alveolar epithelial 
cells from a molecular biochemical perspective. 
5.4.1 Cytochemica l characterisat ion of ATII, A 5 4 9 & T T l phenotypes 
The A549 adenocarcinoma cell line has been extensively characterised [177, 178] and com-
monly used as a model for primary ATII cells. Despite producing phospholipids and staining 
positive for Lbs, there are several discrepancies with respect to A549 expression of ATII-
specific markers reported in the literature. Fuchs et al. characterised A549 cells as a ho-
mogeneous population, expressing high levels of SPC and low levels of caveolin-1, which 
were not influenced by time in culture [137]. These findings correspond to an ATII cell 
pattern, and are supported by Campbell et al, who reported that A549 cells lack caveolae 
structures and only weakly express caveolin-1 [139]. However, immunoblotting by Wither-
den et al. detected no expression of SPC or surfactant protein A (SPA) mRNA by A549 
cells [141]. A549 cell cultures examined here did not stain positive for ALP (in agreement 
with McCormick et al. [179]) or pSPC, and weakly expressed both isoforms of caveolin-1 
(Figure 5.2C and personal observation of additional western blots, Figure C-1, Appendix C), 
indicating significant differences between the phenotype of A549 cells and that of primary 
ATII cells. With respect to other phenotypic markers, Carolan et al. reported that A549 cell 
monolayers demonstrate significantly lower transepithelial electrical resistance (TEER) than 
monolayers of primary ATII cells [180], Nakano et al. demonstrated that A549 cells strongly 
express the ATI-specific marker receptor for advanced glycation end products (RAGE) [181], 
and Pechkovosky et al. reported significant differences in the pattern of nitric oxide synthase 
mRNA expression between ATII and A549 cells [182]. It has been suggested that the con-
flicting results regarding A549 cells reflect inconsistencies between batches of A549 cells, 
possibly depending on culture conditions and passage number [141]. For the A549 cells 
examined here, however, it is clear that they express some phenotypic features of both pri-
mary ATII cells (positive Lb stain, weak caveolin-1 expression) and ATI-like cells (negative 
staining for ALP and pSPC). 
TT l cells demonstrated morphology consistent with that of ATI-like cells, and exhibited 
weak staining for Lbs. Several vacuole-like structures were observed, and could be reminiscent 
of residual or incomplete Lbs [137]. In addition, TTl cells did not stain positive for ALP 
or pSPC, but expressed caveolin-1 at a level comparable to in vitro derived ATI-like cells 
(Figure 5.2C). These results agree with the recent characterisation of TTl cells by Kemp et 
al. [175], and indicate that, based on the markers probed here, TTl cells express an ATI-
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like phenotype. This was expected since the immortalised TT l cell line was derived from 
cultures of primary ATII cells which had spontaneously differentiated towards an ATI-like 
phenotype. 
5.4.2 R a m a n spectral characterisat ion of ATII , A 5 4 9 & T T l phenotypes 
Biomolecular characterisation of A549 and TTl cells with Raman micro-spectroscopy re-
vealed that, like primary ATII cells, both cell lines exhibit similar variation between lipid-
rich cytoplasm spectra and protein/nucleic acid-dominated nucleus spectra. However, typical 
cytoplasm spectra presented in Figure 5.3 indicate that Raman scattering from the phospho-
lipid headgroups of PCh and phosphatidylethanolamine (PE; peaks at 717 and 875 cm~\ 
respectively [150]) was much more intense for ATII cells than for A549 and TT l cells, which 
could suggest differences in the composition of phospholipids within each cell type. The 
lower intensity and SNR observed in A549 and TTl cytoplasm spectra are likely due to 
fewer numbers of Lbs in these cells (Figure 5.1). Fewer Lbs may also explain the higher 
protein: lipid content in A549 and TT l cytoplasm spectra, evidenced by broadening of the 
amide I band (^1656 cm"^), decrease in C~C and POg stretch modes from ~1050-1150 
c m ' ^ decreases in characteristic lipid stretches at 1301 and 1740 cm~\ and higher signal 
contribution from aromatic amino acids {e.g. tyrosine at 645, 828, 854 cm" \ tryptophan at 
645 cm"^; and phenylalanine at 1003, 1033 cm"^). 
Computation of an average Raman spectrum for each cell enabled the comparison of cellu-
lar biomolecular signatures within and between groups of ATII, A549 and TTl cells. Raman 
spectral phenotyping produced highly reproducible and information-rich spectra. The low 
cell-to-cell spectral variation for each group is indicated by the small standard deviations 
about the mean spectra (Figure 5.4), and suggests consistent phenotypic expression within 
the cell cultures analysed. This is expected for immortalised and cancerous cell lines, but is 
also observed within cultures of primary ATII cells (early time point, d3-4), reflecting the 
high ATII cell purity (~95%) afforded by the robust isolation protocol [140]. 
A549 cells have previously been characterised using Raman micro-spectroscopy in sev-
eral investigations. Notingher et al. collected Raman spectra of A549 cells in culture to 
identify spectral differences between live and dead cells [14], while Verrier et al. [91], Not-
ingher et al. [183, 184] and Owen et al. [18] extended this research to investigate spectral 
markers associated with drug-induced apoptosis of A549 cells. The spectra of healthy A549 
cells reported in those investigations were similar to each other, but exhibited much less 
lipid character than spectra obtained here. Rather, A549 cell spectra in those reports were 
dominated by features of proteins and nucleic acids, demonstrating marked differences in 
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molecular vibrations due to DNA (the 786 cm~^ O - P - 0 and POg stretches of DNA), pro-
teins (ring breathing mode of tyrosine at 854 cm~\ C-H deformation at 1342 cm~\ and 
amide I band), and lipids (1740 cm"^ C=0 stretch, and 1656 cm'^ C=C stretch) compared 
to A549 cell spectra reported here. Increased spectral contribution from DNA in previous 
reports could stem from the analysis of asynchronous A549 cell cultures, and hence cells in 
the S and Gg/M phases of the cell cycle with higher DNA content. The discrepancies between 
the Raman spectra of healthy A549 cells between the current and previous studies further 
reflect the inconsistencies in phenotypic expression by the A549 cell line. However, the use 
of different substrates (fused silica coverslips by Notingher et al. and Verrier et al. versus 
MgFg by Owen et al. and in the current study), culture conditions (F12K culture medium in 
previous reports versus DMEM used here), and cell passage number may be responsible for 
some of these discrepancies. Furthermore, differences in cell culture preparations may also be 
responsible, as A549 cells were incubated for different periods of time in each study. Stearns 
et al. observed an ATI-like cell morphology with very few Lbs in sub-confluent A549 cells 
(cultured in F12K medium), which after three days in culture developed into characteristic 
ATII-like monolayers [185]. Analyses of A549 cells by Notingher et al. and Owen et al. were 
conducted only 24 hours post-seeding, which could explain the lower lipid content observed 
in their spectra. In the experiments reported here, A549 cells were analysed between 48-96 
hours post-seeding (including 24 hour serum starvation to synchronise cultures), after which 
time cells reached ~70% confluence on MgF2 coverslips and exhibited significant accumula-
tion of cytoplasmic Lbs. Irrespective of the discrepancies between previously published A549 
spectra and those presented here, the A549 cell line, which has the capacity to yield Raman 
spectra rich in hpid signatures, may not be the best cell line with which to analyse increases 
in cellular phosphoHpids due to oxidative damage during apoptosis [18, 91, 183, 184]. 
5.4.3 Differences b e t w e e n spectra of ATII, A 5 4 9 and T T l cells 
Differences between the Raman spectra of ATH, A549 and TTl cells were very similar 
to the differences between primary ATII and in vitro derived ATI-like cells identified in 
the previous chapter. These differences (Figure 5.4), include variation in the molecular 
vibrations of phosphohpids (717, 1061, 1082, 1301, 1740 cm"^), proteins (extended amide 
III band at ~1350 c m ' \ amide I band at ~1656 cm"^), and DNA (786 and 1575 cm"^). 
These sources of variation were consistent with the PCs and spectral factors generated by 
the unsupervised PCA and subsequent constrained eigenvector rotation, respectively. ATII 
cell spectra had noticeably stronger peaks corresponding to phosphohpid vibrations, owing to 
more Lbs within the cytoplasm of ATII cells, confirmed by Lb staining. This observation was 
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supported by the separation of cell clusters within the factors score plot (Figure 5.8), which 
indicated higher contribution of the phospholipid factor in spectra of ATII cells than A549 
and TT l cells. Furthermore, the semi-quantitative spectral modelhng results (Table 5.3) 
point to significantly higher signal contribution of lipids to ATII cell spectra, which on 
average are roughly 6% higher than for A549 cell spectra and 12% higher than for TTl cell 
spectra. 
Protein variation between spectra manifested primarily in C-H deformation vibrations in 
the extended amide III region (1320, 1342 cm~^). Also, the amide I band centred at ~1656 
cm"^ was broader in A549 and TTl cell spectra than in spectra of ATII cehs, indicating 
lower unsaturated phospholipid and higher protein content in spectra of A549 and TTl cells. 
Spectral modelling confirmed this observation, and estimated the protein signal content of 
ATII cell spectra to be approximately 10% lower than for A549 and TT l cell spectra. The 
protein factor (Figure 5.7) described predominantly a-helix proteins (amide I band centred 
at 1658 c m ' \ amide III band at 1320 cm" \ and skeletal C-C stretch at 935 cm"^), and the 
distribution of protein factor scores (Figure 5.8) indicates that much higher levels of these 
proteins were detected in A549 cells than in ATII and TT l cells. 
Raman peaks corresponding to molecular vibrations of DNA (O-P-0 stretch at 786 
cm"\ adenine and guanine nucleotide vibrations at 1575 cm"^) were higher in spectra of 
TTl cells than in ATII and A549 cell spectra. One of the factors generated in the factor 
analysis (Figure C-2) exhibited strong features of DNA along with several correlated protein 
vibrations (possibly from histone proteins associated with DNA), confirming that DNA vi-
brations were an important source of spectral variation between cell phenotypes. This was 
further supported by spectral modelling, which indicated significantly higher spectral levels 
of nucleic acids for TTl cells over ATII and A549 cells. 
5.4.4 Comparison of ATII, A 5 4 9 and T T l cell phenotypes 
The PC1-PC2 score plot (Figure 5.6) depicts clusters of cell populations, whereby grouping 
is based on spectral similarity. This bi-variate scatter plot presents a graphical representation 
similar to the results observed in flow cytometry. The cluster pattern indicates that TTl 
and A549 cell spectra occupy regions in the PC1-PC2 plane similar to middle (dlO-11) and 
late (dl7-18) time point ATII cells, respectively. Thus, with respect to the common basis 
vectors PCI and PC2, the spectra of TTl and A549 cells resemble those of middle and late 
time point ATII cells, respectively, which express an in vitro derived ATI-like phenotype. 
This suggests that A549 cells are not a good model for primary ATII cells, for if they were, 
both A549 and early time point ATII cell spectra would occupy a similar region within the 
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PC1-PC2 score plot. Instead, they occupy distinct regions and exhibit very httle cluster 
overlap. In contrast, the spectral similarity of TTl cells with ATI-like cells is consistent with 
the cytochemical staining for Lbs, ALP, pSPC and immunoblotting for caveohn-1, and given 
that the T T l cell line was derived from in vitro derived ATI-like cells [175]. 
The qualitative PCA results, based on only 65% of the data, were supported by quanti-
tative comparisons of ATII, A549 and TTl cell spectra by calculating correlation coefficients 
(Table 5.1) and by spectral modelling (Table 5.3). Correlation coefficients provide a statis-
tical measure of the similarity between spectra based on the entire data set. Calculation 
of pair-wise correlation coefficients between spectra of A549 cells and those of early, mid-
dle, and late time point ATII cells, revealed that A549 cell spectra are statistically more 
similar to those of middle and late time point ATII cells, which express an ATI-like phe-
notype, than to early time point ATII cells. Likewise, the spectra of TTl cells were found 
to be most similar to those of middle and late time point ATII cells expressing an ATI-like 
phenotype. The spectral modelling results support these findings: in the previous chapter, 
spectral modelling revealed that the ATII phenotype was characterised by high lipid and low 
protein spectral levels, with the opposite pattern corresponding to an ATI-like phenotype. 
The protein spectral content of A549 and TTl cell spectra (both ~61%) was similar to that 
of primary ATI-like cells (~62%), while the lipid content of ATI-like cell spectra (~19%) 
was in between the values obtained for A549 (~22%) and TT l cells (~16%). With signifi-
cantly higher lipid and lower protein levels for early time point ATII cells (~28% lipid, ~52% 
protein), it is clear that A549 cell spectra are more similar to those of ATI-like cells rather 
than ATII cells, while the spectral phenotype of TT l cells also corresponds to an ATI-like 
phenotype. 
5.4.5 Spectral discriminat ion of ATII , A 5 4 9 and T T l cells 
Notingher et al. used Raman micro-spectroscopy to non-invasively characterise several bone 
cell phenotypes used in tissue engineering, including primary human osteoblasts (HOB), an 
immortahsed osteoblast cell line (SV40), and osteosarcoma-derived MG63 cells [16]. In that 
study, the authors were able to identify biochemical differences in cellular spectra using mul-
tivariate analysis, and exploited these differences to discriminate between cancerous (MG63) 
and non-cancerous (HOB, SV40) bone cell phenotypes. No significant differences were de-
tected between primary and transfected osteoblasts, suggesting that SV40 immortalised os-
teoblasts may provide a more suitable model for primary osteoblasts than cancer-derived 
MG63 cells. In contrast, the LDA presented here demonstrates clear distinction between 
not only cancerous (A549) and non-cancerous (ATH and TTl) cells, but also exhibits excel-
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lent pair-wise discrimination between primary, cancerous, and transduced cells. The clear 
separation of cell populations in the LD1-LD2 score plot (Figure 5.9) and excellent 99% 
overall classification accuracy of the LDA model (Table 5.2) demonstrate that the cells can 
be distinguished from one another based solely on their Raman spectral signatures. Of the 
174 cells analysed, the only misclassifications were two TT l cells predicted as A549 cells. 
The model exhibited 100% spectral discrimination between primary ATII cells and both 
A549 and TT l cell lines, providing further evidence that A549 cells are spectroscopically 
distinct from primary ATII cells. In addition, although spectra of TTl cells were found to 
be similar to middle and late culture ATII cells, a separate PCA-based LDA provided > 99% 
spectral discrimination between primary ATI-like cells and the immortalised TT l cell line 
(Figure C-3, Table C-1, Appendix C). This indicated that biochemical alterations induced by 
transduction were detected by Raman micro-spectroscopy, and that these differences could 
be exploited by multivariate analysis to distinguish between in vitro derived and transformed 
ATI-like cells. 
The suitability of the A549 cell line as a model for primary ATII cells was questioned by 
Mason et al. in 1982, when they discovered that the phosphohpids produced by cultures of 
A549 cells were significantly different from those of freshly isolated ATII cells [173]. Since 
then, several discrepancies regarding A549 cell expression of ATII-specific and ATI-specific 
ultrastructural and cytochemical markers have led researchers to question the stability and 
robustness of the A549 cell line. Raman spectral phenotyping of ATII and A549 cells pre-
sented here cast further doubt on the use of A549 cells to represent ATII cells. The spectra 
of A549 cells were more similar to those of differentiated ATI-like cells than undifferentiated 
ATII cells, and 100% spectral discrimination between primary ATII cells and the A549 cell 
line was achieved. A549 cells are still commonly used in lung cell biology, but considering 
the differences between A549 and ATII cells, and the inconsistency of the A549 phenotype, 
it is important to recognise the limitations of the A549 cell line. Applications where the 
A549 cell line may be most appropriate include cancer studies of adenocarcinoma, and as a 
model for dysfunctional ATII cells, as suggested by Bahs et al. [186]. 
In contrast, the recently derived TTl cell line provides a suitable model for ATI-like 
cells, exhibiting positive expression of ATI-specific markers and negative expression of ATII-
specific markers. Multivariate statistical comparison of ATI-like and TTl cell spectra also 
revealed significant similarities between the two cell types. This new cell line has significant 
potential and will undoubtedly be used in future applications to study the biochemical and 
transport properties of ATI-like cells. 
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5.5 F u t u r e work 
R a m a n spectral characterisat ion of Lb phosphol ipid structure in alveolar 
epithelieJ cells 
Differences in cytoplasm spectra between primary ATII cells and A549 and TTl cell lines 
(Figure 5.3) were highlighted in the Discussion, which could suggest differences in the com-
position of surfactant phospholipids within each cell type. Mason et al. [173] and Bahs et 
al. [186] reported significant differences in the composition of phospholipids produced by 
primary ATII cells and the A549 cell line. Their results, based on surfactant isolated from 
cell culture media, indicated that phospholipids from A549 cell cultures exhibit lower levels 
of disaturated PCh and phosphatidylglycerol compared to pulmonary surfactant from both 
primary human and rat ATII cells. More recently, Postle et al. [151] demonstrated that 
ATII cell differentiation has a profound effect on composition of surfactant phospholipids, 
especially on acyl chain length. Future experiments in our laboratory are planned to use 
Raman micro-spectroscopy to non-invasively analyse the composition and physical proper-
ties of surfactant phospholipids stored in Lbs within the cytoplasm of live ATII, A549 and 
TTl cells. The aim is to identify phospholipid changes during ATII cell differentiation, and 
phospholipid differences between primary ATII and ATI-like cells and their respective A549 
and TT l cell line models. This hne of research will require a true confocal spectrometer 
system equipped with a high power NIR {e.g. 785 nm) dot laser with diffraction-hmited 
spatial resolution to probe individual Lbs (which typically range from 1-2 ^,m in diameter). 
The current experiments were performed on a dedicated Raman system equipped with 
a high power NIR line-focus laser and optimised for rapid, real-time analysis of single living 
cells. However, the lower spatial resolution offered by the current configuration only permits 
the acquisition of spectra from bulk cellular regions, rather than single organelles {e.g. Lbs) 
within living cells. This limits any interpretation of the phospholipid differences between 
Lbs of ATII, A549 and TTl cells based on cytoplasm spectra. Despite this limitation, the 
spectra in Figure 5.3 suggest that there are differences in the composition of Lb phospholipids 
between ATII, A549 and TTl cells. These differences include the aforementioned more 
intense Raman scattering from PCh and PE headgroups observed in spectra of ATII cells 
than in A549 and TTl cell spectra. Also, the relative intensities of C=C stretching and =C-H 
bending modes versus the C = 0 stretching, C-H bending, and CH2 twisting modes indicate 
differences in the degree of unsaturation of the lipid acyl chains. The patterns in these 
characteristic lipid peaks reported here for ATII, A549 and TTl cytoplasm spectra is similar 
to the pattern identified by Takai et al. for less unsaturated, moderately unsaturated and 
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highly unsaturated Upids, respectively, stored in cytotoxic granules within single living human 
lymphocytes [150]. In particular, the high intensity of CHg twisting mode at 1301 cm"^ and 
C = 0 ester stretch at 1740 cm" \ combined with low C—C stretching intensity at 1656 cm"^ 
relative to the C-H bending modes at 1440 cm"^ in ATII cytoplasm spectra suggests that 
the phospholipids synthesised and stored in Lbs of ATII cells are less unsaturated {i.e. more 
saturated) than those found in A549 and TTl cells. Furthermore, Takai et al. generated 
Raman intensity calibration plots using a series of triacylglycerols of known composition, 
in order to predict the degree of unsaturation and acyl chain length of lipids stored within 
cytotoxic granules based on their Raman spectra. By generating similar standard curves the 
same can be done for phospholipids stored within Lbs of live cells. To illustrate, consider 
the phospholipid factor in Figure 5.7, which describes the spectral signature of phospholipid 
species which differ between ATII, A549 and TT l cells. Using the curves generated by Takai 
et al., the degree of unsaturation was estimated by calculating the Iiebe/hYAe ratio with 
respect to n {i.e. the number of C=C bonds per acyl chain), and acyl chain length m by 
calculating the Iiese/huo ratio with respect to n/{m — 2n), the ratio of C=C bonds and 
aliphatic carbon atoms, where I represents the integrated band intensity. The estimated 
values are n = 0.66 and m = 19.5, suggesting that average Lb phosphoHpid acyl chain 
structure described by the phospholipid factor is highly saturated (on average, less than 
one C=C double bond per acyl chain, or approximately two unsaturations per three acyl 
chains) and of intermediate chain length {e.g. longer than the two 16-carbon acyl chains of 
dipalmitoyl-PCh, but shorter than 20-carbon acyl chains found in stearoylarachidonoyl-PCh 
and 22-carbon chains found in palmitoyldocosahexaenoyl-PCh [187]). 
5.6 Conclusions 
In this chapter, Raman micro-spectroscopy was used to non-invasively characterise the pheno-
types of primary ATII cells and the A549 and TT l cell hnes. The A549 cell line is commonly 
used as a model for ATII cells, while the recently established TTl cell line was derived from 
ATI-like cells obtained following spontaneous in vitro differentiation of primary ATII cells. 
Spectral results were correlated with cytochemical staining and immunoblotting for ATII-
and ATI-specific markers in order to assess the suitability of the A549 and TTl cell lines as 
models for primary ATII and ATI-like cells, respectively. The spectral profiles of A549 and 
TTl cells exhibited much lower phospholipid content than ATII cells, and more so resembled 
spectra of differentiated ATI-like cells. The lower phospholipid content in A549 and TT l cell 
spectra was confirmed by spectral modelHng, which indicated that the hpid content of A549 
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and TT l cell spectra was 6% and 12% lower than in spectra of ATII cells, respectively. This 
was further supported by multivariate factor analysis, which generated a phospholipid-rich 
spectral factor as the main discriminator between lung cell phenotypes, with much higher 
score values for spectra of ATII cells than for A549 and TT l cells. These results were in 
agreement with cyto chemical staining for Lbs, which revealed fewer phospholipid-rich Lbs 
in the cytoplasm of A549 and TT l cells than in ATII cells. Clustering of cells by PCA con-
firmed the spectral similarity of A549 and TTl cells to differentiated ATI-like cells. Spectral 
discrimination between ATII, A549 and TTl cells was achieved using LDA, which proved 
that ATII and A549 cells could be distinguished solely by their Raman spectra, as could 
ATI-like and TTl cells. The results presented here indicate that the immortalised TT l cell 
line represents an appropriate model for primary ATI-like cells, but question the suitability 
of the A549 cell line as a model for primary ATII cells. 
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Non-invasive assessment of in vitro 
osteogenesis 
In this chapter, Raman micro-spectroscopy is used to characterise bio-minerahsation within 
cell culture systems in vitro. Conventional techniques for studying cell culture mineralisa-
tion involve destructive or invasive sampling methods, which can alter the physical and/or 
biochemical properties of samples. Non-contact optical analysis of mineralising cell culture 
systems with Raman micro-spectroscopy enables the non-invasive analysis of live samples 
in the absence of fixatives or labels. 
Here, spectral analysis is performed on three murine cell culture systems which have 
shown promise for tissue engineering applications: embryonic stem cells (mES), mesenchy-
mal stem cells (i.e. murine bone marrow stromal cells, mBMSC), and osteoblasts (MOB). 
Cells were cultured with osteogenic supplements to induce osteoblast differentiation and the 
production of mineralised bone nodules. Live cell cultures were analysed with Raman micro-
spectroscopy over a four week period (time points: d7, 14, 21, 28) to monitor mineralisation, 
which was confirmed with ARS staining and FTIR spectroscopy. A detailed comparison 
of mature (d28) nodules produced by each cell type is also presented. Raman spectra of 
nodules derived from all cell types demonstrated profiles similar to native mouse bone (cal-
varium), exhibiting peaks describing molecular vibrations of both mineral (phosphate and 
carbonate species) and protein matrix environments. The results indicate that MOB and 
mBMSC cultures mineralised along a similar route, with evidence of Col Il-rich matrix and 
hydroxyapatite mineral precursors at early stages of nodule development and mineralisa-
tion. The first mineral evident in mES cultures was a more crystalline, carbonated apatite, 
and the protein matrix was rich in a-helix rather than collagenous proteins. All cultures 
demonstrated significant mineral deposition and an increase in mineral crystallinity by d28. 
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Univariate band analysis was used to evaluate bone nodule mineral: matrix ratios and car-
bonate substitution, while multivariate factor analysis was used to identify the mineral and 
matrix environments present in bone nodules formed by each cell type. The results indicate 
that the bone-producing capacity varies between cell culture systems, and that the bone 
tissue synthesized by each cell type contained different mineral and matrix environments, 
indicated by their different biomolecular Raman signatures. 
The chapter concludes with an outline of potential Raman spectroscopy applications 
to study in vitro cell culture mineralisation in order to elucidate the intricate mechanisms 
of mineralisation, and for selection of cells and culture conditions to optimise osteogenic 
potential of in vitro systems for bone tissue engineering. 
6.1 In t roduc t ion 
Severe skeletal trauma and disease can lead to bone loss too severe for the body to heal. 
In such cases, a graft is necessary to restore the structural integrity of the bone tissue. 
Current therapies to repair bone defects, including autografts, allografts, xenografts and 
prosthetic implants, suffer from a range of complications, including availability of suitable 
bone graft material, donor-site morbidity, immune rejection, biocompatibility, and failure of 
implant prostheses [188, 189]. These limitations have prompted the development of tissue 
engineered bone graft alternatives, in which biocompatible/bioresorbable scaffold materials 
are combined with cells and osteogenic growth factors to promote new bone formation and 
enhance integration with the surrounding host tissue [190]. In this strategy, the source of 
cells is an important consideration, with critical factors including cell expansion, immune 
response and differentiation to an appropriate phenotype. Several osteogenic cell culture 
systems, including primary osteoblasts (OB) [191], embryonic stem (ES) cells [192, 193], and 
mesenchymal stem cells (MSG, e.g. from marrow stroma) [194] have the potential to express 
an osteoblastic phenotype and produce mineralised nodules in vitro which demonstrate some 
morphological, molecular, and biochemical characteristics of embryonic/woven bone, and are 
useful quantitative in vitro assays of bone formation [191, 195]. As sources of cells for tissue 
engineering applications, these cell culture systems each have advantages and disadvantages. 
Pluripotent ES cells have the potential to differentiate into any cell type, and theoretically 
'unlimited' proliferative potential, however even targeted differentiation protocols often result 
in mixed cell populations, and their high proliferative capacity can possibly lead to the 
formation of teratomas [196]. Multipotent MSCs, while less versatile and dynamic than 
ES cells, have the potential to differentiate to various cells of the mesenchymal lineage {e.g. 
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adipocytes, chondrocytes, osteoblasts, etc.) and can avoid immune rejection by being patient-
specific, but also suffer from imperfect differentiation protocols, limited supply, have only a 
finite capacity for self-renewal and their proliferative potential and capacity for differentiation 
diminishes with age [197]. Unlike stem cells, OBs provide cultures highly enriched with 
target cells (i.e. bone cells), and like MSCs can be patient-specific. Unfortunately, the supply 
of terminally-differentiated primary OBs is limited, the proliferative potential of OBs is much 
lower than that of stem cells, and loss of osteoblastic phenotype by primary OBs has been 
observed with expansion in vitro [198]. Despite extensive scientific research into the subject, 
the 'best' cell culture system for studying the mineralisation process has yet to be identified. 
Furthermore, questions still remain as to how closely model cell culture systems biochemically 
replicate bone, due in part to lack of suitable characterisation techniques to indentify and 
monitor the biochemical species produced by cell culture systems during the mineralisation 
process. A better understanding of the properties of in vitro mineralisation may aid in the 
selection of the most appropriate cell sources to develop better tissue engineered substitutes. 
Bone tissue is a complex composite of inorganic carbonated calcium phosphate mineral 
arranged in an apatitic lattice, and hydrated, collagen-rich extracellular matrix, assembled in 
a detailed, hierarchical fashion from the nano- to the macro-scale [199]. The process of bone 
formation involves a complicated network of distinct mechanisms. In vivo this is a dynamic 
process, involving the differentiation of progenitor cells to a skeletal/osteoblastic lineage, 
extracellular matrix production, mineralisation and subsequent remodelling [200]. In vitro 
mineralisation by cell cultures provide simplified model systems with which researchers can 
investigate the composition of the mineral and matrix environments in early mineralised 
tissue, which is crucial to understanding the initial mineralisation process. Previous reports 
have shown that deposition of poorly crystalline apatite occurs in osteoblastic cell cultures in 
an analogous manner to in vivo calcification [201], and that needle-like crystalline structures 
observed in cultured osteoblasts are similar to those detected in sectioned rat calvaria [202]. 
Furthermore, laboratory-based cell culture models can be designed to systematically target 
specific features of bone formation, and the use of homogeneous cell populations helps to 
focus on bio-mineralisation by eliminating competing cellular activities. While no doubt 
an over simplification of the in vivo process, cell culture systems are by no means trivial; 
Zimmermann et al. have previously identified several distinct patterns of mineralisation 
within a single culture system of foetal rat calvarial cells [203]. 
Traditional analytical techniques used for structural and compositional analysis of bone 
include light and electron microscopy, histology, x-ray diffraction, and chemical analysis [69]. 
Routine histology is commonly used to study the organic matrix of bone, including morphol-
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ogy, structure and cellularity of bone tissue. Scanning and transmission electron microscopy 
(EM) have been used to examine the ultrastructure of bone at high resolution [194, 204], 
while X-ray microanalysis (XRMA) [205], energy dispersive X-ray (EDX) analysis [206], 
and inductively coupled plasma atomic emission spectroscopy (ICP-AES) [207] provide 
quantitative information on chemical/elemental composition of mineral content {e.g. Ca: P 
ratio). In contrast. X-ray diffraction (XRD) [208] and scanning small angle X-ray scattering 
(SAXS) [209] provide a direct measure of the physical characteristics of apatite crystals 
{e.g. thickness and orientation). While useful, these approaches are limited, as they do not 
provide molecular information, and in the case of XRMA, elemental detection is limited to 
higher atomic numbers (greater than five). These are also destructive techniques requiring 
invasive sample processing steps which may include a combination of fixation, dehydration 
and sectioning (in the case of histology and XRMA), or even acidic dissolution of matrix-
bound material (in ICP-AES). Histological, chemical and physical analytical techniques have 
also been used along with cytochemistry/immunocytocliemistry to characterize mineralised 
tissue derived from cell culture systems [191, 192]. Histochemical staining of bone nodules 
and native bone tissue with (ARS) [210] and von Kossa [211] staining has been extensively 
used to verify mineral deposition. The shortcoming of these stains is that they only identify 
the presence of mineral, and cannot be used to characterise the species that constitute the 
deposited mineral lattice. In addition, staining of bone or mineralised cell cultures cannot 
be carried out in situ, and requires samples to be fixed and/or dried (desiccated) prior to 
analysis. Cytochemical techniques such as polymerase chain reaction, flow cytometry and 
fluorescence microscopy have been used to assess the phenotype of cells within mineralising 
culture systems, by examining for expression of progenitor or osteoblast-specific genes and 
proteins, including alkaline phosphatase, osteonectin, osteocalcin, osteopontin, bone sialo-
protein and collagen-I [192, 206, 207]. The sample preparation required for the physical and 
chemical techniques outlined here range from minimally invasive to destructive, and can alter 
bone structure and composition. Vibrational spectroscopy is an alternative characterisation 
technique which offers several advantages to conventional techniques, including: minimal 
sample preparation, non-destructive data acquisition, the ability to obtain information at 
the molecular level, and versatile sampling arrangements [69]. 
6.1.1 Vibrat ional spectroscopy of mineral ised t issues 
Fourier transform infrared (FTIR) absorption spectroscopy and Raman scattering spec-
troscopy are laser-based techniques which probe the vibrational modes of the various molec-
ular and ionic species found within a sample. As such, FTIR and Raman can simultaneously 
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characterise the molecular composition of both the inorganic (mineral) and organic (matrix) 
phases of bone tissue, which facilitates the study of both components and their interaction. 
Examples of FTIR and Raman spectra of bone are shown in Figure 6.1, and a summary of 
FTIR and Raman band assignments and positions for bone tissue is presented in Table 6.1. 
The phosphate (PO^" ) ui symmetric stretch band is a prominent marker of mineral con-
tent, describing both the degree of mineralisation and crystallinity of the mineral species. 
The other phosphate and carbonate modes are indicators of change in mineral composition 
and environment, e.g. carbonate substitution within the apatitic lattice which has previously 
been used as an indicator of bone maturity. The amide modes (I and III in Raman, I, II and 
III in FTIR) and CH2 wagging mode characterise the proteins in the extracellular matrix of 
bone, and in conjunction with mineral spectral information indicate the mineral-to-matrix 
ratio of the tissue. These molecular vibrations provide insight into the biochemical species 
produced by the mineralisation process, and non-destructive sampling allows for spatial dis-
tribution mapping of bone constituents. The excellent spatial resolutions achievable with 
FTIR and Raman spectroscopy (10-20 fxm in FTIR and potentially 1 ^m in Raman) makes 
them prime candidates for the analysis of biological samples at the microscopic level. A 
detailed literature review on the application of vibrational spectroscopy to study mineralised 
tissues has been reported [212]. 
Assignment Wavenumber range Observed in 
(cm^^) (Raman intensity) 
p o | - ^2 422-454 Raman (m) 
P 0 | - 578-617 Raman (m) / IR 
C - C stretching, 815-921 Raman (w) 
proline ring (855), 
hydroxyproline ring (876) 
C 0 | - 1/2 860-890 IR 
P 0 | - :/! 957-962 Raman (vs) / I R envelope 
( P - 0 symmetric stretch) 
HP 0 4 " z/3 ; ring breathing 1003-1005 Raman (m) / IR envelope 
mode of phenylalanine 
P 0 = - 1/3 1006-1055 Raman (m) / I R envelope 
( P - 0 asymmetric stretch) 
c o g - z/i 1065-1072 Raman (m) / I R envelope 
( C - 0 in plane stretch) 
amide III 1243-1269 Raman (m) 
(C-N-H stretch) 
CH2 wag 1447-1452 Raman (m) / IR 
amide II 1540-1580 IR 
amide I 1595-1720 Raman (m) / IR 
( C - C - N stretch) 
Table 6.1: Raman and infrared (IR) spectroscopic band assignments for bone. Reproduced from [56, 212]. 
vs, very strong; m, medium; w, weak. 
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Figure 6.1: Typical Raman and FTIR spectra of murine calvarial bone. Spectra are the average of five 
measurements, with details of measurements described in the Materials & Methods section. Both spectra 
exhibit peaks describing protein and mineral vibrations, as indicated, with the frequency of each vibration 
listed in Table 6.1. The IR envelope in the FTIR spectrum includes PO4 i^ i 
CO?" 1^ 1 vibrations. 
HPO:- us , PO4 j/3 , and 
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Fourier transform infrared (FTIR) spectroscopy 
FTIR spectroscopy is more established than Raman spectroscopy, and consequently has been 
used to a much greater extent for analysis of mineralised tissues (see [213] for a detailed 
review). The larger spot size and faster acquisition times of FTIR compared to Raman make 
this technique useful for studies in which spatial averaging is acceptable or desirable. The 
lack of fluorescence interference in FTIR spectra of biological samples made this technique 
more attractive than Raman spectroscopy prior to the development of FT-Raman and NIR 
dispersive Raman systems with sensitive charge coupled device (CCD) detectors in the mid-
to late-1980s. FTIR spectral parameters derived from spectra of bone have been correlated 
with other characterisation techniques {e.g. X-ray diffraction, chemical elemental analysis) 
to establish quantitative metrics for measuring mineral composition (phosphate content, 
carbonate substitution, phosphate acid content, etc.), crystallinity, and the maturity of the 
collagenous organic matrix [214]. Several researchers have used FTIR metrics to investigate 
differences between normal and diseased (e.g. osteoporotic [215, 216]) or damaged bone 
[217], age-dependent changes {e.g. increase in mineral: matrix ratio, carbonate: phosphate 
ratio, mineral crystallinity and collagen maturity) in bone composition in a number of species 
[218, 219], and to study the properties of tissue-engineered bone with respect to the native 
tissue [220, 221, 222]. 
Non-contact FTIR absorbance measurements of bone are normally collected in transmit-
tance, which requires samples to be fixed, dehydrated and then embedded in a hard resin 
to obtain micro-tomed sections 2-3 fim thick which are then suitable for analysis. However, 
in an FTIR investigation into the effects of fixation on bone tissue, Pleshko et al. found 
that different fixatives adversely affected different bone tissue components {e.g. ethanol on 
matrix proteins and formalin on both mineral and matrix structure) [223]. In a separate 
FTIR study, Pleshko et al. examined the effects of sectioning on bone tissue, and found that 
the effect of polymethylmethacrylate (PMMA) mounting medium on the FTIR spectrum of 
bone was negligible, indicating no chemical interaction between the bone and PMMA [224]. 
However, other studies have shown that the removal of PMMA resin from bone sections can 
alter the physical properties of the sample {e.g. removal of thin trabeculae), while leaving 
the resin in place can lead to interference in the FTIR spectrum of bone from the vibrational 
spectral signature of PMMA, and subtraction of the PMMA signal can distort FTIR spectra 
of bone [225]. The adverse effects of fixation and sectioning of bone tissue for analysis with 
FTIR, histology and other techniques questions the validity of such sample processing, and 
leads to concerns that specimens thus treated (and potentially chemically altered) and not 
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truly representative of native or untreated bone tissue [212]. 
FTIR spectra of whole, non-sectioned bone tissue and cell culture derived bone nodules 
collected in reflectance or transmittance modes are of poor quality and provide little in-
formation (personal observations). Researchers have adopted different protocols to prepare 
cell culture bone nodule samples for FTIR analysis. Boskey et al flattened mineralised 
bone nodules from chick limb bud mesenchymal cell cultures by pressing them between two 
FTIR-transparent BaFg windows to collect FTIR spectra in transmittance [226]. Karp et 
al. collected FTIR transmittance spectra of desiccated bone nodules from cultures of human 
embryonic stem cells by mixing the dry, powdered samples in KBr (an FTIR transparent 
medium) and pressing them into pellets [206]. Unfortunately, these approaches destroy 
the sample, may alter the chemical and physical properties, and preclude further analysis 
{e.g. histochemical). Alternatively, Shimko et al. used attenuated total reflectance (ATR) 
FTIR spectroscopy to directly analyse intact, desiccated bone nodules on the culture sub-
strate [207]. However, this approach requires contact between the sample and ATR crystal 
{e.g. Ge, ZnSe, diamond, etc.), which can damage the sample (personal observations; see 
FigureD-1, Appendix D). In any case, FTIR analysis of bone and bone nodules is invasive 
(or requires invasive sample processing), so that the non-destructive feature of vibrational 
spectroscopy cannot be fully exploited. Furthermore, because water is a strong absorber of 
infrared light, samples must be dehydrated or the water signal subtracted from hydrated 
specimens, which makes FTIR unsuitable for in situ analysis of bone nodules derived from 
live cell culture systems. 
Raman micro-spectroscopy 
The advantages of Raman micro-spectroscopy over FTIR spectroscopy were highlighted in 
Chapter 1. Since it is a scattering rather than an absorbance technique, it is not limited 
to thin/transparent samples and can be used in several different configurations, though the 
most commonly used is a microprobe with 180° back-scattering collection geometry [212]. In 
addition, the weak inelastic scattering of aqueous media makes Raman micro-spectroscopy 
amenable and uniquely-suited to in situ analysis of mineralisation in live cell culture systems 
in the absence of fixatives or labels. An excellent review of recent developments in Raman 
micro-analysis of bone tissue has been published [227]. 
The ui symmetric stretch is the most prominent vibrational band in the Raman 
spectrum of mineralised tissue (Figure 6.1). Both the frequency and shape of this band 
are sensitive to the local mineral environment, and can therefore reveal changes in ionic 
incorporation and crystallinity. Studies on synthetic and biological apatites have correlated 
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characteristic PO^" i/i frequencies with different mineral environment composition, including 
that of hydroxyapatite (HAp), carbonate-substituted apatite (CHAp), amorphous calcium 
phosphate (ACP), octacalcium phosphate (OCP), /?-tricalcium phosphate (/3-TCP), and di-
calcium phosphate dihydrate (DCPD) [228, 229]. The most commonly encountered mineral 
environments in biological apatites are normally classified into three broad categories: a 
B-type carbonate-substituted apatite (carbonate substituted for phosphate in the hydrox-
yapatite lattice), which produces a PO^" Raman-shifted frequency in the range 955-959 
cm"^; a crystalline non-substituted hydroxyapatite, with Raman-shifted frequency between 
962-964 cm"^; and a disordered phosphate apatitic lattice (arising from ACP and/or A-
type carbonate substitution, i.e. carbonate for hydroxide), with Raman-shifted frequency 
between 945-950 cm"\ While the most prominent mineral environment in bone tissue is a 
carbonated apatitic phosphate {i.e. PO^" band in the 955-959 cm"^ range), most bone 
tissue contains some amount of each of these three mineral environments, which all con-
tribute to the PO^" band, often leading to an asymmetric band shape [59]. Imperfect 
stoichiometry in the mineral phase(s) also leads to band broadening [62]. Furthermore, the 
full-width at half-maximum (FWHM) of the PO^" Ui band is a direct indication of the local 
crystallinity of the mineral within the sample, with a lower value indicating a higher degree 
of crystallinity [230]. Other researchers have also reported that the FWHM of this band 
is sensitive to the carbonate substitution, with higher FWHM indicating higher carbonate 
content [231]. The other key mineral band in the Raman spectrum of bone is the ~1070 
cm"^ C0\~ vi stretch, which is used to estimate B-type carbonate substitution within the 
phosphate apatite lattice. Carbonate concentration in calcified tissue has been shown to 
vary with tissue type [212], maturity [59, 232], crystallinity [232, 233], age [234], bone 
structural features [235, 236], and even history of fracture [237]. Several researchers have 
used the ~1070 cm~^ band as an indicator of bone maturity or health [62], despite its close 
proximity and overlap with the triply degenerate PO^" z/g vibrations in apatite, which occur 
at ~1030, 1045 and 1076 cm"^ [238]. 
Initial Raman studies of bone (^pre-1986) were conducted on de-proteinated samples 
to overcome fluorescence interference believed to originate from within the organic matrix 
as a result of visible wavelength laser excitation (e.g. aromatic amino acid residues) [69]. 
Decomposition of the organic matrix with hydrazine and hydrogen peroxide effectively elimi-
nated fluorescence interference, but raised concerns that such treatments alter the structural 
or chemical properties of the mineral [228], and detectable spectral shifts and loss of car-
bonate bands in the Raman spectra of de-proteinated bone have been reported [239]. The 
development of FT-Raman and dispersive Raman systems with NIR excitation and sensitive 
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CCD detectors dramatically reduced fluorescence interference, enabling the analysis of bone 
samples not exposed to the detrimental effects of de-proteination treatments. For live cell bi-
ology applications, it has been shown that excitation of Raman scattering with near-infrared 
(NIR) lasers {e.g. 785, 830, 1064 nm) does not alter cell viability or phenotype, even at high 
laser powers {e.g. > 100 mW) [92, 13]. Analysis of cell biology systems with NIR lasers also 
avoids potential photodegradation {e.g. double-stranded DNA scission) associated with UV 
lasers, and problematic background fluorescence observed with visible excitation of organic 
compounds [5]. 
However, despite these non-invasive advantages, the majority of Raman investigations 
involve bone tissue samples which have been fixed and/or sectioned in order to study the 
surface and sub-surface compositional properties of native bone tissue. Timlin et al. analysed 
sectioned bone specimens to study the spatial distribution of phosphate mineral species in 
mature and newly generated mammalian cortical and trabecular bone using Raman hyper-
spectral imaging [58]. Using a similar approach, Tarnowski et al. were able to identify key 
trends in mineralisation in ethanol-fixed specimens of mouse calvaria at different points of a 
developmental time course (embryonic to postnatal) [59], and Kazanci et al. were able to 
analyze the biophysical characteristics of intact, preserved osteons within bone tissue [240]. 
Raman micro-spectroscopy has also been used to investigate the differences between healthy 
and diseased or damaged bone, and to assess the biocompatibility of prosthetic implant 
coatings. Timlin et al. induced fatigue-related micro-damage in bovine bone sections, and 
identified spectral markers linked to carbonate substitution to distinguish between damaged 
and undamaged bone [52]. Tarnowski et al. developed a model system to study mineral 
and matrix changes in ethanol-fixed mouse skulls undergoing force-induced craniosynostosis 
(premature fusion of skull bones at sutures) [60]. De Grauw et al. have examined the 
mineral content and crystallinity of fixed and sectioned calcium phosphate bone implant 
coatings in a 24-week rat femoral model [61]. While the analysis of invasively processed 
samples can provide valuable information, the issues concerning the fixation and sectioning 
of bone {e.g. altered tissue composition) raised for FTIR analysis of bone tissue also apply 
to Raman spectral analysis (Figures D-2, D-3, D-4, Appendix D) [58, 11]. 
In contrast to studies involving Raman analysis of bone tissue, few studies have focussed 
on the analysis of bone nodule formation in cell culture systems. Raman micro-spectroscopy 
has previously been used to characterise mineral deposition in cultures of an osteotropic 
prostate cancer cell hne (C4-2B) [241], to identify trends in early mineralisation of mouse 
calvarial osteoblastic cell cultures [62], to characterise mineral production during differen-
tiation of dental pulp stem cells [242], and for physicochemical analysis of bone mineral 
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formed in cultures of rat bone marrow stromal cells [205, 243]. In all but one of these 
studies [62], Raman micro-spectroscopy was used as an ancillary characterisation technique 
to simply verify mineral deposition, rather than being the core analytical technique. In each 
of these studies the cell cultures were fixed prior to Raman analysis, and to the best of 
our knowledge, no investigations have exploited the non-invasive and in situ advantages of 
Raman micro-spectroscopy to analyse bone nodules in live cell cultures. 
In this chapter Raman micro-spectroscopy is used to non-invasively characterise the in 
vitro mineralisation within live cell culture systems. Live cultures of murine embryonic stem 
(mES) cells, mesenchymal stem cells {i.e. murine bone marrow stromal cells, mBMSC) and 
mature osteoblasts (MOB) were analyzed at several time points to monitor trends in min-
eralisation for each cell type, to identify the bone mineral and matrix environments present 
and to compare them with those observed in native bone. Mineral deposition was confirmed 
by ARS staining and FTIR spectroscopy. An in-depth Raman spectroscopic study of 'ma-
ture' (day 28) bone nodules produced by each cell type is presented. Bone nodule spectra 
were analysed with univariate and multivariate statistical methods to identify spectral mark-
ers describing the biochemical differences between native bone tissue and mineralised bone 
nodules derived from different cell culture systems. Univariate band analysis was used to 
identify mineral environments and crystallinity, and to evaluate parameters describing the 
mineral: matrix ratio and carbonate substitution within the bone nodules. Multivariate 
principal components-based factor analysis was used to identify the spectral signatures of 
mineral and matrix species observed in bone nodules formed by each cell type. 
Additional preliminary results on the effects of fixation and dehydration/drying of cell 
cultures on Raman spectroscopic analysis, direct comparisons Raman and FTIR, and po-
tential avenues of further study, including high-spatial resolution line-focus hyperspectral 
Raman imaging of bone nodules, are included in the Future work section and Appendix D. 
6.2 Mater ia l s and M e t h o d s 
The analysis of cell culture bone nodules with Raman micro-spectroscopy was a collaborative 
project involving Dr. Eileen Gentleman and Dr. Nick Evans, both members of Dr. Stevens 
research group. Dr. Gentleman performed all cell culture experiments, while Dr. Evans 
was responsible for collagen II staining of cultured bone nodules. Both Drs. Gentleman and 
Evans collected light and fluorescence microscope images the ARS-stained bone nodules. All 
Raman and ATR-FTIR spectroscopy experiments and data analysis were performed by the 
author. 
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6 .2 .1 Cell cu l ture 
Mouse embryonic s tem cells 
E14/TG2a mouse embryonic stem (ES) cells (a kind gift from Austin Smith) were routinely 
cultured on 0.1% bovine gelatine coated (Sigma-Aldrich Company, Ltd., Dorset, UK) tissue 
culture flasks in Dulbecco's modified Eagle's medium (DMEM) supplemented with 10% 
batch-tested foetal bovine serum (FBS), 1% penicillin/streptomycin solution (P/S), 2 mM L-
glutamine (all from Invitrogen, Paisley, UK), and 100 //M /3-mercaptoethanol (Sigma). 1000 
U/mL leukemia inhibitory factor (ESGRO @, Chemicon Europe, Ltd., Hampshire, UK) was 
added to the culture medium just prior to use. Cell culture medium was changed daily. Only 
cells with population numbers lower than 20 were used in all experiments. Embryoid bodies 
were formed by briefly trypsinising cells such that colonies lifted off the tissue culture plastic, 
but cells were not individually dispersed. Floating colonies were transferred to non-tissue 
culture treated Petri dishes and cultured in Alpha Minimum Essential Medium (aMEM; 
Invitrogen) supplemented with 15% FBS, and 1% P /S for 5 days; culture medium was 
changed on the third day. Embryoid bodies were disrupted with 0.05% Trypsin/EDTA 
solution (Invitrogen) and cells were plated at 30,000 cells/cm^ in aMEM supplemented with 
15% FBS, 1% P/S, 50 fig/mL ascorbic acid, and 10 mM /^-glycerophosphate (both from 
Sigma) on 0.1% bovine gelatine coated MgFg coverslips (Global Optics, UK) and tissue 
culture flasks. Starting on the 14*'" day after plating, 1 u^M dexamethasone (Sigma) was 
added to the differentiation medium. Culture medium was changed every other day. MgFg 
coverslips are commonly used as a cell culture substrate for biomolecular analysis with Raman 
micro-spectroscopy, because the intense scattering of polystyrene-based tissue culture plastic 
overwhelms the scattering signal from cell and tissue biopolymers. 
The use of osteogenic supplements used here have previously been shown to direct the 
differentiation of stem cells to the osteoblastic lineage [244], and promote the formation of 
mineralised nodules in osteogenic cell cultures [192]. 
Mouse calvarial osteoblasts 
Mouse calvarial osteoblasts (MOB) were derived from neonatal mice as described previously 
[244]. Briefly, 2-day-old mice were sacrificed by cervical dislocation in accordance with 
Imperial College London ethical guidelines and calvarial tissue was removed. Calvariae were 
sequentially washed in phosphate buffered sahne (PBS), finely chopped with scissors, and 
then digested four times for 20 minutes in a 10% solution of 0.05% trypsin/EDTA (Invitrogen) 
in Hank's balanced salt solution containing 1.0 mg/mL collagenase at 37°C. A fifth digest 
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was performed for 2 hours. The supernatant from the last three digests was pooled and 
centrifuged at 200 x g for 5 minutes. The resulting cell pellet was then resuspended in 
aMEM supplemented with 15% FBS and 1% P /S and plated on standard tissue culture 
plastic. Cells from the third or fourth passage were used in experiments. To initiate bone 
nodule formation, cells were plated on 0.1% bovine gelatine coated MgFg coverslips and 
tissue culture flasks and cultured for 28 days in aMEM supplemented with 15% FBS, 1% 
P /S, 50 /Ug/mL ascorbic acid, and 10 mM /^-glycerophosphate. As in mES cultures, 1 /xM 
dexamethasone was added starting at day 14 of differentiation. 
Mouse bone marrow stromal cells 
Mouse bone marrow stromal cells (mBMSCs), also known as mesenchymal stem cells were 
obtained from the marrow stroma of mouse femora and tibiae according to previous reports 
[207]. Briefly, mice were sacrificed by cervical dislocation according to Imperial College 
London ethical guidelines and their hind legs were removed. Femora and tibiae were then 
cleaned of soft tissue and repeatedly washed with sterile PBS. The penultimate washing step 
was in a solution of 20% P /S in PBS for 5 minutes. After washing, bone epiphyses were 
removed with scissors, leaving only the diaphyses. The marrow cavities of diaphyses were 
thoroughly flushed with aMEM supplemented with 15% FBS and 1% P /S pushed through 
a 22-gauge syringe needle. The resulting marrow was then pulled repeatedly through the 
syringe needle and placed directly in a tissue culture flask containing aMEM supplemented 
with 15% FBS and 1% P/S. Culture media was changed on days 4 and 8 after harvest. 
On day 9, cells were trypsinized and seeded at 30,000 cells/cm^ on 0.1% bovine gelatine 
coated MgF2 coverslips and tissue culture flasks. Cells were allowed to differentiate for 28 
days in aMEM supplemented with 15% FBS, 1% P/S, 50 /ig/mL ascorbic acid, and 10 mM 
/^-glycerophosphate, with 1 juM dexamethasone added starting at day 14 of differentiation. 
6.2 .2 M o u s e calvarium, col lagen, and syn the t i c C H A p samples 
Spectra of native bone, collagen proteins, and synthetic carbonated hydroxyapatite (CHAp) 
were measured for comparison with spectra collected from mineralised bone nodules and 
mineral and matrix factors generated in multivariate factor analysis. Bone samples were 
harvested from the calvaria of adult mice (6 months old) and analysed in DMEM immediately 
following excision. Collagen I (bovine tendon) and II (chicken sternal cartilage) samples were 
obtained from Sigma (UK) and used without further preparation. Synthetic CHAp was a 
generous gift from Professor Racquel LeCeros, and was prepared by a precipitation route as 
described previously [245]. 
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6.2 .3 Alizeirin red S s ta in ing 
ARS staining of nodules was used to monitor in vitro mineralisation at days 14, 21, and 28. 
Cell culture plates were fixed in 10% phosphate-buffered neutral formalin for 20 minutes, 
washed in 0.01 M phosphate-buffered saline and stained for calcium with a 2% solution of 
ARS for 10 minutes [192, 207]. Plates were washed in running tap water and then left to air 
dry. Dried, stained cultures were viewed under epi-fiuorescense microscopy, with excitation at 
510-560 nm and emission > 590 nm. Fluorescence micrographs were taken of representative 
areas. 
6 .2 .4 Fourier t r a n s f o r m infrared ( F T I R ) m i c r o - s p e c t r o s c o p y 
On day 28 (d28), mineralised mES, MOB, and mBMSC cultures were rinsed with distilled 
HgO and dried in a desiccator prior to analysis with a Perkin Elmer Spotlight FTIR micro-
spectrometer with a germanium ATR crystal. Intact nodules were examined directly on the 
culture substrate by contact with the ATR crystal. At least five FTIR spectra were collected 
per nodule by c6-adding 32 scans at 2 cm~^ resolution over the mid-infrared spectral region 
700-1900 c m " \ with a minimum of three nodules examined per culture. The FTIR aperture 
was set to scan square 50 fim x 50 /im areas, and spectra were collected along a line through 
the centre of each nodule at equally-spaced intervals. These spectra were compared to FTIR 
spectra of native, unfixed bone tissue, and FTIR spectral parameters describing mineral and 
matrix content were compared to those obtained using Raman micro-spectroscopy of live cell 
cultures and the same mouse calvarial bone sample. 
6.2 .5 R a m a n m i c r o - s p e c t r o s c o p y 
Raman spectra were measured with a Renishaw In Via spectrometer connected to a Leica 
microscope, described in detail in Chapter 2. Spectra of MOB, mES, and mBMSC cultures 
were measured in DMEM with 1% P /S maintained at 37°C with a heated stage. Raman 
spectral characterisation of MOB and mES cultures was performed at days 7, 14, 21 and 
28, and at days 14, 21, and 28 for mBMSC cultures. Prior to the formation of minerahsed 
nodules, spectra of ECM-rich regions and cells were collected to characterise protein produc-
tion and ECM formation. In mineralised cultures (d28), several nodules were analysed by 
acquiring several spectra (at least five) at different sites per nodule. Spectra of the extended 
fingerprint region 400-1900 cm"^ were recorded at 1-2 cm"' resolution, collected along a line 
through the centre of each nodule at equally-spaced intervals, with 100 seconds integration 
time per spectrum. 
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6.2 .6 D a t a analys i s 
All Raman and FTIR data were processed and analysed with software developed in-house for 
the Matlab (The Mathworks, Natick, MA) environment, and with the multivariate statistical 
analysis PLS-toolbox (Eigenvector Research, Manson, WA). Raman spectra were intensity-
corrected for instrument response to minimise the effects of day-to-day spectral variation 
[16], and the background subtracted using the Modpoly algorithm described by Lieber and 
Mahadevan-Jansen (5"" order polynomial, 1000 iterations) [108]. Spectra were smoothed 
using a Savitsky-Golay filter (5 points, 2°"^  order polynomial) [107], and the wavenumber 
axis of each spectrum was standardised and aligned to the sharp phenylalanine peak at 1003 
c m " \ and truncated to the 415-1800 cm"^ spectral region. FTIR spectra of native bone 
and cell culture derived bone nodules were normalised with extended multiplicative signal 
correction [109], baseline corrected, and displayed over the spectral range 700-1800 c m " \ 
Univariate analysis 
Univariate band analysis of Raman spectra of bone nodules was used to estimate both min-
eral and matrix content and carbonate substitution into the apatitic lattice (the carbonate: 
phosphate ratio), as described by Tarnowski et al. [59]. Curve-fitting of the data was 
performed using Renishaw Wire 2.0 software, to estimate band position, the full-width at 
half maximum (FWHM), and area. Before univariate analysis, the SNR for each spec-
trum was computed to verify that each spectrum had a SNR > 3 in the vi envelope 
(920-985 cm"^), and hence described mineralised regions [59]. Before band area calcula-
tions a linear baseline was subtracted from each band envelope. Phosphate mineral content 
was estimated by fitting a pair of bands to the asymmetric 960 cm'^ PO^" ui stretch, to 
model the symmetric peak and asymmetric shoulder describing crystalline and amorphous 
mineral, respectively. B-type carbonate substitution was estimated by calculating the area 
of the COg" z/i symmetric stretch at ~1070 cm~\ obtained by fitting three bands (~1030 
cm~^ P 0 | ~ 1/3, ~1045 cm"^ PO^" 1/3 and ^1070 cm"^ COg" ui) to the baseline-corrected 
PO^" 1/3 , CO3" ui envelope (1015-1100 cm'^). The ratio of the 1070 cm"^ band area to that 
of P O ^ ' ui band at 960 cm"^ has been shown to be a good metric for estimating carbonate 
content in apatites [231]. To estimate the matrix content, two or three curves were fit to 
the baseline-corrected 1600-1720 cm"^ spectral region to model the amide I band at ~1650 
c m " \ and the C=C stretch of amino acids tyrosine (Tyr) and tryptophan (Trp) at ~1620 
c m ' \ Global average ± standard deviation mineral: matrix and carbonate: phosphate ra-
tios were calculated for bone scans as well as scans from bone nodules derived from each cell 
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type. Differences in univariate peak parameters between samples were tested for statistical 
significance using the Kruskal-Wallis test (significance noted at p < 0.05). 
Multivariate analysis: principal component analysis and factor analysis 
PCA and factor analysis described in detail in Chapter 2. Pre-processed Raman spectra 
were vector normalised and analysed using a singular value decomposition PCA-algorithm 
written in Mat lab. Multivariate curve resolution was then used to rotate the significant PCs 
subject to non-negativity constraints to generate factors describing the spectral signatures 
of biochemical components that vary within the data set. In the case of bone tissue spectra, 
the factors represent the spectral signatures of mineral and matrix species described by the 
spectra. The algorithm also rotates score values, so that factor scores indicate the relative 
amount of each factor present in the original spectra. The multivariate curve resolution 
program in the PLS-toolbox was used to rotate the significant PCs using a constrained 
iterative least squares solver subject to non-negativity constraints. Spectral comparisons 
were quantified by computing the correlation coefficient (R), which provides a statistical 
measure of the similarity between spectra (R=l for identical spectral profiles) [68]. 
6.3 Resul t s and Discussion 
To investigate the differences in mineralisation in vitro by mES, MOB and mBSMC cells, 
these cell culture systems were maintained with growth supplements known to induce os-
teogenic differentiation [191, 192, 207]. The following sections describe the patterns of 
mineralisation observed in each of these live cell culture systems at several time points (days 
7, 14, 21 and 28), combining qualitative ARS staining to verify mineral deposition with 
Raman micro-spectroscopy to identify the chemical composition of mineral and matrix en-
vironments. 
6.3 .1 Minera l i sa t ion t rends in m E S , M O B , and m B M S C cul tures 
Day 7 
Cultures of mES and MOB cells proliferated rapidly, and formed confluent monolayers by day 
7 (d7). In contrast, mBMSC cells grew at a much slower rate [207], and so the non-confluent 
mBSMC cultures were not analysed at the d7 time point. In both mES and MOB cultures, 
dense nodular colonies containing multilayer clusters of cells and/or protein matrix were 
observed, but neither mES nor MOB d7 cultures stained positive for ARS (data not shown). 
Raman spectra collected from mES and MOB nodules were dominated by spectral features 
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of proteins, but distinctly different protein signatures were observed between the two culture 
systems (Figure 6.2). The mean spectrum collected from an mES nodule (Figure 6.2A) 
resembles the spectra of mES cells reported by Notingher et al. [15], and was dominated by 
a-helix protein vibrations, indicated by an amide I centre frequency of 1659 cm~\ skeletal 
C-C stretching vibrations at 936 cm" \ and weak amide III vibration characteristic of a-helix 
proteins at 1284 cm"^ [69]. It is possible that these spectral features are due to osteocalcin, 
the most abundant non-collagenous protein in bone [246], which is characterized by a-helix 
secondary structure [247, 248]. Also present are peaks describing vibrations of nucleic acids 
(O-P-0 stretch of DNA at 786 cm"\ POg stretch at 1095 cm" \ G, A nucleotide vibration at 
1575 cm"^) and phospholipids (CN+(CH3)3 symmetric stretch of phosphatidylcholine at 717 
cm~\ skeletal C-C trans and gauche stretch vibrations at 1065 and 1127 cm"^, respectively, 
and the in-phase CH2 twisting mode at 1301 cm~^). The presence of nucleic acid vibrations 
suggests the nodule contains mitotically active cells, rather than simply consisting of an 
acellular protein matrix. The absence of mineral peaks in mES nodule spectra suggests that 
no mineral has been formed at this stage in the areas probed by Raman micro-spectroscopy. 
Peaks describing nucleic acid vibrations were much less prominent in MOB spectra, which 
could indicate that the cellularity in MOB nodules was lower than for mES nodules, or that 
the cells differ in the rate of proliferation and/or matrix production. The protein signature 
of MOB nodule spectra was dominated by collagen (Figure 6.2B), indicated by the C-C 
backbone stretch of collagen at 815 cm"\ increased signal from proline and hydroxyproline 
at 853, 872 and 921 cm" \ both essential collagen residues, C-N-H amide III stretch at 1246, 
1269 cm~\ and extended amide III stretch at 1318, 1345 cm'^ [76]. Interestingly, these 
protein signatures were more similar to type II collagen (Col II) than type I collagen (Col I). 
The correlation coefficient between spectrum 1 and Col II was R=0.83, but a much higher 
correlation was observed (R=0.96) if calculated without the dissimilar amide I band. These 
values were higher than the correlation coefficients calculated with Col I (R=0.80 and 0.92). 
Col II is the dominant protein of hyaline cartilage, whereas Col I is the primary matrix 
protein in bone. These findings suggest that the MOB cultures examined here may miner-
alise via an endochondral-type ossification process, i.e. bone formation via a cartilaginous 
intermediate [199], rather than the accepted intramembranous ossification of calvaria in 
vivo [59]. The artificially-induced hypoxic environment in vitro may promote endochondral 
ossification within cell culture systems. The discrepancy between the amide I bands may be 
due to inter-species and tissue differences between collagen-rich nodules grown in calvarial 
MOB culture and purified, freeze-dried chemical-grade Col II extracted from chicken sternal 
cartilage. Strong collagen protein features were observed in several MOB nodules, and some 
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F i g u r e 6.2: A Typical protein-dominated Raman spectrum collected from a nodule of dense aggregate 
protein and cellular material in mES culture at d7 (below the graph). The spectrum shown is the average of 
3 measurements collected from the unniineralised nodule. B Select Raman spectra collected from a nodule in 
MOB culture at d7 (below the graph). The spectrum of collagen II is included to highlight the characteristic 
collagen II features in the MOB d7 spectra. C Signs of early mineralisation in MOB cultures at d7 (to the 
right of the graph), with peaks indicating the presence of disordered phosphate species ACP (950 cm~^) and 
OOP (955 cm~^). The sites of spectral acquisition are indicated. Scalebar = 50 /im. 
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nodules also exhibited early signs of mineralisation at d7 (Figure 6.2C). The Raman peaks 
at 950 cm~^ (spectrum 2, Figure 6.2C) and 955 cm~^ (spectrum 1) indicate the presence 
of the disordered phosphate species amorphous calcium phosphate (ACP) and octacalcium 
phosphate (OCP), respectively [59, 62]. This is in contrast to Stewart et al, who detected 
a poorly-carbonated crystalline apatitite (PO^^ vi at 960 cm"^) as the first mineral envi-
ronment observed in d8 cultures of an osteogenic, clonal MOB cell line (MC3T3-E1) with 
Raman micro-spectroscopy [62]. The lack of evidence for precursor mineral species in their 
study may be due to the use of a biochemically altered clonal cell line rather than primary 
MOB cells. 
Day 14 
By day 14 (dl4), nodules in mES cultures increased in number and appeared dense, opaque, 
and dark under light microscopy (Figure 6.3, top left-hand corner, and Figures 6.4A and 
6.4B). The presence of calcium deposits in mES cultures was confirmed by intense positive 
staining for ARS (Figure 6.3), which was extensive throughout cultures. Raman spectra of 
nodules from mES dl4 cultures (Figures 6.4A, B) exhibited prominent PO^" ui stretching 
at ~960 cm"\ suggesting significant mineral deposition. Some nodules {e.g. Figure 6.4A) 
demonstrated both non-mineralised (spectra 4 and 5) and mineralised regions with varying 
degrees of mineralisation (spectra 1, 2, 3). Spectral features of nucleic acids and lipids are 
clearly present in spectra 3, 4, and 5, but appear only faintly in spectrum 2 and are absent 
in spectrum 1, in which P 0 | ' ui stretching is greatest. This could indicate regions of the 
nodule with higher mineral and/or matrix content and fewer numbers of cells. There is a 
clear shift in the centre of the 1050-1100 cm"^ envelope from ~1090 cm~^ in non-mineral 
spectra, representing POg stretching in nucleic acids, C-C stretching in lipids, and C-C, 
C-N stretching in proteins, to ~1075-1080 cm~^ in mineralised spectra, which describes 
COg" f i and PO^^ 1/3 vibrations. This is accompanied by a change in protein secondary 
structure, with a-helix proteins (amide I band at ~1660 cm"\ spectrum 5) dominant in non-
mineralised regions and collagenous proteins in mineralised regions (C-C backbone stretch 
of collagen at 815 cm"\ proline and hydroxyproline stretches at 853, 872, and 921 c m ' \ 
amide I band at '^1665 cm"'-, spectrum 1). In contrast to disordered phosphate species 
detected in early mineralised d7 MOB cultures, the first mineral detected in cultures of mES 
cells at dl4 was a lightly carbonated crystalline apatite (PO^" vi stretch at ~960 cm"' and 
~1075 cm"' CO3' inland PO^" 2^3 band). This was true of nodules exhibiting moderate 
(Figure 6.4A) and high (Figure 6.4B) degrees of mineralisation, although a scan from one 
region of the nodule in Figure 6.4A indicated a mineral region of slightly lower crystalhnity 
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(spectrum 3: ui centre 958.8 cm"\ FWHM of 18.9 cm~^). It is possible that, like MOB 
cultures, early mineral species in mES cultures were initially disordered {i.e. less crystalline) 
but increased in crystallinity by dl4, in which case the time resolution of our experiments 
precluded the detection of amorphous mineral precursors in the mES cell culture system. 
mES MOB mBMSC 
Figure 6.3: Histochemical characterisation of bone nodules in d l4 cultures of mES, MOB, and mBMSC 
cells. Top row: light microscope pictures of unstained cultures. Middle row: Light microscope pictures of 
ARS stained cultures. Bottom row: microscope images of fluorescence from ARS stained cultures. Scalebar 
= 200 /^ m. 
Cells in mBMSC cultures reached confluence after ~9 days in culture, and the nodules 
formed after 14 days in MOB and mBMSC cultures were similar in size and morphology, 
and appeared bright under light microscopy (Figure 6.3 and Figures 6.4C, D). Both MOB 
and mBMSC dl4 cultures stained positive for ARS (Figure 6.3), although staining was less 
intense than observed in mES cultures, and was largely confined to the discrete nodular 
structures. Spectra of dl4 MOB and mBMSC nodules were dominated by collagen protein 
features, and the correlation coefficients between the mean spectrum of non-mineral, collagen-
rich regions of the mBMSC nodule in Figure 6.4D and samples of Col II and Col I were 
B—0.87 (R=0.97 excluding the amide I band), and R=0.83 (R=0.92), respectively. Both 
MOB and mBMSC dl4 cultures stained positive for Col II (Figure D-6, Appendix D). This 
suggests that mBA'ISC cultures analysed here may have mineralised via an endochondral-type 
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F i g u r e 6.4: A Signs of early mineralisation in mES cultures at dl4. B Evidence of highly mineralised nodule 
in mES cultures at dl4. C Raman spectra collected from a nodule in MOB culture at dl4, D Raman spectra 
collected from a nodule in mBMSC culture at dl4. In each case, light microscope pictures of the bone nodules 
appear below each graph, with the sites of spectral acquisition indicated. Scalebar = 20 /nm in A, B, C, 50 
jjLm in D, 
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ossification, similar to that observed in MOB cultures. As in d7 MOB cultures, the presence 
of disordered mineral environments in dl4 MOB and mBMSC cultures was detected, and 
the weak P 0 | ~ ui stretching in MOB and mBMSC nodule spectra suggest significantly less 
mineral deposition in these cultures compared with mES cultures at dl4. The mBMSC 
nodule spectra in Figure 4D indicates the presence of OCP (954 cm~^ peak in spectrum 
1), while multiple mineral environments were detected in the MOB nodule in Figure 6.4C, 
including ACP (952 cm~^ peak in spectrum 3), OCP (954 cm~^ peak spectrum 2), and 
a lightly carbonated apatite (956 cm"^ peak in spectrum 1) with much lower crystallinity 
than the apatitic mineral environment of mES dl4 nodules (evidenced by the blue-shifted 
3 -
4 PO4 stretch at ~960 cm 
Day 21 
The morphological features of mES cultures at day 21 (d21) were similar to those at dl4, 
although the nodules were larger and mineralisation was more extensive throughout the 
culture. The opaque nodules did not have well-defined margins, and because of the high 
proliferation of mES cells, the nodules formed in mES cultures tended to merge and took on 
the appearance of a mineral sheet [207], confirmed by extensive ARS staining (Figure 6.5). 
The increased intensity in mineral bands in the Raman spectra of d21 mES nodules over 
dl4 nodule spectra indicates additional mineral deposition in mES nodules from dl4 to d21 
(Figure 6.6A: spectra 1, 2, and 3). However, some non-mineralised or weakly mineralised 
regions were still present (spectra 4 and 5), and these regions were generally observed near 
the periphery of nodules. The centre frequency and FWHM of the PO^" 1^1 band indicates a 
lightly carbonated apatitic mineral environment of similar crystallinity to dl4 mES nodules. 
The mineral: matrix ratio (4.19±1.18) calculated from the mineral spectra of the d21 nodule 
in Figure 6.6A is nearly double the value (2.19 ± 0.87) calculated for the highly mineralised 
dl4 nodule in Figure 6.6B, further suggesting additional mineral deposition. Furthermore, 
the decrease in the CO3" ; PO^" ratio observed in spectra measured from mES nodules at 
dl4 (0.22 ± 0.03) and d21 (0.12 ± 0.02) suggests that additional phosphate mineral is being 
produced faster than carbonate substitution within the apatitic lattice. 
Day 21 MOB cultures contained both highly mineralised nodules and nodules displaying 
varying degrees of mineralisation. This pattern suggests the initial formation and develop-
ment of new nodules is not confined to early culture periods. MOB nodules were typically 
smaller than mES nodules, with well-defined margins. Cultures stained positive for ARS, 
with the intensity of the staining consistent with the variability in nodule mineralisation 
{i.e. more staining with more mineralised nodules). Strong collagen spectral features were 
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mES MOB mBMSC 
F i g u r e 6.5: Histochemical characterisation of bone nodules in d21 cultures of mES, MOB, and mBMSC 
cells. Top row: light microscope pictures of unstained cultures. Middle row: Light microscope pictures of 
ARS stained cultures. Bottom row: microscope images of fluorescence from ARS stained cultures, Scalebar 
= 200 fim. 
155 
C h a p t e r 6: Non- invas ive a s s e s s m e n t of in vitro o s t eogenes i s 
800 1000 1200 1400 1600 1800 
Raman shift (cm'^) 
958.0 
B 
1000 1200 1400 1600 
Raman shin (cm"^) 
960.1 ±0.1 cm'^ 
18.610.2 em'^ FWHM 
CC^v, : 1075.3 ±0.3 cm 
22.6 ± 0.3 cm'^ FWHM 
1000 
Speclrum 
Raman shift (cm* ) 
F i g u r e 6.6: Spectra collected from mineralised bone nodules grown in A mES, B MOB, and C niBMSC 
culture, d21. The nodules are shown (below the graphs in A and B, to the right of the graph in C) and the 
sites of spectral acquisition indicated. Scalebar = RO /./,m in A, 20 //m in B, C. 
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still observed in lesser mineralised nodules. Spectra of highly minerahsed MOB nodules 
(e.g. Figure 6.6B) were dominated by the PO^" stretch, for which the central frequency 
(959.5 ± 0.5 cm"^) and FWHM (19.0 ± 1.6 cm"^) indicate a carbonated apatite mineral 
environment which is more crystalline than MOB nodules at dl4, but less crystalline than 
mES d21 nodules (centre frequency 960.7±0.1 cm"^ and FWHM 16.5±0.3 cm'^). However, 
the mineral content was much higher in this d21 MOB nodule than in the d21 mES nodule 
reported in Figure 6.6A, as judged by the mineral: matrix ratio (11.08 ± 5.34 for MOB and 
4.19± 1.18 for mES). Carbonate; phosphate ratios calculated from the mineral spectra were 
similar between the two nodules (0.11 ± 0.03 for the MOB d21 nodule in Figure 6.6B, and 
0.12 ± 0.02 for the mES d21 nodule in Figure 6.6A), suggesting similar levels of carbonate 
substitution. 
The mBMSC cultures analysed at d21 revealed discrete nodules with well-defined mar-
gins, similar in size to d21 MOB nodules. Also consistent with MOB cultures, some lesser 
mineralised nodular structures in mBMSC cultures demonstrated spectral features of type 
H collagen. Positive staining for ARS (Figure 6.5) was confined to discrete mineralised 
nodules. The strong PO^" stretching in spectra from mineralised mBMSC nodules {e.g. 
Figure 6.6C) indicates significant mineral deposition by mBMSC cultures from dl4 to d21. 
The centre frequency and FWHM of this band (960.1 ±0.1 cm~^ and 18.6 ±0.2 cm" \ respec-
tively) indicated a lightly carbonated apatite which was much more crystalline than observed 
in dl4 mBMSC nodules, and of intermediate crystallinity compared with d21 mES and MOB 
nodules. The mineral content observed in d21 mBMSC nodules (mineral: matrix ratio of 
4.10 ± 1.23 for the nodule in Figure 6.6C) was similar to that of mES d21 nodules, and the 
carbonate substitution (carbonate: phosphate ratio of 0.14 ± 0.02) was similar to the values 
obtained for both mES and MOB d21 nodule spectra. 
Day 28 
By day 28 (d28), mES cultures were heavily mineralised with numerous opaque nodules on 
an extensive mineral sheet which often covered the majority of the culture surface. In some 
cases, the entire culture surface stained positive for ARS, with more intense staining localised 
to highly calcified nodules (Figure 6.7). Even Raman spectra collected away from highly 
opaque nodular regions demonstrated moderate PO^" stretching, confirming extensive 
minerahsation throughout mES cultures. A linescan of spectra collected from a typical mES 
nodule at d28 are shown in Figure 6.8A. Compared to mES nodules analysed at days 14 
and 21, there appears to be no significant change in the crystalUnity of the apatite mineral 
within the nodular regions analysed, as estimated from the centre frequency and FWHM of 
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the ui stretch. The mmeral: matrix ratio of the spectra in Figure 6.8A range in vahie 
from 2.17 to 5.30, which suggests non-uniform minerahsation, at least in the regions probed 
along this particular linescan. The mean mineral: matrix ratio for this nodule (3.91 ± 1.25) 
is similar to that reported for the mES d21 nodule in Figure 6.6A, which could indicate 
that mineral deposition in mES cultures from d21 to d28 is committed more to extending 
the mineral sheet than to accumulation of mineral within discrete nodules. The COg" : 
ratio was more consistent along the linescan (0.16 ±0.03), with values intermediate of 
those estimated from spectra of dl4 (Figure 6.4B) and d21 (Figure 6.6A) mES nodules, which 
could suggest stabilisation of carbonate substitution from d21 to d28 within the apatitic 
mineral deposited in mES nodules at earlier growth stages [e.g. from dl4 to d28). More 
research is needed to test these hypotheses. 
mES MOB mBMSC 
Figure 6.7: Histocheraical characterisation of bone nodules in d28 cultures of mES, MOB, and mBMSC 
cells. Top row: light microscope pictures of unstained cultures. Middle row: Light microscope pictures of 
ARS stained cultures. Bottom row: microscope images of fluorescence from ARS stained cultures. Scalebar 
= 200 / i m . 
Unlike the extensive mineral sheet observed in mES cultures, MOB and mBMSC cultures 
at d28 contained several discrete nodules with well-defined margins. Positive ARS staining in 
these cultures was concentrated solely in and around discrete calcified nodules (Figure 6.7). 
Raman spectra of non-nodular regions (i.e. those negative for ARS staining) were dominated 
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F i g u r e 6 .8: Spectra collected from a mineralised bone nodule grown in A mES culture, B MOB culture, 
and C m B M S C culture, d28. The nodules are shown (to the right of the graphs) and the sites of spectral 
acquisition indicated. Scalebar = 20 jum. 
159 
Chapter 6: Non- invasive assessment of in vitro os teogenes is 
by collagenous protein signatures and contained little or no mineral peaks, indicating that 
mineralisation was largely confined to discrete nodules. Spectra of both MOB and mBMSC 
nodules demonstrated intense PO^" ui stretching, and yielded significantly higher mineral; 
matrix ratios than spectra of mES d28 nodules (discussed in detail in Section 6.3.3). In con-
trast to the abnormal growth patterns and non-apatitic mineral deposition by clonal mouse 
calvarial osteoblasts cultured on non tissue culture grade fused silica coverslips observed by 
Stewart et al. [62], MOBs cultured on MgF^ coverslips in this experiment demonstrated 
similar growth pattern and mineralisation to MOBs cultured on standard tissue culture plas-
tic. Spectra from a highly mineralised d28 MOB nodule in Figure 6.8B revealed very high 
mineral: matrix ratios (9.83 ± 1.62) — significantly higher than the maximum mineral: ma-
trix ratio recorded from any mES nodules, d28 or otherwise. Mineral: matrix ratios for 
d28 mBMSC nodules were intermediate of mES and MOB nodules {e.g. 5.65 it 0.79 for the 
nodule in Figure 6.8C). The MOB and mBMSC nodules in Figure 6.8 demonstrated similar 
levels of carbonate substitution (carbonate: phosphate ratios: 0.10 ±0.01 and 0.12 it 0.02 for 
MOB and mBMSC nodules, respectively), which were slightly lower than those calculated 
for the mES nodule in Figure 6.8A. 
The centre and FWHM values for the nodules in Figure 6.8 reveal a common, lightly 
carbonated apatite mineral environment, with slight variations in mineral crystallinity. This 
indicates that the mineral content in at least some MOB nodules increases in crystallinity by 
d28. In vitro mineralisation by mES, MOB, and mBMSC cells was also confirmed by ATR-
FTIR: spectra collected from a d28 mES nodule are shown in Figure 6.9, and demonstrate 
the variation in mineral and matrix content within cell culture derived bone nodules. Similar 
results were obtained for both MOB and mBMSC d28 bone nodules (Figures D-7 and D-8, 
Appendix D). The nodules appear different in Figure 6.9 because the picture of the dried 
nodule was collected in the epi-illumination configuration, while the nodules depicted in 
Figures 6.2, 6.4, 6.6, and 6.8 were submerged in DMEM cell culture medium and collected 
in the trans-illumination configuration. 
6.3 .2 B iomolecu lar character i sat ion of d28 nodu le s w i t h v ibrat ional spec-
t r o s c o p y 
To study the mineral and matrix environments in mature bone nodules formed by mES, 
MOB, and mBMSC cells after 28 days in culture, several bone nodules from each cell culture 
system at the d28 time point were analysed. High-quality SNR data sets of Raman spectra 
from highly mineralised nodules were compiled from 80 spectra collected from 11 mES nod-
ules, 87 spectra from 13 MOB nodules, 53 spectra from 9 mBMSC nodules (minimum five 
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Spec t rum 
1600 
W a v e n u m b e r (cm"^) 
F i g u r e 6.9: FTIR spectra collected from a bone nodule from d28 mES cell culture. The spectra indicate 
mineral and matrix variation across the hnescan. The sites of spectral acquisition are indicated. Scalebar = 
50 fj,m. 
spectra per nodule) and 44 spectra collected at different sites from three separate samples of 
mouse calvarial bone. FTIR spectra were collected from only a few nodules (three nodules 
per group, minimum five spectra per nodule) in order to confirm mineralisation. The mean 
Raman and FTIR spectra of bone and bone nodules are reported in Figure 6.10 and resem-
ble previously published Raman and FTIR spectra of bone and bone nodules [207, 59, 62]. 
The Raman spectral profiles of mES, MOB and mBMSC nodules (Figure 6.10A) are sim-
ilar, and all exhibit spectral features characteristic of native bone (R=0.99 for each mean 
spectrum compared with the mean bone spectrum), including prominent mineral vibrations 
and matrix peaks characteristic of collagenous proteins (Table 6.1). Despite exhibiting simi-
lar biomolecular signatures, bone nodule spectra exhibit less intense Raman scattering from 
C-C stretching in the 815-921 cm"^ region, PO^" z/g vibrations at 1030 and 1045 cm"\ and 
C-N-H stretching vibrations in the extended amide III region (1240-1350cm-1) than native 
bone tissue, indicating differences in biochemical composition. The Raman spectra were 
scaled to represent equal I'l stretching intensity, and with this scaling it is clear that 
the intensity of matrix bands are higher in spectra of mES nodules than in bone spectra, but 
lower in spectra of MOB and mBMSC nodules. The Raman spectra of mouse calvarial bone 
obtained here are similar to spectra of fixed postnatal mouse calvaria reported by Tarnowski 
et al. [59]. However, there is a noticeable 2-4 cm~^ shift in several bands {e.g. PO^" ui band 
position of 956 cm^^ versus 960 cm"^ observed here) relative to the amide I centre frequency, 
observed at ~1666 cm"^ in both cases, and may be due to differences in calvarial samples 
and/or experimental protocols. Mean FTIR spectra (Figure 6.10B) from both mES and 
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mBMSC d28 nodules were quite similar to the FTIR spectrum of bone (R—0.98 and 0.96, 
respectively), while spectra from MOB d28 nodules revealed less well resolved amide protein 
bands (R—0.76). 
Mouse bone 
B 
Mouse 
800 1000 1200 1400 1600 1800 
Raman shift (cm'^) 
800 1000 1200 1400 1600 1800 
Wavenumber (om'^) 
Figure 6.10: A Mean Raman spectra collected from native bone (mouse calvarium) and bone nodules grown 
in mES, MOB, and mBMSC cultures for 28 days. The mean spectra reported here represent the average of 44, 
80, 87 and 53 measurements, respectively, normalised to maximum unity intensity and offset for comparison. 
B Representative mean FTIR spectra collected from mouse calvarial bone, and bone nodules derived from 
cultures of mES, MOB, and mBMSC cells (d28). The mean spectra reported here each represent the average 
of at least 15 measurements per group, normalised to maximum unity absorbance and offset for comparison. 
6.3 .3 Univar ia te d a t a analys is 
Curve-fitting analysis of PO^" vi , CO^" and amide I Raman spectral bands was per-
formed to calculate band areas, positions, and FWHM values to estimate mineral deposition, 
composition, crystallinity, and carbonate substitution. Band areas and ratios are plotted in 
Figures 6.11 and 6.12, respectively, while band positions {i.e. centre frequency) and FWHM 
values are reported in Table 6.2. 
Mineral content and mineral: matrix ratios 
The bi-variate graphs in Figure 6.11 plot the area of the PO^" u\ band versus that of the 
amide I band (Figure 6.11A), and the area of the COg" i^ i band to that of the PO^" i^ i band 
(Figure 6.11B) from spectra of bone and bone nodules. The slopes of the dotted lines in 
Figure 6.11A and B indicate curves along which the mineral; matrix ratio (1,2, 3 , . . . , 12) and 
carbonate: phosphate ratio (0.1, 0.2, 0.3, 0.4), are constant. These plots indicate a significant 
amount of inter- and intra-nodule variability for each cell type. While a broad range of 
mineral (phosphate) peak areas were observed for a given matrix peak area, the general trend 
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mES MOB 
Samp le 
Figure 6.12: A Mean ± standard deviation mineral to matrix ratio and B carbonate to phosphate ratio 
for Raman scans of native bone and d28 bone nodules from mES, MOB and mBMSC cell cultures. Average 
values were calculated from Mineral: matrix and carbonate: phosphate ratios obtained from 44, 80, 87, and 
53 spectra from bone, mES, MOB, and mBMSC bone nodules, respectively. 
Symbols: statistically significant difference between Sample X and *Bone, ^mES, *MOB, and ^mBMSC, 
respectively (p < 0.05). 
p o r - v\ c o % - v\ Amide I 
Cent re F W H M Cent re F W H M Cent re 
(cm"^) ( c m ' i ) ( c m ' i ) (cm~^) 
Bone 960.3 ± 0 . 1 16.8 ± 0 . 3 1072.8 ± 0 . 2 21.3 ± 0 . 2 1665.3 ± 1.2 
(n=44) 
niES 960.3 ± 0.2 16.5 ± 0 . 6 * 1074.1 ± 0 . 9 * 24.1 ± 2 . 9 * 1664.0 ± 0 . 9 * 
(n=80) 
M O B 959.9 ± 0 . 3 ' ^ ^ 17.9 ±1 .0*^ 1074.0 ± 1.1* 2 2 . 6 ± 1.2*f 1664.2 ± 1.7* 
(n=87) 
m B M S C 960.4 ± 0 . 2 1 7 . 6 ± 0 . 4 * t 1074.0 ± 0 . 6 * 22.5 ±1.0*^ 1666.0 ± 1 .7*" 
(n=53) 
C H A p 962.1 ± 0 . 3 14.7 ± 0 . 1 1072.6 ± 0 . 3 18.5 ± 0 . 2 — 
(n=3 ) 
Table 6.2: Phosphate, carbonate, and mineral band parameters, as determined by curve-fitting. Reported are 
the average ± standard deviation centre fi-equency and FWHM for the PO®" vi stretch, the COg" stretch, 
and the centre frequency of the amide I band. The number of spectra for each group (n) is shown in 
parentheses. 
Symbols: statistically significant difference between Sample X and "Bone, ^mES, ^MOB, and ^mBMSC, 
respectively (p < 0.05). All comparisons between biological samples and synthetic CHAp were statistically 
significant, except for the COg" t/i centre frequency of bone spectra. 
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revealed an increase in mineral content with increasing matrix content. Although the highest 
mineral levels were detected in mouse bone spectra, the matrix protein levels in these spectra 
were also high, yielding moderate mineral: matrix ratios between 3 and 5, with a mean value 
of 3.81 ±0.42 (Figure 6.11A). These estimates of mineral: matrix ratios from Raman spectra 
of calvaria of 6 month old mice are lower than those reported by Tarnowski et al, who 
estimated an average mineral: matrix ratio of ~7, but more closely match their results for 
post-natal 14 day old mice (mean mineral: matrix ratio ~4). The reasons for this discrepancy 
are unknown, but may arise from ethanol fixation of their samples, which has been shown to 
have an adverse effect on matrix proteins [223], and hence could influence mineral: matrix 
ratios. Of the bone nodule samples, spectra from mBMSC indicated the highest mineral 
deposition, followed by MOB and mES nodules, both of which exhibited significant variance 
in phosphate mineral content. However, the matrix content in spectra of MOB nodules was 
much lower than in mBMSC nodule spectra, and the observed mineral: matrix ratios for 
MOB nodules (mean: 6.58 ± 2.68) were on average slightly higher than those of mBMSC 
nodules (6.26 ± 1.53), with both significantly higher than mean values obtained for bone 
and mES nodules. Interestingly, the mineral: matrix ratios for mBMSC nodules are roughly 
4.5x higher than those estimated from FTIR spectra by Shimko et al. [207], who observed 
significantly lower mineral: matrix ratios in mBMSC nodules than in mES nodules. These 
differences could be due different mBMSC cellular isolation procedures, culture conditions, 
and characterisation by different vibrational spectroscopic techniques (Raman versus FTIR). 
Nodules from mES cultures had the lowest mineral content and matrix content intermediate 
of MOB and mBMSC nodules, and consequently the lowest mineral: matrix ratios (range: 
0.56-5.73, mean value: 2.47 ± 1.31) of any group. These values for mES nodules agree with 
the mineral: matrix ratios of human ES cultures estimated by Karp et al. [206] and mES 
cultures by Shimko et al. [207] using FTIR spectroscopy. Differences in mean mineral: matrix 
ratios between all groups reported here were statistically significant, except for comparison 
between MOB and mBMSC nodules. 
Mineral crystallinity 
The average Raman shift (position) of the PO^" band (Table 6.2) indicates the presence of 
a lightly carbonated apatite mineral environment in bone and bone nodules, and the variation 
in FWHM of this band suggests varying degrees of mineral crystallinity. The apatite mineral 
detected in synthetic CHAp was much more crystalline than the biological apatites, indi-
cated by the ~2 cm"^ shift in PO4" ui band position to ~962 cm~^ and much lower FWHM. 
Although the mean Raman shift of the PO^" vi band was statistically similar for bone (960.3 
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cm"^) and both mES (960.3 cm~^) and mBMSC (960.4 cm"^) nodule spectra, the FWHM 
values indicate that mineral crystallinity is highest in mES (FWHM=16.5 cm"^) nodules, 
slightly lower in bone (FWHM=16.8 cm'^), and lower still in mBMSC (FWHM=17.6 cm~^) 
nodules. The least crystalline mineral was detected in MOB nodules, as indicated by a lower 
P04~ z/i band position (959.9 cm~^) and higher FWHM (FWHM=17.9 cm"^). Although 
statistically significant differences in the amide I band position were observed between na-
tive bone tissue and bone nodules, no major diEerences in the structure of the collagenous 
proteins between samples could be deduced from their Raman spectra, and warrants further 
investigation. 
Carbonate substitution 
The mean Raman spectra in Figure 6.10A indicate that the carbonate mineral content in 
bone and mES, MOB, and mBMSC nodules is predominantly B-type carbonation (carbonate 
substituted for phosphate in the hydroxyapatite lattice), evidenced by the COg" vi stretch 
at ~1070 cm~\ the position of the PO^" wi stretch, and the weak COg^ 1/4 bands at 689 and 
715 cm~^ [238]. However, trace amounts of A-type carbonation (carbonate substituted for 
hydroxide) is evidenced by a small shoulder of the ~1070 cm"^ carbonate band at 1107 cm"^ 
[229]. Broadening of the asymmetric left-tail of the symmetric PO^" 1^1 stretch may also be 
indicative of A-type carbonate substitution [229, 59]. 
The general trend in carbonate: phosphate mineral ratios revealed an increase in carbon-
ate peak area with increasing phosphate peak area for all samples. The highest levels of both 
carbonate and phosphate mineral were detected in mouse bone (Figure 6.11B), for which the 
mean carbonate: phosphate ratio was 0.16 ±0.02. This ratio was identical to the mean value 
obtained for MOB bone nodules (0.16 ± 0.08), however the absolute areas for MOB nodules 
were much smaller and the ratios had a much higher variance than observed in bone. The 
carbonate: phosphate ratios for Raman spectra of MOB nodules are nearly an order of mag-
nitude higher than those reported by Stewart et aL, and may be due to their use of a clonal 
MOB cell line and different culture conditions [62]. The lowest carbonate: phosphate ratios 
were detected in mBMSC nodules (mean value: 0.12 ± 0.02), and the highest were obtained 
for mES nodules (mean value: 0.22 ±0.08). Thus the degree of carbonate substitution in the 
apatitic mineral environments of bone nodules followed the trend: mBMSC < MOB < mES. 
However, both Awonusi et al. [238] and Krajewski et al. [231] have reported a positive 
linear correlation between the FWHM of the PO^" ui band and weight percent carbonate 
content in synthetic apatites. An increase in carbonate content leads to a more amorphous 
mineral structure, which manifests as an increase in FWHM and a decrease in the in the 
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frequency of the PO^" vi band in the Raman spectrum. Thus mineral crystallinity is neg-
atively correlated with substitution, so that a lower Raman shift and higher FWHM of the 
P 0 | ~ vi band normally indicates a more substituted and less crystalline apatitic mineral 
phase. Shimko et al. observed a negative correlation between carbonate substitution and 
crystallinity by examining FTIR spectra of mES and mBMSC nodules [207]. On the basis 
of this argument, the results in Table 6.2 and interpretation of mineral crystallinity would 
imply that the trend in carbonate substitution should instead be mES < mBMSC < MOB. 
One possible explanation for this apparent discrepancy may be method used to estimate the 
carbonate content from the combined carbonate-phosphate peak at 1070-1076 cm"^ The 
mean position of this band was ^^1074 cm"^ (Table 6.2), which could indicate more contribu-
tion from the PO^" z/g band expected at ~1076 cm"^ than from the CO^" vi peak expected 
between ^1070-1072 cm~^ [238]. Thus the area of this band in the 3-peak curve-fitting 
model (1015-1100 cm"^ region) relative to the area of the PO^" band may not be an ac-
curate indication of carbonate content, and hence carbonate substitution within the apatitic 
mineral lattice. Awonusi et al. developed a sophisticated curve-fitting routine to estimate 
the carbonate content of substituted apatites by using a 7-peak model in the 1000-1100 
cm'i spectral region to resolve the overlap of COg" ui and P 0 | ~ 1/3 bands [238]. However, 
their model cannot be used to analyse biological apatites such as the bone and bone nod-
ules examined here, because severe band broadening associated with such high carbonate 
content samples (> 3%) precludes such high-fidehty peak-fitting resolution. Indeed, their 
7-peak model reduces to a 3-peak model when the % carbonate content by weight exceeds 
3%, which is consistent with the methods used in this chapter. Non-invasive estimation of 
carbonate content in biological apatites by vibrational spectroscopy (FTIR and Raman) is 
an important topic which will no doubt garner more research interest in the future. 
The high degree of inter- and intra-nodule variability in spectral parameters observed for 
each cell type may be due to the analysis at d28 of nodules of varying 'maturity', i.e., nodules 
that had developed for different periods of time. The experiments presented here focused on 
nodules at d28, but did not consider the effects of nodule maturity. All cell culture systems 
exhibited variation in the growth and development of bone nodules: there was evidence 
of both highly and moderately mineralised nodules in dl4 mES cultures (Figure 6.4A, B), 
while both MOB and mBMSC cultures at d21 exhibited evidence of recently-formed nodules 
characterised by an un-mineralised or moderately mineralised, collagen-rich matrix. It is 
therefore likely that these differences in nodule maturity account for at least some of the 
variance observed in bone nodule spectral parameters. 
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6 .3 .4 Mul t ivar ia te d a t a analys is 
The simultaneous analysis of large, high-dimensional data sets makes multivariate analysis a 
powerful tool for spectroscopy. Univariate analyses such as band area or intensity ratios are 
more subjective than multivariate approaches, and normally only use a small fraction of the 
information available. And as demonstrated in the previous section, univariate analysis of 
overlapping spectral bands {e.g. COg" Ui and PO^" z/g) can sometimes lead to confusing or 
conflicting results if the bands are not adequately resolved. In contrast, multivariate spectral 
analysis approaches make use of the entire spectral range, are easy to automate, and because 
they analyse each spectrum with respect to every other spectrum in the data set, have an 
inherent signal-averaging effect [97, 111]. 
PCA-based factor analysis 
Factor analysis is a multivariate technique which can resolve spectral components that are 
present in different proportions in a series of spectra. The varying contributions of mineral 
and matrix components in the Raman spectra of bone and bone nodules can be exploited 
to extract isolated spectral factors describing the mineral and matrix environments present 
in the composite tissue. The more factors required to describe bone tissue or nodules the 
more mineral and matrix environments present. Each factor has a corresponding set of score 
values, which describe the relative amount of that factor present in each original spectrum 
of the data set. For example, if two tissue components {e.g. matrix and mineral) are found 
in similar proportions between samples, then factor analysis will produce only a single factor 
in which the spectral signatures of the two tissue components are combined. However, if 
the ratios of two tissue components vary between different samples {e.g. bone and bone 
nodules), then their spectral signatures will be separated into two factors, and their score 
values will reflect the variation between samples. Factor analysis can therefore be used to 
detect variations in the mineral and matrix environments between native bone tissue and 
bone nodules derived from different cell culture systems. 
In order to identify the mineral and matrix environments of native bone tissue and mES, 
MOB, and mBMSC bone nodules detected by Raman micro-spectroscopy, separate factor 
analyses were conducted for each sample group. In each case, a PC A was performed to 
identify the main descriptors of spectral variance. For each data set, the PCs accounting for at 
least 95% of the spectral variance (typically 3-5 PCs) were retained, and the remaining PCs, 
which described the noise in the system, were discarded. Significant PCs were identified by 
examining the scree plot of singular values generated by each PCA, and by comparing original 
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spectra to PC- and factor-reconstructed data [58]. The significant PCs were then rotated 
subject to non-negativity constraints to produce spectral factors that describe the mineral 
and matrix environments which characterise the sample in question. In some cases, minor 
manual rotation adjustments were required to obtain factors with realistic, non-negative 
band shapes and corresponding non-negative scores. These adjustments were necessary even 
if more PCs were included in the analysis, which suggests this requirement is not a product 
of retaining too few PCs. Other researchers also required manual adjustments during factor 
analysis of spectra of biological samples [98]. 
The factor analysis of mouse calvarial bone produced only a single spectral factor (not 
shown) with combined mineral and matrix signatures, which was nearly identical to the mean 
bone spectrum (R > 0.99). This indicates that the bone spectra were very similar, and the 
proportion of mineral and matrix components are fairly consistent between measurements. 
This agrees with the univariate data analysis (Table 6.2, Figures 6.11 and 6.12), which 
revealed the lowest variation in Raman peak data, mineral; matrix and carbonate: phosphate 
ratios of any sample group. This is in contrast to the bone nodule spectra (from all cell types), 
which exhibited much greater spectral variation in mineral and matrix content, thereby 
facilitating the extraction of separate factors describing the mineral and matrix environments. 
The mineral and matrix factors recovered from factor analyses of mES, MOB and mBMSC 
data sets are included in Figure 6.13. Factor analysis of mES bone nodule spectra revealed 
a single matrix and two mineral factors (Figure 6.13A, B, C). Surprisingly, the matrix factor 
(Figure 6.13A) was dominated by a-helix protein vibrations, and was more similar to the 
mean Raman spectrum of non-mineralised d7 mES nodules (Figure 6.2A, R—0.99) than to 
the spectrum of Col I (R=0.80, and 0.86 excluding the amide I band). This was unexpected, 
as the matrix features of some mES nodule spectra appeared to assume more collagen-like 
features during mineralisation {e.g. Figure 6.4A, B), and the mean centre frequency of the 
amide I band for mES bone nodule spectra was 1664 ± 0.9 cm~^ (Table 6.2), similar to 
that of Col I and bone. As mentioned earlier, the production of extracellular matrix rich in 
a-helix proteins rather than collagen I protein during mES cell minerahsation may be due 
to enhanced production of osteocalcin [246]. Shimko et al. detected extracellular matrix 
rich in either Col I or osteocalcin only (but did not observe co-localisation) in immuno-
stained cultures of minerahsed mES cells [207]. The implications of low Col I production 
on cell culture derived bone nodules are not fully understood, and will be the focus of future 
research. 
The primary mineral factor (Figure 6.13B) reveals the presence of a lightly carbonated 
crystalline apatite (PO^" , 960.3 cm^\ FWHM 16.4 cm"\ COg" vi, 1073.5 cm"'), and 
169 
Chapter 6: Non- invas ive assessment of in vitro os teogenes i s 
mES FACTORS MOB FACTORS mBMSC FACTORS 
500 1000 1500 
f 
I 
0) 
I 
500 1000 1500 
0.15 
0.1 
0.05 
0 
500 1000 1500 
500 1000 1500 
0.2 B 
960.3 
0.1 16.4 1073.5 
L 22-0 
959.9 
1073,5 
500 1000 1500 
C 1 0.2 F 
959.9 1074.1 
0.1 
980.4 
20.4 
. 21.4 15.5 
0 . v s ^ ^ 
500 1000 1500 
500 1000 1500 
1077.1 
Raman shift (cm'^) 
500 1000 1500 
0.2 
0.1 
1 
961 
19.6 1075.1 
^ 2 ^ . 1 
1000 1500 
960.7 
1000 1500 
948.8 1077.2 
500 1000 1500 
Figure 6.13: Separate factor analyses of mES, MOB, and mBMSC d28 data. A Matrix and B, C mineral 
factors generated by factor analysis of spectral data collected from d28 mES cultures. D Matrix and E, F, 
G mineral factors generated by factor analysis of spectral data collected from d28 MOB cultures. H Matrix 
and I, J, K mineral factors generated by factor analysis of spectral data collected from d28 mBMSC cultures. 
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is very similar to the spectrum of synthetic CHAp (R=0.96). The sharp phenylalanine peak 
at 1003 cm~^ is barely distinguishable in this factor, indicating excellent separation of the 
mineral and matrix environments from the spectral data. The secondary mineral factor 
(Figure 6.13C) describes a more highly carbonated, less crystalhne apatite (PO^" , 959.9 
c m ' \ FWHM 20.4 cm"\ COg" ui , 1074.1 cm"^), and analysis of the factor scores indicated 
only minor contribution of this factor to d28 mES nodule spectra. This minor mineral 
factor accounts for the asymmetric left shoulder in the PO^" ui band, identified by data 
reconstruction with and without inclusion of this noisy factor. The irregular band shapes in 
the ~1200-1800 cm"^ range appear to be slightly inverted matrix bands. The identification 
of multiple mineral environments illustrates the advantage of multivariate over univariate 
analysis techniques, with which detection of similar yet separate mineral species would be 
extremely difficult, if not impossible. It is worth re-iterating that only the d28 mES nodule 
data was included in the PCA-based factor analysis, so the mES d7 scan collected from early 
mES cultures was not included in the data set from which the matrix factor was generated. 
The similarity of the primary mineral and matrix factors to the Raman spectrum of CHAp 
and the mES d7 scan are highlighted in Figure 6.14. 
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Figure 6.14: Mineral and matrix factors generated by factor analysis on mES d28 nodule data. A Min-
eral factor describing carbonated hydroxyapatite (CHAp) content within nodule spectra, compared with the 
spectrum from a sample of synthetic CHAp (R=0.96). B Matrix factor describing protein/matrix content in 
nodule spectra, compared with the spectrum collected from d7 mES cultures (R=0.99). 
The factor analysis of MOB d28 bone nodule spectra identified single matrix and three 
mineral factors. The MOB matrix factor (Figure 6.13D) was a collagen-dominated protein 
signature, which was very similar to Raman spectra from non-mineral regions of d7 MOB 
nodules (R=0.97 between the MOB matrix factor and spectrum 1 of Figure 6.2A), and 
also had features similar to the spectrum of Col I (R=0.80, and 0.88 excluding the amide I 
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band). The first two MOB mineral factors (Figure 6.13E, F) describe a carbonate-substituted 
apatitic mineral (PO^" ui, 959.9 cm"\ FWHM 17.4 cm'^; CO^" ui , 1073.5 cm"^), and a 
non-substituted (or very weakly substituted), more crystalline apatite (PO^" vi, 960.4 c m ' \ 
FWHM 15.5 cm"^). The non-substituted apatitic mineral factor is very similar to the single 
mineral factor obtained by Stewart et al. in a factor analysis of Raman spectra of bone 
nodules derived from cell cultures of clonal MOBs [62]. The broad background signal from 
900-1100 cm~^ in these two mineral factors is most likely residual protein fluorescence sig-
nal contribution occurring with the same distribution as the mineral phases within MOB 
bone nodule spectra [62], which was not successfully eliminated during the background sub-
traction. Analysis of the factor scores indicated that both mineral environments contribute 
significantly to the original spectra. The third, minor MOB mineral factor (Figure 6.13G) 
describes a disordered phosphate species (PO^" , 955 c m ' \ FWHM 29.1 cm"^) such as 
OOP, as well as CO^" , P 0 | ~ 1/3 vibrations at 1077.1 cm"^ (FWHM 25.6 cm"^), and some 
minor matrix features (phenylalanine breathing mode at 1003 cm"^, amide IH band at 1246 
and 1270 cm"\ CH2 wag at 1449 cm~\ and amide I band at 1665 cm~^). The incorpo-
ration of all of these features into the same factor indicates that these bands are observed 
in similar proportions in MOB d28 bone nodule spectra. The detection of three separate 
mineral environments within d28 bone nodule spectra is consistent with the assertion that 
most bone tissue contains some amount of the three main mineral environments outlined ear-
lier, namely a carbonate-substituted apatite, a crystalline non-substituted hydroxyapatite, 
and a disordered phosphate mineral species [59]. These results are consistent with previous 
factor analyses of Raman spectra of bone samples [59, 52], and demonstrate the versatility 
of multivariate factor analysis to detect subtle band variations between Raman spectra. 
The factor analysis of d28 mBMSC nodules yielded similar results to that of MOB nod-
ules, i.e. a single matrix factor and three separate mineral factors. The matrix factor 
(Figure 6.13H) was a collagen-dominated protein signature which was similar to spectra of 
non-mineral regions of dl4 mBMSC nodules (R=0.96 between the matrix factor and the 
mean of spectra 2-5 in Figure 6.4D). In contrast to the non-mineral dl4 scans of mBMSC 
nodules, which had a higher correlation with Col H compared to Col I, the mineral factor 
of d28 nodules is more similar to Col I (R=0.83, and 0.90 excluding the amide I band) 
than Col II (R=0.78, and 0.85), suggesting a change in protein matrix composition during 
mineralisation of mBA/ISC nodules. All three mineral factors contributed significantly to the 
original spectra, as indicated by the score values (data not shown). The mineral environ-
ments detected included a substituted apatite (Figure 6.131: PO^" ui, 961 cm"^, FWHM 19.6 
c m ' \ COg" vi, 1075.1 cm"^), a non-substituted crystalline hydroxyapatite (Figure 6.13J: 
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ui, 960.7 cm"\ FWHM 15.3 cm"^), and an ACP species (Figure 6.13K; P 0 | ~ , 
948.8 cm~\ FWHM 21.8 cm~^) with strong signal from COg" z/i and vibrations 
at 1077.2 cm~^ (FWHM 23.3 cm~^). The factors describing the mineral environments of 
mBMSC bone nodules are broadly similar to those obtained by Tarnowski et al. in a factor 
analysis of Raman spectra of postnatal mouse calvaria, where they identified three separate 
mineral environments with varying degrees of substitution and crystallinity [59]. The factors 
describing the non-substituted crystalline hydroxyapatite mineral environments in MOB and 
mBMSC nodules (Figures 6.13F and J, respectively) were quite similar (R > 0.99), and the 
factors describing the disordered phosphate species (Figures 6.13G and K, respectively) imply 
that the amorphous component of mBMSC nodule mineral is more disordered than that of 
MOB nodules. One unexpected result was the high FWHM value of the PO^" band (19.6 
cm'^) in the substituted apatitic mineral factor (Figure 6.131) relative to the Raman shift 
(961 cm~^). A shift this high is normally associated with non- or poorly-substituted apatitic 
minerals with higher crystallinity, for which a lower FWHM value closer to that of the sub-
stituted apatitic mES mineral factor (Figure 6.13B, FWHM 16.4 cm"^) or even the non- or 
poorly-substituted, crystalline apatitic mBMSC mineral factor (Figure 6.13J, FWHM 15.3 
cm'^), is expected. This discrepancy could be due to our use of a line focus laser with low 
spatial resolution in order to analyse live cell culture systems. The xyz-spatial resolution 
of our system is 10 jim x 20 //m x 25 yum, and so the roughly ellipsoidal volume probed 
by each scan is approximately 3140 /im^ ( = ^ x 5 x l 0 x l 5 which is much higher 
than the theoretical ^ 1 achievable with diffraction-limited spatial resolution at 785 nm 
excitation [3]. Bone tissue can be very heterogeneous, exhibiting variation in biochemical 
composition on the micron scale [59]. Thus the probing of such large sample volumes is 
likely to yield spectra describing multiple mineral environments in close proximity, which 
otherwise might be distinct/separate if analysed at diffraction-limited spatial resolution. If 
this is indeed the case, then individual mineral factors generated by multivariate factor anal-
ysis could describe features of several different mineral environments simultaneously. Thus 
the substituted apatitic mineral environment described by the mBMSC mineral factor in 
Figure 6.131 could in fact be an amalgamation of a non- or poorly-substituted, crystalline 
hydroxyapatite mineral (accounting for the Raman shift of the PO^^ vi band at 961 cm~^), 
and a substituted, less crystalline apatitic mineral (accounting for the high FWHM of 19.6 
cm'^). This limitation may also manifest in spectral data sets of bone, mES and MOB bone 
nodules, and may contribute to the discrepancy between mineral crystallinity and carbonate 
substitution observed in univariate data analysis of mES bone nodule spectra. 
It is clear from both univariate and multivariate spectral analyses that significant differ-
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ences exist between bone nodules derived from mES, MOB, and niBMSC cell culture sys-
tems, and these differences manifest in both the mineral and matrix environments present 
within the nodules. Furthermore, the spectra of these nodules in turn exhibit distinct bio-
chemical differences to native bone tissue. It is not clear from the results presented here 
which osteogenic cell culture system produces the 'best' bone-like nodules, i.e. those that 
are biochemically most similar to native bone. Multivariate factor analysis enabled identi-
fication of the biochemical mineral and matrix species present in mES, MOB, and mBMSC 
nodules, thereby providing insight into the carbonation and crystallinity of local mineral en-
vironments. Univariate band analysis revealed carbonate substitution in MOB bone nodule 
mineral was statistically (as measured by the correlation coefficient) more similar to that of 
native bone than mES and mBMSC bone nodule mineral, despite a large variance in the 
carbonate substitution parameter. However, phosphate mineral band and matrix band areas 
indicated that mBMSC nodules exhibited the highest mineral content which was closest to 
native bone, but no cell culture system managed to replicate the mineral: matrix balance 
characteristic of the native tissue. Although discrete mBMSC nodules had the highest min-
eral content and MOB nodules the highest mineral: matrix ratios, there is no doubt that 
mineral deposition was highest in cultures of mES cells, which demonstrated an extensive 
mineral sheet. Shimko et al. found that mineral deposition was 50x higher by mES cells 
than in mBMSC cells in identical culture conditions, assessed by quantitative ARS staining 
[207]. However whether or not the mineral sheet in mES cultures has the capacity to develop 
into a sheet of bone-like material with biochemical and physical properties of native bone 
tissue remains to be seen. More work is needed to test the physical properties of cell culture 
derived bone nodules with mechanical testing. In addition, the time course of bone nodule 
development should be extended beyond 28 days in order to determine whether or not the 
nodules become more bone-like over time. These experiments will hopefully shed further 
light on the complex mechanisms involved in the formation and maturation of bone. 
6.4 F u t u r e work 
Given the versatility of Raman micro-spectroscopy and the wealth of detailed, biomolecular 
information it provides, there is no doubt that this technology will play an important role in 
future studies involving the characterisation of bone and in vitro cell culture models of bone 
formation. The following subsections outline exciting potential avenues of future research 
being explored in our laboratory. 
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6 .4 .1 A s s e s s i n g o s t e o g e n i c p o t e n t i a l of cell cu l tures w i t h different cul ture 
condi t ions 
The osteogenic cell culture supplements used in this chapter were consistent with previously 
established protocols for promotion of osteoblastic differentiation and mineralisation [191]. 
However, optimal osteogenic cell culture conditions may be cell specific, and these optimal 
conditions have yet to be established for the large number of osteogenic cell culture systems. 
Several researchers have investigated the influence of several non-standard supplements {e.g. 
basic fibroblast growth factor [207]) on osteogenic differentiation, with conflicting results 
obtained using invasive characterisation methods (FTIR, ICP-AES, etc.). The non-invasive 
assessment of mineralising cell cultures with Raman micro-spectroscopy could potentially 
provide an ideal technique with which to explore the effects of additional supplements and to 
optimise the composition and concentrations of supplements required to stimulate maximal 
cell growth and mineral production. For example, previous studies by Xynos et al. have 
shown that culturing human osteoblasts (HOB) in media conditioned with bio-active glass 
dissolution ions enhances osteoblast differentiation, proliferation, and bone formation in vitro 
[120]. Jell et al. further demonstrated that Raman micro-spectroscopy could be used to non-
invasively detect accelerated differentiation of foetal osteoblast cells by media conditioned 
with bio-active glass dissolution ions [19]. The efl'ects of media conditioned with dissolution 
ions from strontium-enriched bio-active glass on the in vitro mineralisation by primary human 
osteoblasts (HOBs) cultured on MgFg coverslips with standard osteogenic supplements was 
investigated in some preliminary experiments. The spectra of d28 HOB nodules grown in 
media conditioned with bio-active glass dissolution ions exhibited a much higher degree of 
substitution than nodules grown in control media, as indicated by the mean nodule spectra 
in Figure 6.15. The similar band position at ~1072 cm~^ in both spectra indicates that 
the substitution ion is the same in both cases — likely to be B-type carbonate substitution, 
rather than substitution by a Sr-based ionic species. Furthermore, the difference in intensity 
of the matrix peaks suggests that the mineral: matrix ratios of the treated nodule are lower 
than those of the control nodule, at least for the nodules examined here. In addition, the 
derivative-like peak at ~960 cm"^ in the difference spectrum indicates a slight shift in the 
PO^" i^ i band, which could indicate a more crystalline mineral species within the bio-active 
glass treated bone nodules. Further research will be required to determine whether or not 
these differences are significant, or are merely due to inter-nodule variability within the cell 
culture systems. 
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F i g u r e 6.15: Mean R a m a n spect ra of bone nodules grown by HOB cells (d28) cul tured with or wi thout 
(control) media conditioned with dissolution ions of Sr-enriched bioactive-glass in addition to s tandard os-
teogenic supplements. Each spec t rum is the mean of a t least 10 measurements from two separate nodules 
(minimum 5 scans per nodule), and have been vector normalised following baseline subtract ion with the 
modpoly algorithm. Also shown is the difference spect rum. 
6.4 .2 C o m p a r i s o n of b o n e n o d u l e character i sat ion w i t h R a m a n and F T I R 
micro - spec troscopy 
The detrimental effects of desiccation on bone nodule biochemistry highlighted in Appendix D 
question the suitability of analysis of desiccated samples by both Raman and FTIR spec-
troscopy. FTIR, more so than Raman, is routinely used to analyse cell culture derived bone 
nodules, in order to estimate bone mineral composition, crystallinity, and maturity of the 
collagenous organic matrix. To compare the parameters derived from Raman and FTIR 
bone nodule spectra, ATR-FTIR spectra were collected from the same d28 mBMSC nodule 
discussed in Figure D-4 and plotted in Figure 6.16. Only three FTIR spectra of the bone 
nodule could be collected (compared to 5 with Raman) due to the large size of the ATR crys-
tal (~100 /j,m in diameter). The bone mineral and matrix parameters were then computed 
from the Raman spectra of the live and desiccated nodule, and compared with those obtained 
with ATR-FTIR analysis of the same desiccated nodule (Table 6.3). FTIR spectral param-
eters were computed as described by Shimko et al. [207]. The results indicate that, while 
the FTIR-predicted mineral: matrix ratio (6.49 ±2.94) of the desiccated nodule is similar to 
that predicted by Raman spectroscopy (6.73 ± 1.73), both values are much lower than the 
Raman-estimated ratio from the bone nodule in live cell culture (8.72 ± 0.29). Furthermore, 
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the carbonate ratios are significantly different in each case, and indicate a much lower degree 
of carbonate substitution in the nodule after desiccation. The Raman shift and FWHM of 
the P 0 | ~ ui stretch also indicates that the nodule mineral is more crystalline and less sub-
stituted after desiccation. While these crystallinity parameters are not directly comparable 
to the FTIR spectral parameter, this combination of techniques may be useful in correlating 
Raman spectral parameters with those from FTIR spectra {e.g. crystallinity and collagen 
maturity parameters), as well as with other characterisation techniques such as XRD and 
EDX. Although the mineral: matrix ratios estimated by Raman and FTIR spectroscopy were 
similar for this desiccated nodule, additional experiments in our laboratory have generated 
seriously conflicting results for identical nodules characterised with both Raman and FTIR 
spectroscopy. Thus, results obtained from analysis of desiccated bone tissue samples may 
not be a true reflection of the bone tissue parameters. These findings strengthen the case 
for in situ analysis of bone nodules in live cell culture with Raman micro-spectroscopy. 
Spectrum 
800 1000 
Wavenumber (cm"^) 
1 2 3 
1800 
F i g u r e 6.16: A T R - F T I R spect ra collected from a d28 mBMSC bone nodule. T h e sample was rinsed with 
d H 2 0 and desiccated prior to analysis. T h e nodule is the same one depicted in Figure D-4. Scalebar = 25 
l^m. 
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Technique Sample Mineral: matrix 
ratio 
CO^- : PO^-
ratio 
Crystallinity* 
Raman 
Live 
Desiccated 
8.72 ± 0.29 
6.73 ± 1.73 
0.082 ±0.010 
0.039 ± 0.004 
960.2 ±0.4(18.5 ±0.3) 
961.7 ±0.3(17.6 ±0.2) 
FTIR Desiccated 6.49 ± 2.94 0.010 ± 0.002 1.09 ±0.002 
Table 6.3: Bone nodule parameters derived from Raman and ATR-FTIR spectra collected from a d28 
mBMSC bone nodule in live cell culture (Raman) and after rinsing with dH20 and desiccation (Raman, 
FTIR). Parameters represent mean ± standard deviation. 
* Crystallinity parameter for Raman spectra is listed as the Raman shift (FWHM) of the PO^" stretch 
(both in cm~^), and for FTIR spectra is listed as the ratio of absorbance values at wavenumbers at 1020 and 
1032 cm i.e. Aozo/iosz-
6 .4 .3 R a m a n i m a g i n g of minera l i sed b o n e n o d u l e f o r m a t i o n 
The large inter- and intra-nodule variance associated with univariate spectral parameters 
reflects the heterogeneity of bone tissue, which is known to exhibit heterogeneity on the 
micron scale, and perhaps even smaller [59]. In order to study the changes in mineral and 
matrix spectral parameters of bone nodules in more detail, Raman mapping experiments of 
mES, MOB, and mBMSC bone nodules in live cell culture at d28 were performed. The maps, 
similar to those in Figure D-3 of Appendix D, were collected at 20 fim spatial resolution (the 
larger axis of the line focus laser), and consist of 100 spectra (10 second integration time 
per spectrum) from a 10 x 10 grid defined on the nodules in culture, with the origin at the 
centre of each nodule. In this approach, a complete Raman spectrum is acquired at each 
pixel. The spectral data sets were individually processed, and then univariate pseudo-colour 
maps describing the mineral: matrix ratio at individual pixels were generated for each nodule 
(Figure 6.17). The mineral: matrix ratios of all colour maps were normalised to a common 
value, corresponding to the overall maximum mineral: matrix ratio of all data sets (which 
occurred in the mBMSC nodule data set). In the colour maps, red pixels correspond to 
higher mineral: matrix ratios and blue pixels to lower ratios. Light microscope pictures of 
the nodules are also included. The colour maps of MOB and mBMSC nodules, which exhibit 
a central cluster of red pixels surrounded by blue pixels, describe the discrete, well-defined 
boundaries observed in these nodules. They also reveal similar mineral: matrix ratios within 
these nodules. In contrast, the colour map of the mES nodule indicates that mineral: matrix 
ratios for this nodule are much lower, and also reflect the lack of strong boundaries between 
mES nodules and the surrounding mineral sheet. This approach also enables 'multivariate 
images' based on PCA or factor analysis score values to be generated. 
An improvement in spatial resolution can be obtained by using the LF laser for LF-
mapping, a high-spatial resolution mapping approach discussed in Chapter 1. Raman scat-
tering generated along the long axis of the LF laser can be collected by different rows of 
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mES MOB mBMSC 
Figure 6.17: Raman mapping of mES, MOB, and mBMSC bone nodules (d28). The pseudo colour maps 
describe the mineral: matrix ratio at different positions within each nodule, and are normalised to the 
maximum mineral: matrix ratio obtained for the combined set of spectra. Scalebars: 50 ^m (mES) and 25 
Aim (MOB, mBMSC). 
CCD pixels in order to obtain spatially-resolved Raman spectra with approximately 1 fjm 
spatial resolution [49]. Several Raman investigations of bone (and one of bone nodules [62]) 
using LF-mapping to collect Raman transects (Hnes of point spectra) have been reported in 
the literature [59, 60, 58, 52, 230]. Technically speaking, the Raman micro-spectroscopic 
system used here is not configured for accurate line focus (LF) scanning, and would require 
a cylindrical line focus lens {e.g. a Powell lens line generator, as used by Timlin et al. [52]) 
in order to smooth the power distribution to ensure homogeneous illumination [230]. This 
is because the power in the line focus laser beam is not equally distributed throughout the 
beam — rather, it follows a Gaussian distribution, with the highest laser power at the centre 
of the beam, and decreasing power with increasing distance from the beam centre. However, 
it is possible to correct for this intensity variance across the laser beam, by collecting spectra 
of intensity calibration standards in line focus mode and using those spectra to generate 
intensity correction factors. This intensity calibration step was performed to generate the 
Raman transect of a desiccated MOB nodule (d28) in Figure 6.18. The transect of 108 spec-
tra was compiled by collecting 12 spatially-resolved spectra per scan, and then translating 
the laser beam along the line shown on the nodule in the figure inset. This offers a spatial 
resolution of ~1.2 jim (scattering from the ends of the LF laser, where the power is lowest, 
are not included during each scan). As for the Raman maps, the large number of spectra per 
transect can either be analysed with univariate or multivariate statistical techniques in order 
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to study changes in minerahsation and matrix parameters along the transect. LF-mapping of 
live bone nodules in culture is an exciting prospect currently being pursued in our laboratory. 
0 0 -
Spectrum Raman shift (cm - I N 
Figure 6.18: Raman LF mapping of an MOB bone nodule (d28). Scalebar = 50 nm. 
6.5 Conclusions 
This chapter demonstrated that Raman micro-spectroscopy is a powerful technique with 
which to study the biochemistry of in vitro mineralisation. Raman micro-spectroscopy of-
fers significant advantages over more familiar bone tissue characterisation technologies such 
as FTIR, XRD, EM and histochemical staining, enabling non-invasive and in situ analysis 
of live cell culture systems. This approach was used to characterize the trends in min-
erahsation within three osteogenic cell cultures which have shown significant potential for 
tissue engineering applications. All cell cultures produced highly mineralised bone nodules 
by d28, but the route to mineralisation varied between cultures. Evidence of a Col Il-rich 
protein matrix in early time point cultures of MOB and mBMSC cells was detected, sug-
gesting an endochondral-type ossification process. Nodules in these cultures also exhibited 
evidence of disordered hydroxyapatite mineral precursors {e.g. ACP, OCP), which increased 
in crystallinity during maturation. To the best of our knowledge, this is the first vibrational 
spectroscopic study of cell cultures providing evidence for such disordered mineral precursors 
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[59]. In contrast, early mES cultures were characterized by a-helix protein signatures, and 
the first mineral environment detected in mES cultures was a more crystalline carbonated 
apatite. Mineral deposition in MOB and mBMSC cultures was concentrated in small, dis-
crete nodules, while an extensive mineral sheet with large, diffuse nodules was observed in 
mES cultures. 
Raman biomolecular signatures of mature mES, MOB, and mBMSC nodules at d28 indi-
cated the production of bone-like tissue with strong substituted apatitic mineral and protein 
matrix features. The combination of both univariate and multivariate analysis techniques 
enabled biochemical characterisation of the composition of mineral and matrix environments 
present in cell culture bone nodules. Parameters from bone nodule spectra were used to 
identify variation within and differences between cell culture systems with respect to min-
eral and matrix production, degree of carbonate substitution and crystallinity of the mineral 
species. Univariate and multivariate analysis provided complementary information: uni-
variate band area ratios facilitated the quantification of carbonate substitution within the 
apatitic mineral lattice, while multivariate factor analysis revealed the detection of multiple 
mineral environments with subtle differences in mineral composition and crystallinity. The 
results indicate that bone-producing capacity varies between cell culture systems, and that 
the bone tissue synthesized by each cell type contained different mineral and matrix environ-
ments, indicated by their different biomolecular Raman signatures. More work is required 
to further investigate the differences between in vitro mineralised nodules and native bone 
tissue {e.g. physical/mechanical properties), and to identify the 'best' cell culture system for 
laboratory-based engineering of bone-like tissue. 
This chapter also outlined exciting and promising avenues for future research, which 
describe the vast potential of Raman micro-spectroscopy to aid in the elucidation of the in-
tricate mechanisms of bone formation, and for bone tissue engineering applications, where the 
selection of cells and identification of optimal osteogenic culture conditions are of paramount 
importance. 
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Conclusions 
In this thesis, several novel biological applications of Raman micro-spectroscopy were devel-
oped. These applications were explored using an approach which combined Raman spectral 
analysis of live cell culture systems, advanced signal processing and multivariate statistical 
analysis to extract important biochemical information from Raman spectral signatures, and 
correlation of spectral analysis with validation results obtained using gold standard biological 
techniques. The versatility, high sensitivity and non-invasive sensing capabilities of Raman 
micro-spectroscopy were exploited to analyse live cell culture systems in situ, thereby avoid-
ing perturbation of biological systems induced by invasive sample preparation {e.g. fixation, 
dehydration, desiccation and embedding), which have been shown previously and in this the-
sis to potentially alter the biochemistry of biological samples. Digital signal processing is a 
powerful and convenient method to standardize spectral data to facilitate multivariate anal-
ysis, which enables robust, automated, and objective analysis of large, high-dimensional data 
sets. And parallel experiments employing gold standard techniques removes ambiguity and 
aids interpretation of spectral data with respect to the biological system under investigation. 
The biological processes examined here, namely cell cycle dynamics, cellular differenti-
ation, and bio-mineralisation, all involve changes in cellular biochemistry, which were suc-
cessfully detected and characterized using Raman micro-spectroscopy. A dedicated Raman 
micro-spectroscopy system optimized for real-time analysis of single living cells was used to 
characterize biochemical changes related to cell cycle dynamics within cells synchronized in 
different stages of the cell cycle, and to discriminate between cells synchronized in different 
phases based solely on their Raman spectra. The same approach facilitated the identifica-
tion of spectral markers which characterize the spontaneous in vitro differentiation of primary 
ATII cells to ATI-like cells. Significant changes in the Raman spectra were correlated to cel-
lular changes in morphology and marker protein synthesis, and linked to clearance of cellular 
C h a p t e r 7: Conc lus ions 
phospholipids during differentiation. Raman spectral phenotyping was then used to assess 
the suitability of A549 and TTl cell lines commonly used as models for primary ATII and 
ATI-like cells, respectively. Significant differences between A549 and ATII cells questioned 
the suitability of the A549 model cell line, while TTl cells were identified as an appropriate 
model for the ATI-like phenotype. Finally, Raman micro-spectroscopy was used to charac-
terize the in vitro mineralization by three different osteogenic cell cultures systems. Trends 
in mineralization were monitored for each system, and detailed univariate and multivariate 
analyses were used to identify spectral parameters and factors to distinguish between the 
mineral and matrix environments produced by each cell culture system and native bone 
tissue. 
In each study, multivariate statistical analyses were used to process high-dimensional data 
sets and to help understand complex spectral patterns. Robust chemometric techniques such 
as PCA, LDA, factor analysis and least-squares spectral modeling facilitated the qualitative 
and (semi-) quantitative analysis of Raman spectra to identify spectral changes and differences 
between sample groups. Interpreting spectral results with respect to the underlying biological 
phenomena was made possible by parallel characterization of the system with gold standard 
biological techniques. For the investigations presented here, these included flow cytometry, 
cytochemical/histochemical staining, immunocytochemistry, immunoblotting and FTIR. For 
Raman micro-spectroscopy to reach its full potential as a powerful technology for non-invasive 
analysis of live cell culture systems, the importance of such parallel experiments cannot be 
overemphasized. 
It is hoped that the promising results presented in this thesis will encourage more re-
searchers in biological Raman micro-spectroscopy to focus their efforts on the analysis of 
live cell culture systems, to avoid invasive and artefact-inducing sample preparation {e.g. 
fixation, embedding) which currently dominates the field, and to recognize the importance 
of independent characterization methods to validate results generated by spectral analysis. 
7.1 F u t u r e direct ions 
Potential avenues for future research were outlined at the end of each study. This final section 
briefly addresses general trends and potential future directions in the field of biological Raman 
micr o-sp ectroscopy. 
The field of optical diagnostics is growing ever more rapidly. Raman spectroscopy is 
at the forefront of this research, the ultimate aim of which includes both detection and 
diagnosis of diseases such as cancer [73, 75], atherosclerosis [249], arthritis [250], and 
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dermatological pathology [82]. For example, researchers have used Raman spectroscopy 
to study calcification in atherosclerotic plaques in vitro [251], with a view to real-time 
catheter-based examination in vivo. Cancer of intestinal, breast, uterine, laryngeal, skin 
and brain tissues have all been studied with Raman micro-spectroscopy, with the ultimate 
objective of replacing cancer biopsy with fibre-optic Raman spectroscopy. To this end, several 
researchers have developed compact Raman spectrometers fitted with fibre-optic probes to 
collect in vivo measurements [252, 253]. While in vivo Raman spectroscopy shows significant 
promise, adoption of this technology in the clinical setting will require further improvements 
in stability, reliability and speed of high-fidelity Raman measurements. Several excellent 
reviews on in vivo and clinical applications of Raman spectroscopy have been published 
[5, 50,67,66,254,255,256^ 
In the laboratory, applications of Raman micro-spectroscopy for biochemical analysis of 
cells and tissues is expected to grow as spectrometer systems become faster, more stable, 
and user-friendly. Further sophistication of biological technologies will increase the number 
of applications where Raman micro-spectroscopy is a suitable and attractive alternative to 
conventional characterization techniques. Optimization of Raman microprobe technology for 
cell biology platforms such as microarrays and multiple-well plates will encourage scientists 
to take advantage of automated analysis and high-throughput capability. The combination of 
Raman micro-spectroscopy with optical tweezers (LTRS, laser tweezers Raman spectroscopy) 
to study cells in suspension has generated impressive results [88], which show promise for 
the development of a non-invasive LTRS-based flow cytometry system, whereby cellular 
analysis is based on inherent cellular biochemical signatures rather than surface phenotype 
or fluorescent labels. The growth of biological applications of RRS, SERB, CARS, and 
other enhanced Raman techniques is also likely to continue, however, the increased technical 
complexity of these approaches over spontaneous (non-resonant) Raman micro-spectroscopy 
is likely to retard their routine use in biological laboratories compared with conventional 
Raman micro-spectroscopy. Increased communication between physical and life scientists 
will hopefully foster improvements in experimental protocols and analysis/interpretation 
of biological spectral data for conventional and enhanced Raman techniques. And linking 
researchers with clinicians is likely to prompt compilation of spectroscopic tissue databases 
in university and medical laboratories, which will doubtless facilitate clinical applications of 
Raman spectroscopy. 
The fact that no single characterization technique will ever be perfect or suitable for ev-
ery foreseeable application has spurred the development of several 'hybrid' modular systems, 
which offer dual characterization capacity. In these cases, the modalities often complement 
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or enhance each other. The most obvious and widely available combination is that of Raman 
and FTIR spectroscopy, available from several manufacturers. These systems offer complete 
vibrational spectroscopic characterization of samples, and offer 'same-spot' technology, which 
eliminates the need for sample re-positioning to acquire both Raman and FTIR spectra. Such 
a system would be ideal for analysis of bone and bone nodules, whereby Raman spectra of 
live, fixed, and then desiccated bone nodules could be acquired before ATR-FTIR analysis 
of the same nodules using a single piece of equipment. More recently, van Apeldoorn et al. 
developed a parallel high-resolution confocal Raman spectrometer and scanning electron mi-
croscope (SEM) to analyse inorganic and organic bone matrix constituents [205]. Although 
SEM sample preparation is invasive, this system combines non-destructive ultrastructural 
and chemical data analysis at high resolution, and is therefore useful when both of these 
features are relevant to an investigation. A development that holds significant potential for 
cell biology applications is the hybrid confocal Raman-fluorescence micro-spectrometer de-
veloped by van Manen et al. [257]. This system has been used to analyse fiavocytochrome 
bgsg in neutrophilic granulocytes labeled with semiconductor fluorescent quantum dots, and 
to study the association between lipid bodies and phagosomes within single leukocytes [56]. 
Raman micro-spectroscopy has also been combined with atomic force microscopy (AFM), 
offering automated nondestructive chemical and high resolution topographical imaging with 
the same system and software environment. The simultaneous acquisition of data using 
Raman-AFM, also known as tip-enhanced Raman spectroscopy (TERS), enables researchers 
to beat the diffraction limit, as the AFM tip acts as an aperture to collect Raman scat-
tered light from areas less than 200 nm [258]. This cutting-edge technique has been used 
to biological alginates [259] and silicon nanowires with a view to analysis of single strands 
of DNA [260]. By coating the AFM tips in gold, silver, or another SERS-active material, 
significant signal enhancement can be obtained to aid in the characterization of materials 
on the nanoscale. It is likely that hybrid systems such as these will become more popular in 
the future, and will help to promote the use of Raman micro-spectroscopy for non-invasive 
chemical analysis of biological samples. 
With regard to live cell spectroscopy and imaging, future improvements in spectroscopic 
instrumentation and computing power will lead to shorter scan times, so that hyperspectral 
Raman chemical imaging of single living cells may become possible. The development of 
new ultrafast confocal Raman micro-spectrometers such as the WITec alpha-series, which is 
capable of collecting 40,000 Raman spectra in only 42 seconds, is a promising step in the 
right direction. 
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A p p e n d i x A 
Peak assignments 
Assignment 
P e a k ( c m - 1 ) D N A / R N A P r o t e i n s L i p i d s 
1 ,736 C = 0 e s t e r 
1,655-1,680 A m i d e I C = C s t r . 
1^17 C=C Tyr, Trp 
1^ 07 C = C P h e , T y r 
^^ 78 G , A 
1,420-1,480 G , A , C H def C H def C H def 
^^ 42 A,G 
1,320 G 
IJOl C H 2 t w i s t 1,220-1,284 T , A A m i d e I I I = C H b e n d 
1 ,209 C-CoHg str. 
P h e , T r p 
1^ 76 C - H b e n d T y r 
1J58 C-C/C-N str. 
l j j8 C—N str. 
1,060-1,096 P O g s t r . C h a i n C - C s t r . 
1,033 C - H in—plane P h e 
1,003 S y m . R i n g b r P h e 980 C - C B K s t r . = C H b e n d 
937 C - C B K s t r . 
ck—helix 
C - C - N " ^ s y m s t r . 
877 
854 R i n g b r T y r 
828 O - P - O a s y m s t r . R i n g b r T y r 
811 O-P-O str. RNA 
788 O-P-O str. DMA 
782 U , C , T r i n g b r 
760 R i n g b r e a t h T r p 
729 A 
717 C N + ( C H 3 ) 3 s y m 667 T , G 
645 C—C twist Tyr 621 C - C t w i s t P h e 
C a r b o h y d r a t e s 
CHdd 
CHAd 
C - O s t r . 
C—O, C—C s t r . 
C - O — C glycoB. 
b o n d C - O - C r i n g 
Table A-1; Prominent Raman frequencies in cellular spectra and their assignments. Abbreviations: str, 
stretching; def, deformation vibration; sym, symmetric; asym, asymmetric; bk, backbone vibration; U, C, 
T, A, G, ring breathing modes of the DNA/RNA bases uracil, cytosine, thymine, adenine, and guanine, 
respectively; Try, tyrosine; Trp, tryptophan; and Phe, phenylalanine. Reproduced from [90]. 
A p p e n d i x B 
Supplementary information for 
Chapter 4 
A 
Day 4 Day 11 Day 18 
B 
pSPC 
Day 4 Day 11 Day 18 Day 18 control 
Figure B-1: Characterization of primary ATII cell differentiation. A Positive ALP and B pSPC staining of 
human ATII cells grown on MgF2 coverslips. 
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600 800 1000 1200 
Raman shift (cm" ) 
1400 
-1, 1600 1800 
Figure B-2: Spectrum 1: Raman spectrum of DMEM culture medium. Spectrum 2: Raman spectrum 
collected from a thin cytoplasmic attenuation in a flattened, ATI-like cell (late time point, dl7-18). Each 
spectrum was integrated for 40 seconds (R=0.90). The spectra have been intensity and baseline corrected, 
scaled to unity maximum intensity, and are offset for clarity. 
.1 
I 
600 800 1000 1200 
Raman shift (cm 
1400 
-1\ 
1600 1800 
Figure B-3: Interpreting PCI ; comparison of PCI (spectrum 1) with the difference spectrum (spectrum 2) 
between the mean of early and late time point ATII cell spectra (R=0.84). The spectra have been normalised 
to absolute maximum intensity values and are offset for clarity. 
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A p p e n d i x B : S u p p l e m e n t a r y i n f o r m a t i o n for C h a p t e r 4 
600 800 1000 1200 
Raman shift (cm~ 
1600 1800 
F i g u r e B-4: Comparison of the protein factor (spectrum 1) generated by eigenvector rotation of significant 
PCs and a model protein spectrum generated by least-squares fitting (R=0.98). The spectra have been 
normalised to maximum intensity values and are offset for clarity. 
3 
.1 
t 
W 
c 
Middle 
f 
600 800 1000 1200 1400 
Raman shifft (cm"^) 
1600 1800 
F i g u r e B-5 : Spectral modelling of middle and late time point ATII cells with Raman micro-spectroscopy: 
The mean spectra of middle and late time point cells are shown in black, the model fits in gray, and the 
residual spectra in black (R=0.996 for each fit). 
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A p p e n d i x B ; S u p p l e m e n t a r y i n f o r m a t i o n f o r C h a p t e r 4 
c 3 
0.65 (• 
0.6^  
g 
5 0.55 
5 
0 0.5 • 
o 
% 
8 0.451 
1 Q_ 
0.4 -
o Early (d3-4) 
» Late (d 17-18) 
0.35 -
O.3L 
o m 
y=-0.76x+0.73 
R =0.96 
0.1 0.2 0.3 0.4 
Lipid fit coefficient (arbitrary units) 
F i g u r e B - 6 : Model-predicted fit coefficient of protein versus fit coefficient of lipid for all ATII cells analyzed 
a t t he three t ime points. T h e d a t a has not been scaled/normalised to represent percent relative signal 
contr ibution, and is expressed in arb i t rary units. T h e line-of-best-fit is plot ted and the regression parameters 
and coefficient of determinat ion (R^) are reported. 
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Caveolin-1 western blot 
Cav-1a 
Cav-1 p 
I > > > c H 
< — — — 
m a. a. Q. o a 01 U >< << 
00 
> 
u> 
F i g u r e C-1; Western blot of caveolin-1 expression from ATII, A549 and T T l cells, indicating weak positive 
expression of both a - and /3-isoforms by A549 cells. HUVEC represents the positive control. 
A p p e n d i x C: Supplementary informat ion for Chapter 5 
c 
3 
I I 
t § 
600 800 1000 1200 1400 
Raman shift (cm~^) 
1600 1800 
Figure C-2: Additional factors generated by eigenvector rotation. These factors do not represent pure 
biochemical component spectra; rather they represent correlated spectral features from multiple components 
(e.g. protein and lipid, protein and nucleic acids), and also describe minor shifts in some of the peaks. The 
zero-line represents an empty factor. The factor describing residual noise is not included. 
Raman-predicted 
phenotype 
Phenotype ATI-like TT l 
ATI-like 124 1 
TT l 0 56 
Sensitivity (%) 99 100 
Specificity (%) 100 98 
Table C-1: LDA-based phenotype classification accuracy between ATI-like and T T l cells, as assessed by 
leave-one-out cross-validation. 
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A p p e n d i x C: S u p p l e m e n t a r y i n f o r m a t i o n for C h a p t e r 5 
1200 
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Q 400 
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o 
-400 
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F i g u r e C-3: LDA comparing only ATI-like and T T l cells. LDA scores were computed by project ing scores 
on the first 25 P C s onto the single linear discriminant funct ion L D l . 
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Bone nodule damage dur ing A T R - F T I R measuremen t s 
Before After 
F i g u r e D-1: Bone nodule damage with contact ATR-FTIR measurements: light microscope (epi-illumination 
configuration) pictures of desiccated bone nodules before & after contact with ATR-FTIR crystal. 
A p p e n d i x D: S u p p l e m e n t a r y in format ion for Chapter 6 
T h e effects of bone nodule f ixat ion and desiccation 
Pleshko et al used FTIR to examine the effects of fixation on bone tissue, and found that 
different fixatives had an adverse affect on different bone tissue components, e.g. formahn 
on mineral structure, and ethanol on matrix proteins [223]. Considering that these two 
biological preservatives are widely used in preparation of bone tissue samples for a number 
of characterisation techniques {e.g. EM, histochemical staining, etc.), it is clear that the 
choice of fixative should be carefully considered, depending on what bone fraction is under 
scrutiny [212]. Furthermore, it also implies that characterisation techniques where these 
preservatives are required for sample processing preclude reliable, simultaneous analysis of 
both mineral and matrix components of bone tissue. 
As shown in Chapter 6, Raman micro-spectroscopy enables the non-invasive analysis of 
in vitro mineralisation by live osteogenic cell culture systems in the absence of fixatives or 
labels. However, most Raman investigations involve fixed and/or dehydrated bone [59] and 
bone nodule samples [226]. Yeni et al. performed a detailed analysis of the effect of fixation 
and embedding on the Raman spectral properties of bone tissue [11], which complemented 
Pleshko's earlier FTIR investigations. They found that both fixation and embedding had 
significant effects on the Raman spectral properties of bone tissue, and expressed concern 
that these processing steps may alter the composition and physicochemical status of bone 
tissue, resulting in alterations in the spectral parameters such as mineralisation, mineral 
crystallinity, and non-stoichiometric substitutions to the mineral crystal lattice. 
As a preliminary investigation into the effects of formalin fixation on the Raman spectra 
of bone nodules, Raman spectra of bone nodules at day 32 (d32) in live mES cell cultures 
were collected, and then spectra from identical positions within the same nodules collected 
after they had been fixed with formalin and rinsed with dHgO. In both cases, spectra were 
collected in DMEM with 1% P/S maintained at 37°C with a heated stage. A picture of a 
mES nodule is included in Figure D-2, along with a plot of normafised maximum intensity 
of the POl" vi stretch against spectrum number (matching the positions indicated in the 
picture of the nodule). Note the lack of well-defined margins on the mES nodule, which is 
surrounded by an extensive mineral sheet. The plot in Figure D-2B indicates that there is 
significant variation in signal intensity between live and fixed nodules at several positions, 
suggesting that the effects of fixation are not uniform across the nodule. Significant intensity 
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variations were also observed in several other mineral (CO3 ui stretch) and matrix peaks 
(amide III, CH2 wag, and amide I). 
Live 
• - Fixed 
2 3 4 5 
Spectrum number 
F i g u r e D-2 : Effects of fixation on Raman spectral properties of a mES bone nodule (d32). A The nodule 
in live cell culture, with the sites of spectral acquisition indicated. B The normalised Raman intensity of the 
PO®" stretch (~960 cm"^) at sites 1 through 7 for the live (sohd line) and fixed nodule (dash-dot line). 
The variation in spectral intensity indicates tha t the effects of fixation are not uniform across the nodule. 
Similar intensity differences were observed in other mineral and matrix peaks. Scalebar = 20 ^m. 
A Raman micro-spectroscopic mapping experiment of an mES nodule at d32 was con-
ducted to further investigate the effects of fixation. A 10 x 10 grid was defined on a nodule 
(Figure D-3A) with the origin at the centre of the nodule, and spectra were collected at 20 fXYn 
intervals, i.e. at positions x = —90, —70, —50,. . . ,90 for positions y = —90, —70, —50,... , 90, 
and repeated this procedure after fixing the nodule with formalin. Each spectrum was in-
tegrated for only 10 seconds, rather than the 100 seconds used in our main bone nodule 
study. Thus 100 spectra were collected from the live nodule and an additional 100 spectra 
from the same positions in the fixed nodule. After background subtraction, the peak area 
of the vi band was computed to approximate the mineral content at each position, 
normalised to the maximum value of the live data set, and plotted on 10 x 10 grids (Fig-
ures D-3C, D). The color scales of the maps are described by the colorbar, with red pixels 
corresponding to higher peak areas {i.e. higher mineral content), and blue pixels describing 
low peak areas. The circular shape of the nodule is noticeable by the cluster of red pixels in 
the centre of each color map. Note the presence of relatively intense phosphate scattering 
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in spectra surrounding the main body of the nodule, indicating the presence of an extensive 
mineral sheet in mES cell culture. The results confirm that the effects of fixation were not 
uniform across the nodule, for if they were, roughly similar patterns in the colormap of both 
live and fixed nodules would be observed. To study the effects of fixation on mineral gradi-
ents across the nodule, the normalised peak areas along the third row of the colormaps in 
Figures D-3C and D (the position of this line across the nodule is indicated by an arrow) 
were plotted in Figure D-3B. The plot indicates significant variation in the normalised area 
of the phosphate mineral peak between live and fixed samples, and that the non-uniform 
effects of fixation follow no discernable pattern. Although the color maps shown here were 
based on univariate analysis of the vi stretch, similar results were obtained by plotting 
score values generated by multivariate factor analysis. 
c l 
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F i g u r e D-3: Effects of fixation on Raman spectral properties of an mES bone nodule (d32). A The nodule 
in live cell culture. B Normalised area of the PO^" i/i stretch (~960 cm~^) at sites 1 through 10 for the 
live (solid line) and fixed nodule (dash-dot line), along the third row of spectra (indicated by white line in 
A). C Pseudo colour map of normalised areas computed from spectral map of live and D fixed bone nodule. 
The colorbar indicates the scale (red pixels correspond to higher peak areas and hence mineral content). The 
variation in peak areas between live and fixed samples manifests as colour differences between corresponding 
pixels. The arrow indicates the row of 10 spectra plotted in B. Scalebar = 20 jum. 
In addition to fixation of bone samples prior to analysis, several characterisation tech-
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niques, including alizarin red staining and ATR-FTIR, require cultures to be dehydrated/desiccated 
prior to analysis. Sample dehydration is likely to irreversibly alter the structure of proteins 
within the organic matrix of bone, and may also influence the mineral phase. To determine 
if this was indeed the case, Raman spectra of a mBMSC nodule at d28 were collected before 
and after rinsing with dHgO and subsequent desiccation (Figure D-4). Note the slight change 
in the shape of the nodule after desiccation. Spectra of the nodule in live cell culture was 
collected with a x63 objective immersed in DMEM with 1% P/S maintained at 37°C, while 
spectra of the desiccated nodule were collected with a x50 air objective. Spectra were in-
tegrated for 100 seconds in both cases. Light microscope pictures of the live and desiccated 
nodule are shown in Figures D-4B and C, respectively. The sites of spectral acquisition 2, 
4, 6, 8, 10 in the live nodule correspond to sites 1, 2, 3, 4, 5 in the dried/desiccated nod-
ule. This label arrangement was done to facilitate plotting and comparison of the spectra in 
Figure D-4A. Here, adjacent spectra represent the Raman spectra collected from the same 
sites in the dried versus live nodule, e.g. spectrum 1 pairs with spectrum 2, 3 with 4, . . . , 
and 9 with 10. It is clear that the signal intensity is generally lower in the scans of the 
desiccated rather than the live nodule, especially in the case of the PO^" stretch at -^960 
cm"^ and COg" stretch at ^1072 cm" \ This was confirmed by plotting the PO^" and 
COg" vi band areas for the five spectra from the live and desiccated bone nodule in Fig-
ures D-5A and B, respectively. The plots indicate that differences in peak areas from site to 
site follow broadly similar trends between the lived and desiccated nodule, but that the peak 
areas are much lower in the desiccated nodule. Plots of carbonate: phosphate and mineral: 
matrix ratios in Figures D-5C and D indicate that values of these spectral parameters are 
significantly underestimated in the desiccated nodule than in the live nodule, suggesting 
that some biochemical changes have taken place during the desiccation process. A shift of 
~1.5 cm"^ in the mean position of the PO^" ui stretch was also detected in spectra of the 
desiccated nodule, which could indicate an increase in mineral crystallinity with desicca-
tion. These results demonstrate the detrimental effects of invasive sample preparation, and 
highlight how fixation- and desiccation-induced artefacts in Raman spectra of bone nodules 
can hinder both qualitative and quantitative analysis. These findings also emphasize the 
importance of analyzing live, unfixed osteogenic cell culture systems when studying miner-
alisation in vitro, for which Raman micro-spectroscopy is uniquely suited and currently the 
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only available technology. 
600 800 1000 1200 1400 1600 1800 Spectrum 
Raman shift (cm ) 
F i g u r e D-4: Effects of desiccation on Raman spectral properties of a mBMSC bone nodule (d28). A 
Raman spectra collected from the same spatial locations in a bone nodule in B live cell culture, and C after 
desiccation. The sites of spectral acquisition are also indicated (site 2 corresponds to site 1, 4 to 3, etc.). In 
A , adjacent spectra {e.g. 1 and 2, 3 and 4, etc.) correspond to spectra collected from the same locations in 
the desiccated and live nodule. Scalebar = 25 /im. 
Posit ive collagen II s ta ining of M O B &: m B M S C cul tures 
Both MOB and mBMSC cultures were stained for Col II dl4 to investigate the production 
of Col II (Figure D-6). Both cultures show positive staining for Col II. A section of cartilage 
tissue was used as a positive control. 
A T R - F T I R analysis of M O B & m B M S C bone nodules 
Characterisation of MOB (Figure D-7) and mBMSC (Figure D-8) bone nodules at d28 was 
assessed with ATR-FTIR. 
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F i g u r e D-5 : Effects of desiccation on Raman spectral properties of a mBMSC bone nodule (d28). A 
PO4" and B COg" 1^ 1 band areas for the five measurements collected from a bone nodule in live cell 
culture and then desiccated. C Carbonate: phosphate and D minerahmatrix ratios calculated from the 
measurements in A, B , and matrix peak areas (not shown). 
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Cartilage section Negative 
MOB d14 mBMSC d14 
F i g u r e D-6: Positive staining for Col II in d l 4 mBMSC cultures. A section of cartilage tissue was used as 
a positive control. 
Spec t rum 
W a v e n u m b e r (cm" ) 
F i g u r e D-7 : FTIR spectra collected from a bone nodule from d28 MOB cell culture. The spectra indicate 
mineral and matrix variation across the linescan. The sites of spectral acquisition are indicated. Scalebar = 
50 fxm. 
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S p e c t r u m 
W a v e n u m b e r (cm" ) 
F i g u r e D-8 : FTIR spectra collected from a bone nodule from d28 niBMSC cell culture. The spectra indicate 
mineral and matrix variation across the linescan. The sites of spectral acquisition are indicated. Scalebar = 
50 fim. 
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